uric acid has been researched along with Kidney Failure, Chronic in 510 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These data suggest that factors other than uric acid may play a more important role in the regulation of CKD- MBD including vascular calcification and vitamin D metabolism in patients with CKD." | 9.27 | Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial. ( Andrews, ES; Chonchol, M; Jalal, D; Kendrick, J; Nowak, KL; Pasch, A; Perrenoud, L; You, Z, 2018) |
| "We evaluated the association between baseline uric acid and the primary composite outcome of doubling of interstitium or ESRD from interstitial fibrosis and tubular atrophy (IF/TA) in the Angiotensin II Blockade for Chronic Allograft Nephropathy (ABCAN) Trial participants." | 9.19 | Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. ( Hart, A; Ibrahim, HN; Jackson, S; Kasiske, BL; Matas, AJ; Mauer, MS; Najafian, B; Spong, R, 2014) |
| "It is known that chronic renal insufficiency (CRI) patients with gout may have subtle lead poisoning." | 9.09 | Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout. ( Ho, HH; Lin, JL; Lin-Tan, DT; Yu, CC, 2001) |
| " In the present study, blood triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP) breakdown pathway was evaluated in relation to uric acid concentration and xanthine dehydrogenase/xanthine oxidase (XDH/XO) in patients with essential hypertension, patients with chronic renal diseases on dialysis, and control individuals." | 7.80 | Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease. ( Boban, M; Bobana, MD; Cvetkovic, T; Deljanin-Ilic, M; Djindjic, B; Ilic, S; Jevtovic-Stoimenov, T; Kocic, G; Pavlovic, R; Radenkovic, S; Sokolovic, D; Stojanovic, D, 2014) |
| "Elevated serum uric acid has been associated with a variety of cardiovascular disease and with inflammation, but these have been little explored in chronic kidney disease (CKD)." | 7.79 | Is there association between uric acid and inflammation in hemodialysis patients? ( Carraro-Eduardo, JC; da Nóbrega, AC; Lobo, JC; Mafra, D; Stockler-Pinto, MB, 2013) |
| "Elevated serum uric acid (sUA) is usually associated with a high occurrence of acute ischemic stroke (AIS) in the general population." | 7.77 | Serum uric acid is inversely related to acute ischemic stroke morbidity in hemodialysis patients. ( Chen, Y; Ding, X; Fang, Y; Liu, Z; Shen, B; Teng, J; Wang, Y; Xu, S; Zhong, Y; Zou, J, 2011) |
| "Allopurinol was administered to end-stage renal disease (ESRD) patients with elevated uric acid levels presenting with symptoms of gout and also had risk factors of metabolic syndrome." | 7.75 | The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. ( Beavers, D; Bowden, RG; Hartman, J; Shelmadine, B; Wilson, RL, 2009) |
| "An unusual case with kidney stones composed mainly of 1-methyluric acid is described." | 7.73 | An unusual patient with kidney stones composed of 1-methyluric acid. ( Bending, MR; Davies, PM; Fairbanks, LD; Safranow, K; Simmonds, HA, 2006) |
| "Primary gout is characterized by increased plasma and decreased urinary concentrations of hypoxanthine, xanthine and uric acid." | 7.69 | Purine metabolism in patients with gout: the role of lead. ( Herrero, E; Mateos, FA; Miranda-Carús, E; Puig, JG; Ramos, T; Sanz, AG, 1997) |
| "We reviewed the clinical features and uric acid metabolism in 37 female patients with gout." | 7.68 | Female gout. Clinical spectrum and uric acid metabolism. ( Capitán, CF; de Miguel, E; Gijón, JB; Jiménez, ML; Mateos, FA; Michán, AD; Pérez de Ayala, C; Puig, JG, 1991) |
| "A patient with intractable tophaceous gout and advanced renal failure responded favorably to treatment by long-term hemodialysis and administration of allopurinol." | 7.66 | Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol. ( Johnson, WJ; O'Duffy, JD, 1979) |
| "From these data it emerges that hyperaldosteronism, as observed in these patients with CRI, is a relatively reliable marker of the extent of CRI and may occur independently of the activation of the RAA system, given that other factors, such as orthostatic stimulation, alterations in the acid-base equilibrium, and the degree of aldosterone hepatic and urinary clearance, contribute to its pathogenesis." | 5.29 | [Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]. ( Buracchi, P; Carletti, F; Gennari, C; Lucani, B; Martinelli, M; Nami, R; Panza, F; Pavese, G; Saia, F, 1993) |
| "These data suggest that factors other than uric acid may play a more important role in the regulation of CKD- MBD including vascular calcification and vitamin D metabolism in patients with CKD." | 5.27 | Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial. ( Andrews, ES; Chonchol, M; Jalal, D; Kendrick, J; Nowak, KL; Pasch, A; Perrenoud, L; You, Z, 2018) |
| "Changes in systolic blood pressure (SBP), albuminuria, potassium, haemoglobin, cholesterol and uric acid after 6 months of losartan treatment were assessed in the RENAAL database." | 5.20 | The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers. ( de Zeeuw, D; Lambers Heerspink, HJ; Parving, HH; Rossing, P; Schievink, B, 2015) |
| "We evaluated the association between baseline uric acid and the primary composite outcome of doubling of interstitium or ESRD from interstitial fibrosis and tubular atrophy (IF/TA) in the Angiotensin II Blockade for Chronic Allograft Nephropathy (ABCAN) Trial participants." | 5.19 | Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial. ( Hart, A; Ibrahim, HN; Jackson, S; Kasiske, BL; Matas, AJ; Mauer, MS; Najafian, B; Spong, R, 2014) |
| "Hyperuricemia is prevalent in patients with chronic kidney disease (CKD); however, data are limited about the relationship of uric acid levels with long-term outcomes in this patient population." | 5.14 | Uric acid and long-term outcomes in CKD. ( Beck, GJ; Collins, AJ; Greene, T; Kusek, JW; Levey, AS; Madero, M; Menon, V; Sarnak, MJ; Wang, X, 2009) |
| " High-serum uric acid can trigger renal inflammation." | 5.12 | The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy. ( Fu, P; Ma, L; Wen, L; Yang, H, 2021) |
| "Fenofibrate is a potent hypolipemic agent, widely used in patients with mild to severe renal failure in whom hyperlipoproteinemia is frequent." | 5.09 | [Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency]. ( Achard, JM; el Esper, N; Fournier, A; Hottelart, C; Pruna, A, 1999) |
| "It is known that chronic renal insufficiency (CRI) patients with gout may have subtle lead poisoning." | 5.09 | Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout. ( Ho, HH; Lin, JL; Lin-Tan, DT; Yu, CC, 2001) |
| "To evaluate the potential therapeutic value of calcium antagonists in hypertension associated with impaired renal function, blood pressure (BP), certain regulatory factors, and metabolic correlates of cardiovascular risk have been assessed in 15 patients with mild to marked chronic renal failure before and after 6 weeks of therapy with nitrendipine." | 5.06 | Antihypertensive and hypouricaemic effects of nitrendipine in chronic renal failure. ( Gnädinger, MP; Jahn, H; Riesen, W; Schohn, D; Weidmann, P, 1989) |
| " It has been observed that treatment of hyperuricemia with allopurinol in chronic kidney failure has resulted in a fall in blood pressure and inhibition of the progression of kidney injury." | 4.90 | Aggravation of immunoglobulin a nephropathy by hyperuricemia: a mini-review on current findings and new concepts. ( Baradaran, A; Nasri, H, 2014) |
| "(a) To examine the latest information about renal tubular handling of uric acid, its genetic background and contribution to the causation of hyperuricemia." | 4.88 | Hyperuricemia, gout and the kidney. ( Gibson, T, 2012) |
| " Early markers of CVD such as microalbuminuria and uric acid levels need to be added to the routine annual evaluation, particularly among high-risk individuals such as diabetics, hypertensives, smokers, and the elderly." | 4.85 | Chronic kidney disease: a marker of cardiovascular disease. ( Nguyen, PT; Olivero, JJ, 2009) |
| "Gout is the most common form of inflammatory arthritis and is caused by deposition of monosodium urate crystals resulting from a high burden of uric acid (UA)." | 4.12 | Urate-lowering therapy for patients with gout on hemodialysis. ( Alkilany, R; Antonelli, M; Einstadter, D, 2022) |
| "Hyperuricemia is highly prevalent in chronic kidney disease (CKD) patients, but the evidence for a relationship between uric acid (UA) and clinical outcomes in CKD patients is limited and inconsistent." | 4.02 | Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study. ( Ito, S; Miyazaki, M; Nakayama, M; Sato, H; Watanabe, K; Yamada, G; Yamamoto, T, 2021) |
| "This is a medical records review study of 348 hyperuricemia patients identified in 2015, as having been followed with serial uric acid measurements." | 3.91 | Effect of Uric Acid Control on Serum Creatinine. ( Block, C; Field, C; Li, Z; Taylor, T; Xie, J; Yamamoto, T, 2019) |
| "Hyperuricemia is common in chronic kidney disease (CKD), but data regarding the relationship between serum uric acid levels and the long-term outcomes of CKD patients have been limited." | 3.80 | Serum uric acid levels and long-term outcomes in chronic kidney disease. ( Miyaoka, T; Mochizuki, T; Nitta, K; Takei, T; Tsuchiya, K, 2014) |
| "Over a 20-year period, patients on dapagliflozin were projected to experience relative reductions in the incidence of myocardial infarction (MI), stroke, CV death, and all-cause death of 13." | 3.80 | Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes. ( Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J, 2014) |
| " In the present study, blood triphosphate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP) breakdown pathway was evaluated in relation to uric acid concentration and xanthine dehydrogenase/xanthine oxidase (XDH/XO) in patients with essential hypertension, patients with chronic renal diseases on dialysis, and control individuals." | 3.80 | Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease. ( Boban, M; Bobana, MD; Cvetkovic, T; Deljanin-Ilic, M; Djindjic, B; Ilic, S; Jevtovic-Stoimenov, T; Kocic, G; Pavlovic, R; Radenkovic, S; Sokolovic, D; Stojanovic, D, 2014) |
| " The Child-Pugh score, preoperative serum uric acid and proteinuria may be used to predict the risk of post-TACE AKI in HCC patients undergo TACE." | 3.80 | Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma. ( Ding, Y; Du, L; Hao, L; Hou, C; Lu, D; Lv, W; Wang, R; Zhou, C, 2014) |
| " As a potentially modifiable risk factor, we examined whether serum uric acid levels correlate with early hypertension, kidney volume and progression to end-stage renal disease (ESRD) in autosomal-dominant polycystic kidney disease (ADPKD)." | 3.79 | Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease. ( Fick-Brosnahan, GM; Helal, I; McFann, K; Reed, B; Schrier, RW; Yan, XD, 2013) |
| "At the same glomerular filtration rate (GFR), there was no significant difference in the levels of 24 hours proteinuria, blood urea nitrogen (BUN), and serum creatinine between the two groups with different levels of serum uric acid (p > 0." | 3.79 | Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up. ( Cheng, GY; Liu, DW; Liu, ZS; Tang, L; Zhang, N; Zhao, ZZ, 2013) |
| "Elevated serum uric acid has been associated with a variety of cardiovascular disease and with inflammation, but these have been little explored in chronic kidney disease (CKD)." | 3.79 | Is there association between uric acid and inflammation in hemodialysis patients? ( Carraro-Eduardo, JC; da Nóbrega, AC; Lobo, JC; Mafra, D; Stockler-Pinto, MB, 2013) |
| "We investigated the relationship among serum cardiac biomarkers including N-terminal pro-brain natriuretic peptide (NT-pro-BNP), cardiac troponin T (cTnT), uric acid and high-sensitive C-reactive protein (hs-CRP) and noninvasive predictors of atherosclerosis including carotid intima-media thickness (IMT), aortic stiffness (pulse wave velocity (PWV)) and transthoracic coronary flow reserve (CFR) in peritoneal dialysis (PD) patients." | 3.78 | Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients. ( Akagun, T; Alpay, N; Bozfakioglu, S; Caliskan, Y; Ecder, T; Guz, G; Ozkok, A; Polat, N; Tufan, F, 2012) |
| "Elevated serum uric acid (sUA) is usually associated with a high occurrence of acute ischemic stroke (AIS) in the general population." | 3.77 | Serum uric acid is inversely related to acute ischemic stroke morbidity in hemodialysis patients. ( Chen, Y; Ding, X; Fang, Y; Liu, Z; Shen, B; Teng, J; Wang, Y; Xu, S; Zhong, Y; Zou, J, 2011) |
| " Univariate logistic regression analysis revealed a significant association between the onset of CKD and age, male gender, body mass index, blood pressure, fasting plasma glucose, dyslipidemia and uric acid." | 3.77 | Uric acid levels predict future development of chronic kidney disease. ( Dohi, Y; Kimura, G; Sonoda, H; Takase, H, 2011) |
| "Hyperuricemia was defined as a serum uric acid concentration of at least 7." | 3.77 | Hyperuricemia after renal transplantation. ( Einollahi, B; Hossieni, MS; Kalantar, E; Khalili, N; Rostami, Z, 2011) |
| "Serum uric acid (UA) is positively associated with hypertension (HTN)." | 3.77 | Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients. ( Feig, DI; Goldstein, SL; Mattison, P; Midgley, L; Moudgil, A; Silverstein, DM; Srivaths, PR; Upadhyay, K, 2011) |
| "To study the prevalence of chronic kidney disease (CKD) and its impact on allopurinol dosing and uric acid control among patients with gout." | 3.77 | Chronic kidney disease in gout in a managed care setting. ( Dabbous, O; Fuldeore, MJ; Krishnan, E; Pandya, BJ; Riedel, AA; Zarotsky, V, 2011) |
| "We have retrospectively evaluated the uric acid control status and renal function changes over a period of up to 7 years in 35 patients with renal impairment who had stage 3 or higher chronic kidney disease (CKD; stage 3 in 32 patients, stage 4 in 2 patients, and stage 5 in 1 patient) associated with hyperuricemia and were receiving monotherapy with benzbromarone as an antihyperuricemic drug." | 3.77 | Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease. ( Fujimori, S; Moromizato, H; Ooyama, H; Ooyama, K, 2011) |
| "Because approximately 70% of uric acid is excreted from the kidney, hyperuricemia occurs when renal function deteriorates." | 3.77 | Relationship between hyperuricemia and chronic kidney disease. ( Ohno, I, 2011) |
| " In this study, we sought to research the relationship between the insulin resistance, which is one of the risk factors for CVD, and the inflammation markers, especially C-reactive protein, fibrinogen, uric acid, and homocysteine levels in our patients who were recently diagnosed with ESRD and started hemodialysis." | 3.76 | Relationship between insulin resistance and inflamation markers in hemodialysis patients. ( Binici, DN; Borazan, A, 2010) |
| "Clinical studies have suggested that high levels of uric acid may contribute to the development of hypertension and kidney disease." | 3.76 | High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease. ( Choovichian, P; Duangurai, K; Kanjanakul, I; Nata, N; Phulsuksombuti, D; Satirapoj, B; Supasyndh, O; Utennam, D, 2010) |
| "Low serum uric acid is a mortality risk factor in incident hemodialysis patients with a high comorbidity burden and hypoalbuminemia." | 3.75 | Low serum uric acid level is a risk factor for death in incident hemodialysis patients. ( Jaleel, M; Johnson, RJ; Lee, AL; Lee, SM; Stenvinkel, P; Tam, E; Winters, TJ, 2009) |
| " Lower hemoglobin level, higher serum uric acid level, self-reported history of nocturia, and family history of kidney disease are independent risk factors for ESRD." | 3.75 | Risk factors for end-stage renal disease: 25-year follow-up. ( Darbinian, J; Go, AS; Hsu, CY; Iribarren, C; McCulloch, CE, 2009) |
| "Allopurinol was administered to end-stage renal disease (ESRD) patients with elevated uric acid levels presenting with symptoms of gout and also had risk factors of metabolic syndrome." | 3.75 | The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. ( Beavers, D; Bowden, RG; Hartman, J; Shelmadine, B; Wilson, RL, 2009) |
| "The aim of this study is to evaluate connection of plasma level of beta2-microglobulin, C-reactive protein and uric acid as well as sonographic parameters like thickness of synovial membrane, thickness of femoral condylar cartilage and presence of joint effusion and Baker's cysts with bilateral knee pain in dialyzed patients, comparing them with parameters in asymptomatic dialyzed patients." | 3.74 | Laboratory and sonographic findings in dialyzed patients with bilateral chronic knee pain versus dialyzed asymptomatic patients. ( Barisić, I; Bekavac, J; Janković, S; Ljutić, D; Vlak, T, 2007) |
| "An unusual case with kidney stones composed mainly of 1-methyluric acid is described." | 3.73 | An unusual patient with kidney stones composed of 1-methyluric acid. ( Bending, MR; Davies, PM; Fairbanks, LD; Safranow, K; Simmonds, HA, 2006) |
| " The cardinal clinical features in individuals with the uromodulin mutation included hyperuricemia, decreased fractional excretion of uric acid, and chronic interstitial renal disease leading to end-stage renal disease (ESRD) in the fifth through seventh decade." | 3.72 | Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. ( Bleyer, AJ; Deterding, E; Ganier, D; Gorry, MC; Hart, TC; McBride, D; Sandhu, J; Satko, SG; Shihabi, Z; Weller, N; Woodard, AS; Xu, L; Zhu, H, 2003) |
| "We studied 34 apparently healthy children and 2 propositi from kindreds with familial juvenile hyperuricaemic nephropathy (FJHN) - a disorder characterised by early onset, hyperuricaemia, gout, familial renal disease and a similarly low urate clearance relative to glomerular filtration rate (GFR) [fractional excretion of uric acid (FEur) 5." | 3.70 | Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children. ( Cameron, JS; Dalton, N; Haycock, GB; McBride, MB; Moro, F; Ogg, CS; Raman, GV; Rees, L; Rigden, S; Simmonds, HA; Van't Hoff, W, 1998) |
| "Primary gout is characterized by increased plasma and decreased urinary concentrations of hypoxanthine, xanthine and uric acid." | 3.69 | Purine metabolism in patients with gout: the role of lead. ( Herrero, E; Mateos, FA; Miranda-Carús, E; Puig, JG; Ramos, T; Sanz, AG, 1997) |
| " 51Chromium-ethylenediamine tetraacetic acid, para-amino hippuric acid, lithium, and sodium clearances, measurements of serum and urinary electrolytes, and urinary concentration tests were performed." | 3.69 | Kidney function in cyclosporine-treated pediatric heart transplant recipients. ( Holmberg, C; Jalanko, H; Laine, J; Leijala, M; Sairanen, H, 1997) |
| "Increased serum urate concentrations in hereditary nephropathy associated with hyperuricemia and gout are due to severe impairment of uric acid excretion." | 3.68 | Hereditary nephropathy associated with hyperuricemia and gout. ( Calvin, TS; Gil, AA; Jiménez, ML; Mateos, FA; Miranda, ME; Picazo, ML; Puig, JG, 1993) |
| "The concentrations of urea, creatinine, and uric acid were measured in edema fluid and plasma during hemodialysis and 18 h after hemodialysis." | 3.68 | Evaluation of hemodialysis efficiency by an edema fluid model. ( Fujita, Y; Izumi, M; Kajimoto, Y; Nakahama, H; Ochi, S; Shirai, D; Tanaka, Y; Wada, A; Yano, F, 1992) |
| "We reviewed the clinical features and uric acid metabolism in 37 female patients with gout." | 3.68 | Female gout. Clinical spectrum and uric acid metabolism. ( Capitán, CF; de Miguel, E; Gijón, JB; Jiménez, ML; Mateos, FA; Michán, AD; Pérez de Ayala, C; Puig, JG, 1991) |
| "A patient with intractable tophaceous gout and advanced renal failure responded favorably to treatment by long-term hemodialysis and administration of allopurinol." | 3.66 | Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol. ( Johnson, WJ; O'Duffy, JD, 1979) |
| "Eleven patients with hypertension secondary to renal disease were treated with hydrochlorothiazide or furosemide plus other drugs to normalize blood pressure." | 3.66 | Use of diuretics in treatment of hypertension secondary to renal disease. ( Bank, N; Lief, PD; Piczon, O, 1978) |
| " Such a synthesis was measured in 20 healthy controls, 24 patients with primary gout (11 on allopurinol therapy) and 26 patients with chronic renal failure and secondary hyperuricemia (8 on allopurinol therapy)." | 3.65 | [De novo purine biosynthesis. In vitro measurement in hyperuricemia (author's transl)]. ( Brami, M; Brunois, JP; Chanard, J; Funck-Brentano, JL; Kamoun, P; Pleau, JM, 1977) |
| "Treatment with febuxostat resulted in a significant decrease in the serum ADMA level from 1." | 2.84 | Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study. ( Alshahawey, M; Elsaid, TW; Sabri, NA; Shahin, SM, 2017) |
| "A total of 52 patients with ESRD on maintenance haemodialysis were screened for enrolment; 26 patients were randomized to each of the sevelamer and calcium acetate groups." | 2.76 | Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study. ( Chen, YM; Chien, CT; Chu, TS; Hung, KY; Kan, WC; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS, 2011) |
| "Hyperuricemia is a risk factor associated with cardiovascular and renal disease." | 2.73 | Efficacy and (pharmaco)kinetics of one single dose of rasburicase in patients with chronic kidney disease. ( Boni, P; Guardigli, M; Mandreoli, M; Ramazzotti, E; Roda, A; Santoro, A; Sestigiani, E, 2008) |
| "Hyperuricemia is associated strongly with the development of hypertension, renal disease, and progression." | 2.72 | Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. ( Kwan, TH; Leung, KT; Siu, YP; Tong, MK, 2006) |
| "However, no study on diabetic nephropathy has been reported." | 2.71 | Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy. ( Akizawa, T; Koide, K; Koshikawa, S; Sanaka, T, 2004) |
| "Valsartan 80 mg/day was started, and additional anti-hypertensive agents were given according to study protocol if needed." | 2.71 | Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients. ( Dilek, I; Dogan, E; Durmus, A; Erkoc, R; Sayarlioglu, H; Topal, C, 2005) |
| "Patients with ESRD undergo frequent maintenance (haemo)dialysis treatment, and finally must receive a combined liver-kidney transplantation as the only curative treatment option available in PH Type 1." | 2.61 | Targeting kidney inflammation as a new therapy for primary hyperoxaluria? ( Hoppe, B; Kurts, C; Ludwig-Portugall, I; Martin-Higueras, C, 2019) |
| "Nephrolithiasis is a very common (prevalence around 10 to 12% in France) and recurrent disorder." | 2.55 | [Nephrolithiasis of adult: From mechanisms to preventive medical treatment]. ( Baron, S; Bertocchio, JP; Briand, S; Courbebaisse, M; Daudon, M; Houillier, P; Maruani, G; Prot-Bertoye, C, 2017) |
| "A major challenge in preventing diabetic nephropathy is the inability to identify high-risk patients at an early stage, emphasizing the importance of discovering new therapeutic targets and implementation of clinical trials to reduce diabetic nephropathy risk." | 2.50 | Early diabetic nephropathy in type 1 diabetes: new insights. ( Bjornstad, P; Cherney, D; Maahs, DM, 2014) |
| "However, all patients with lupus nephritis have by definition chronic kidney disease (CKD) as they will have proteinuria with varying degrees of renal impairment." | 2.49 | Renoprotective strategies in lupus nephritis: beyond immunosuppression. ( Griffin, B; Lightstone, L, 2013) |
| "Hyperuricemia is particularly common in patients with arterial hypertension, metabolic syndrome, or kidney disease." | 2.48 | New insights into uric acid effects on the progression and prognosis of chronic kidney disease. ( Filiopoulos, V; Hadjiyannakos, D; Vlassopoulos, D, 2012) |
| "Gout is a metabolic disorder of purine metabolism with primary manifestations of acute and chronic arthritis and tophus formation." | 2.48 | The rheumatology of gout. ( Sundy, JS, 2012) |
| "Hypocitraturia and hypercalciuria are risk factors for calcium stone disease." | 2.47 | Diet-induced metabolic acidosis. ( Adeva, MM; Souto, G, 2011) |
| "Hyperuricemia is a specific risk factor for cardiovascular morbidity and mortality." | 2.47 | [Hyperuricemia and uro-nephrological disorders]. ( Hurtes, X; Meria, P, 2011) |
| "Uric acid has previously been viewed as a benign solute in serum until it exceeds its saturation level." | 2.45 | The role of hyperuricemia in vascular disorders. ( Edwards, NL, 2009) |
| "Totally, 290 CAPD-ESRD patients and 50 healthy controls (HCs) were recruited, and their serum omentin-1 levels were measured by enzyme-linked immunosorbent assay." | 1.91 | Correlation of serum omentin-1 level with clinical features and major adverse cardiac and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis. ( Liu, J; Ou, J; Yao, C; Zhou, L, 2023) |
| "Incidence rate for ESRD among patients with no episodes of AKI and one, two, and three or more episodes of AKI was 7." | 1.72 | Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes. ( Chan, JCN; Cheng, YL; Chow, CC; Chow, EYK; Fan, B; Fung, S; Hiu, G; Huang, Y; Jiang, G; Kam, G; Kong, APS; Lan, HY; Lau, E; Lau, ES; Lau, IT; Lau, KP; Lee, KF; Leung, JY; Li, JK; Lim, CKP; Lo, S; Luk, AO; Ma, RCW; Oram, RA; Ozaki, R; Siu, SC; So, WY; Szeto, CC; Tam, CHT; Tang, NLS; Tsang, CC; Tsang, MW; Yeung, VT, 2022) |
| "Uric acid is a waste metabolite produced from the breakdown of purines, and elevated serum uric acid levels are associated with higher risk of hypertension, cardiovascular disease, and mortality and progression of chronic kidney disease (CKD)." | 1.72 | Association of Uric Acid-Lowering Therapy With Incident Chronic Kidney Disease. ( Hassan, W; Kalantar-Zadeh, K; Kovesdy, CP; Potukuchi, PK; Rhee, CM; Shrestha, P; Streja, E; Sumida, K; Sweeney, PL; Thomas, F, 2022) |
| "Malnutrition is common in HD patients and is also associated with mortality." | 1.72 | Boosted machine learning model for predicting intradialytic hypotension using serum biomarkers of nutrition. ( Bano, Y; Cai, Z; Chen, H; Chen, X; Heidari, AA; Ibrohimov, A; Liu, Y; Yang, X; Yu, F; Zhao, D, 2022) |
| " For 137 sessions, in 36 patients the total daily dosage of UV-absorbing drugs was less than 500 mg, and for 6 sessions 3 patients received additional UV-absorbing drugs." | 1.72 | Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate. ( Adoberg, A; Arund, J; Dhondt, A; Fridolin, I; Glorieux, G; Holmar, J; Lauri, K; Leis, L; Luman, M; Paats, J; Pilt, K; Tanner, R; Uhlin, F, 2022) |
| "Carnitine plays a pivotal role in energy synthesis through β-oxidation in mitochondria." | 1.62 | Kinetics of Serum Carnitine Fractions in Patients with Chronic Kidney Disease Not on Dialysis. ( Fukami, K; Ito, S; Kaida, Y; Kinoshita, Y; Kodama, G; Nakayama, Y; Tashiro, K; Yano, J; Yokota, Y, 2021) |
| "Hyperuricemia has an important influence on the progression of ANCA-associated renal vasculitis." | 1.62 | Clinicopathological characteristics and outcomes of anti-neutrophil cytoplasmic autoantibody-related renal vasculitis with hyperuricemia: a retrospective case-control study. ( An, D; Guo, Y; Ma, P; Tang, L; Wang, R; Wu, Y, 2021) |
| "The hazard ratio (HR) of ESRD was higher in the highest (adjusted HR, 2." | 1.56 | Association between Serum Uric Acid Level and ESRD or Death in a Korean Population. ( Chin, HJ; Go, S; Heo, NJ; Kim, K; Lee, H; Park, JH; Ryu, JY; Son, HE, 2020) |
| "The study included ADPKD patients and control group, who carried out uroflowmetry, an assessment of renal function, metabolic and nutritional parameters and an evaluation of endothelial dysfunction and atherosclerotic markers, such as Renal Resistive Index (RRI), Intima-Media Thickness (IMT) and Flow-Mediated Dilation (FMD)." | 1.51 | Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease. ( Cianci, R; Ciccariello, M; Lai, S; Mastroluca, D; Mazzaferro, S; Mittherhofer, AP; Ricciuti, GP; Riviello, L; Salciccia, S; Vocaturi, M; Von Heland, M, 2019) |
| "Early markers of disease progression could facilitate and improve patient management." | 1.51 | Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach. ( Bruck, H; Ceccarelli, F; Gajjala, PR; Heinze, G; Jankowski, J; Jankowski, V; Kribben, A; Marx, N; Noels, H; Saez-Rodriguez, J; Zidek, W, 2019) |
| "Key Message: Hyperuricemia is closely associated with the incidence and progression of CKD." | 1.48 | Significance of Hyperuricemia among Community-Based Screening Participants. ( Iseki, K, 2018) |
| "Although hyperuricemia is common after orthotopic liver transplantation (OLT), its relationship to mortality, progressive kidney disease, or the development of end stage renal disease (ESRD) is not well-described." | 1.46 | Hyperuricemia after orthotopic liver transplantation: divergent associations with progression of renal disease, incident end-stage renal disease, and mortality. ( Atta, MG; Bandak, G; Gelber, AC; Longenecker, JC; McMahon, BA; Murakami, CA; Waheed, S, 2017) |
| "Fifty ESRD patients with the primary cause of IgAN and a short renal survival time of less than ten years after diagnose were enrolled in the case group." | 1.46 | Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study. ( Chen, C; Ding, X; Huang, P; Lin, H; Lv, Y; Shu, D; Su, Z; Xu, F; Zhang, J, 2017) |
| "Overall, the ESRD RBCs were characterized by pathological levels of shape distortions, surface removal signaling, and membrane exovesiculation, but reduced fragility compared to healthy RBCs." | 1.46 | Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy. ( Antonelou, MH; Georgatzakou, HT; Kokkalis, AC; Kriebardis, AG; Papageorgiou, EG; Papassideri, IS; Tzounakas, VL; Velentzas, AD; Voulgaridou, AI, 2017) |
| "IgA nephropathy with chronic renal failure usually occurred in young adults, and it had severe clinical condition and pathological changes, while there was no significant relationship between them." | 1.43 | Clinical and pathological analysis of IgA nephropathy with chronic renal failure. ( Chai, H; Hu, Q; Liu, Y; Shen, P; Tang, L; Yuan, G; Zhou, Y, 2016) |
| "Glycosuria is associated with increased fractional excretion of electrolytes and is related to favorable renal outcomes in nondiabetic patients with stage 5 CKD." | 1.43 | Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic Kidney Disease. ( Chen, HC; Chiang, HP; Chiu, YW; Hung, CC; Hwang, SJ; Lee, JJ; Lim, LM; Lin, HY, 2016) |
| "High uric acid level is a known risk factor for deterioration of renal function in chronic kidney disease (CKD), but its influence on the progression of IgA nephropathy (IgAN) remains unclear." | 1.42 | High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a. ( Itabashi, M; Iwabuchi, Y; Kataoka, H; Moriyama, T; Nishida, M; Nitta, K; Sato, M; Shimizu, A; Takei, T; Uchida, K, 2015) |
| "Hyperuricemia is very common in industrialized countries and known to promote vascular smooth muscle cell proliferation." | 1.42 | Smaller caliber renal arteries are a novel feature of uromodulin-associated kidney disease. ( Adamczak, M; Blondin, D; Dekomien, G; Epplen, JT; Helmchen, U; Januszewicz, A; Januszewicz, M; Litwin, M; Matuszkiewicz-Rowińska, J; Michałowska, I; Prejbisz, A; Rump, LC; Sajnaga, D; Sellin, L; Szwench-Pietrasz, E; Więcek, A; Woznowski, M, 2015) |
| "Uric acid was not associated with death-censored graft loss." | 1.40 | Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients. ( Dahle, DO; Hartmann, A; Holdaas, H; Jenssen, T; Leivestad, T; Mjøen, G; Reisaeter, AV; Toft, I; Vårdal, M, 2014) |
| "Uric acid was associated negatively with FMD% in an age- and gender-adjusted model, while not in the multivariable model." | 1.40 | Uric acid and clinical correlates of endothelial function in kidney transplant recipients. ( Asberg, A; Dahle, DO; Dörje, C; Eide, IA; Halden, TA; Hartmann, A; Holdaas, H; Holme, I; Jenssen, T; Mjøen, G; Pihlstrøm, H; Soveri, I, 2014) |
| "Hypertension was not independently associated with measures of nephron hypertrophy." | 1.40 | Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. ( Alexander, MP; Elsherbiny, HE; Kremers, WK; Lieske, JC; Park, WD; Poggio, ED; Prieto, M; Rule, AD, 2014) |
| "The patient demographics, etiology of ESRD, comorbid conditions and other laboratory parameters were collected." | 1.39 | Uric acid levels and all-cause mortality in peritoneal dialysis patients. ( Feng, S; Jiang, L; Jin, D; Shen, H; Shi, X; Shi, Y; Wang, Z; Zeng, Y, 2013) |
| "The adenine group was subdivided into a model control group (n = 7), a positive control group (200 mg/kg Jinshuibao capsule (JSB; n = 8), and two IF groups (200 mg/kg, n = 8; 100 mg/kg, n = 8)." | 1.39 | Nephroprotective effects of Isaria felina in rats with adenine-induced chronic renal failure. ( Bai, X; Ren, L; Yang, X; Zhang, H; Zhang, S, 2013) |
| "Hyperuricemia is a risk factor for end-stage renal disease." | 1.39 | The association between serum uric acid and renal damage in a community-based population: the Takahata study. ( Ichikawa, K; Ikeda, A; Kato, T; Kayama, T; Konta, T; Kubota, I; Kudo, K; Sato, H; Suzuki, K; Ueno, Y, 2013) |
| "The blood Cr level just reached the chronic renal failure level on the 26th day of the administration (about the 4th week), and obviously exceeded the renal failure level on the 41st day (about the 6th week)." | 1.37 | [Exploration on the establishment of animal models for gouty nephropathy complicated with chronic renal failure]. ( Meng, DM; Ren, W; Xing, RL, 2011) |
| "Prediabetes is a frequent condition in CKD patients." | 1.37 | The frequency of prediabetes and contributing factors in patients with chronic kidney disease. ( Heydari, M; Heydarian, P; Razeghi, E, 2011) |
| "The major causes of ESRD included diabetes mellitus and hypertension seen in 37 (74%) and 10 patients (20%), respectively." | 1.36 | Beta-2 microglobulin levels in hemodialysis patients. ( Anees, M; Bilal, M; Ibrahim, M; Mumtaz, A, 2010) |
| "Correlation between prevalence of chronic renal failure in Udmurtia and HFRS incidence was analysed." | 1.35 | [Long-term outcomes and formation of chronic disease of the kidneys in patients with a history of hemorrhagic fever with renal syndrome]. ( Dudarev, MV; Pimenov, LT, 2008) |
| "In patients with chronic renal failure undergoing hemodialysis (HD), silent cerebral infarctions (SCIs) are associated with high mortality." | 1.35 | Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients. ( Anan, F; Fukunaga, N; Kaneda, K; Nawata, T; Saikawa, T; Yoshimatsu, H, 2008) |
| "Despite the high prevalence of sleep disorders in patients with kidney disease, no relationship has been demonstrated between sleep quality and the degree of renal function in cross-sectional studies." | 1.35 | Sleep quality in patients with chronic renal failure: a 3-year longitudinal study. ( Cianciaruso, B; Crispo, A; Gallo, R; Pisani, A; Pota, A; Ragosta, A; Sabbatini, M; Serio, V; Tripepi, G, 2008) |
| "Allantoin (All) is an oxidative end product of purines in mammals." | 1.34 | Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE. ( Caussé, E; Couderc, F; Dirat, B; Negre-Salvayre, A; Pradelles, A; Salvayre, R, 2007) |
| "To determine whether ESRD causes oxidative stress, we measured basal levels of plasma F2-isoprostanes as a marker of lipid peroxidation in vivo, and peroxynitrite-stimulated formation of F2-isoprostanes, as a marker of the oxidizibility of plasma lipids in vitro, before and after routine hemodialysis." | 1.32 | Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients. ( Buoncristiani, U; Canestrari, F; Davenport, A; Ferraro, B; Frei, B; Galli, F; Kingdon, E; Moore, KP; Rice-Evans, C, 2003) |
| "The cumulative incidence of ESRD was calculated according to quartiles of baseline serum uric acid levels for each sex." | 1.32 | Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. ( Ikemiya, Y; Inoue, T; Iseki, C; Iseki, K; Kinjo, K; Takishita, S, 2004) |
| "Hyperuricemia is the hallmark of severe gout with tophi formation." | 1.32 | [Rasburicase (Fasturtec)]. ( Frey, FJ; Gugger, M; Vogt, B, 2004) |
| "Patients with ADPKD and normal renal function showed plasma urate levels within normal range and normal renal urate handling." | 1.31 | Urate homeostasis in polycystic kidney disease: comparison with chronic glomerulonephritic kidney. ( Magoula, I; Mavromatidis, K; Tsapas, G, 2002) |
| "The prognosis of IgA nephropathy (IgAN) is variable and about 10-20% of patients progress to end-stage renal disease (ESRD) in 10 years." | 1.31 | Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. ( Mustonen, J; Pasternack, A; Syrjänen, J, 2000) |
| "Thirteen patients with ESRD on intermittent haemodialysis treatment, six patients with chronic renal failure not yet on dialysis, and 15 age- and sex-matched healthy controls were examined." | 1.31 | Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients? ( Galle, PR; Himmelsbach, F; Märker-Hermann, E; Schreiner, O; Wandel, E, 2000) |
| "End-state renal disease (ESRD) affects 300000 people in the United States each year." | 1.31 | High-throughput multi-analyte screening for renal disease using capillary electrophoresis. ( Clark, EA; Fanguy, JC; Henry, CS, 2001) |
| "24 patients with stable chronic renal failure (CRF), matched for degree of renal impairment, were also studied." | 1.29 | Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobin. ( Astley, JP; Davenport, A; Goel, S; Hartog, M; Jones, SR, 1993) |
| "We studied 201 end-stage renal disease (ESRD) patients sustained on maintenance hemodialysis (MD) (n = 164) and chronic ambulatory peritoneal dialysis (CAPD) (n = 37) to determine (1) the frequency of acute attacks of gouty arthritis (GA) in those ESRD patients who had GA before dialytic therapy, and (2) the incidence of new-onset GA in hyperuricemic long-term (> 12 years) ESRD patients on MD." | 1.29 | Gouty arthritis in end-stage renal disease: clinical course and rarity of new cases. ( Delano, BG; Dulin, AL; Friedman, EA; Ifudu, O; Tan, CC, 1994) |
| "From these data it emerges that hyperaldosteronism, as observed in these patients with CRI, is a relatively reliable marker of the extent of CRI and may occur independently of the activation of the RAA system, given that other factors, such as orthostatic stimulation, alterations in the acid-base equilibrium, and the degree of aldosterone hepatic and urinary clearance, contribute to its pathogenesis." | 1.29 | [Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency]. ( Buracchi, P; Carletti, F; Gennari, C; Lucani, B; Martinelli, M; Nami, R; Panza, F; Pavese, G; Saia, F, 1993) |
| "Nine patients with stable chronic renal failure (serum creatinine, 1." | 1.29 | Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure. ( Hsu, CH; Patel, S; Vanholder, R, 1993) |
| "Losartan treatment of CRF rats before the removal of colonic tissues reversed the basal net secretion of urate to net absorption." | 1.29 | Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport. ( Freel, RW; Hatch, M; Shahinfar, S; Vaziri, ND, 1996) |
| "The rise in plasma uric acid (UA) in chronic renal failure (CRF) is quite limited." | 1.29 | Effect of chronic experimental renal insufficiency on urate metabolism. ( Freel, RW; Hatch, M; Vaziri, ND, 1995) |
| "A rare case of aplastic anemia which was considered to be induced by allopurinol was reported." | 1.28 | [Aplastic anemia probably induced by allopurinol in a patient with renal insufficiency]. ( Okafuji, K; Shinohara, K, 1990) |
| "Clinical gout was identified in 24% of patients with ADPKD; none of the patients with chronic renal failure of other etiologies had gout." | 1.28 | Hyperuricemia, gout, and autosomal dominant polycystic kidney disease. ( Lluberes, R; Martínez-Maldonado, M; Mejías, E; Navas, J, 1989) |
| " In these patients it is of importance to modify the drug dosage or to abandon the prophylaxis when it interferes with the metabolic changes of renal function impairment." | 1.27 | [Prevention of calculus recurrence in impaired kidney function]. ( Hautmann, R, 1984) |
| " The complement activation measured by the dosage of the C3a Desarg fraction existed in all the patients, reaching an average 6 times the initial level compared to 40 times for Cuprophan." | 1.27 | Evaluation and tolerance of a new polycarbonate membrane in elderly patients. Preliminary results. ( Alibeu, C; Forêt, M; Hachache, T; Kuentz, F; Meftahi, H, 1986) |
| " Monitoring of plasma oxipurinol levels (ideally less than 100 mumol/l) by high-pressure liquid chromatography is helpful for adjusting dosage in renal failure." | 1.27 | Allopurinol in renal failure and the tumour lysis syndrome. ( Cameron, JS; Davies, PM; Morris, GS; Simmonds, HA, 1986) |
| " M at a lower dosage than F has demonstrated an effective diuretic response irrespective the degree of renal impairment." | 1.27 | Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide. ( Bazzato, G; Coli, U; Fracasso, A; Landini, S; Morachiello, P; Righetto, F; Scanferla, F, 1985) |
| "Treatment with cimetidine of patients with renal failure may invalidate measurements of serum creatinine and creatinine clearance as standard routine tests for glomerular filtration rate." | 1.26 | The effects of cimetidine (Tagamet) on renal function in patients with renal failure. ( Bodemar, G; Kågedal, B; Larsson, R; Walan, A, 1980) |
| "Seven ESRD patients were treated by hemofiltration (HF) for 3--4 months using an experimental HF machine and RP6 filters (Hospal)." | 1.26 | [Treatment of chronic renal insufficiency by hemofiltration. Clinical experiences during the first year of utilization in Geneva]. ( Joliat, A; Leski, M, 1978) |
| "Both renal calculi and tophi are frequent in female gout associated with blood dyscrasias." | 1.26 | Some unusual features of gouty arthritis in females. ( Yü, TF, 1977) |
| "The incidence of recurrence was 23." | 1.25 | [Recurrent Urolithiasis during Childhood (author's transl)]. ( Vendl, L, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 237 (46.47) | 18.7374 |
| 1990's | 52 (10.20) | 18.2507 |
| 2000's | 70 (13.73) | 29.6817 |
| 2010's | 124 (24.31) | 24.3611 |
| 2020's | 27 (5.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, G | 1 |
| Luk, AO | 1 |
| Tam, CHT | 1 |
| Ozaki, R | 1 |
| Lim, CKP | 1 |
| Chow, EYK | 1 |
| Lau, ES | 1 |
| Kong, APS | 1 |
| Fan, B | 1 |
| Lee, KF | 1 |
| Siu, SC | 1 |
| Hiu, G | 1 |
| Tsang, CC | 1 |
| Lau, KP | 1 |
| Leung, JY | 1 |
| Tsang, MW | 1 |
| Kam, G | 1 |
| Lau, IT | 1 |
| Li, JK | 1 |
| Yeung, VT | 1 |
| Lau, E | 1 |
| Lo, S | 1 |
| Fung, S | 1 |
| Cheng, YL | 1 |
| Chow, CC | 1 |
| Tang, NLS | 1 |
| Huang, Y | 2 |
| Lan, HY | 1 |
| Oram, RA | 1 |
| Szeto, CC | 1 |
| So, WY | 1 |
| Chan, JCN | 1 |
| Ma, RCW | 1 |
| Alkilany, R | 1 |
| Einstadter, D | 1 |
| Antonelli, M | 1 |
| Mohd Ghazi, A | 1 |
| Teoh, CK | 1 |
| Abdul Rahim, AA | 1 |
| Hassan, W | 1 |
| Shrestha, P | 1 |
| Sumida, K | 1 |
| Thomas, F | 1 |
| Sweeney, PL | 1 |
| Potukuchi, PK | 1 |
| Rhee, CM | 1 |
| Streja, E | 1 |
| Kalantar-Zadeh, K | 1 |
| Kovesdy, CP | 1 |
| Yang, X | 3 |
| Zhao, D | 2 |
| Yu, F | 1 |
| Heidari, AA | 1 |
| Bano, Y | 1 |
| Ibrohimov, A | 1 |
| Liu, Y | 4 |
| Cai, Z | 1 |
| Chen, H | 1 |
| Chen, X | 1 |
| Yang, C | 1 |
| Su, HY | 1 |
| An, N | 1 |
| Wu, HL | 1 |
| Guo, XY | 1 |
| Li, ZH | 1 |
| Chen, XC | 1 |
| Zhu, SP | 1 |
| Wu, D | 1 |
| Li, HY | 2 |
| Pan, QJ | 1 |
| Liang, D | 1 |
| Liu, HF | 1 |
| Adoberg, A | 1 |
| Paats, J | 1 |
| Arund, J | 1 |
| Dhondt, A | 1 |
| Fridolin, I | 2 |
| Glorieux, G | 2 |
| Holmar, J | 2 |
| Lauri, K | 1 |
| Leis, L | 1 |
| Luman, M | 1 |
| Pilt, K | 1 |
| Uhlin, F | 2 |
| Tanner, R | 1 |
| Yu, D | 1 |
| Zou, L | 1 |
| Jin, Y | 1 |
| Wei, M | 1 |
| Wu, X | 1 |
| Zuo, L | 1 |
| Wu, M | 1 |
| Jiang, Y | 2 |
| Huang, Z | 2 |
| Hu, Y | 1 |
| Chen, B | 1 |
| Liang, Y | 1 |
| Li, D | 3 |
| Qiu, W | 1 |
| Zhang, J | 7 |
| Chen, C | 3 |
| Yao, C | 1 |
| Ou, J | 1 |
| Zhou, L | 1 |
| Liu, J | 1 |
| Prezelin-Reydit, M | 1 |
| Combe, C | 1 |
| Fouque, D | 1 |
| Frimat, L | 1 |
| Jacquelinet, C | 1 |
| Laville, M | 1 |
| Massy, ZA | 2 |
| Lange, C | 1 |
| Ayav, C | 1 |
| Pecoits-Filho, R | 1 |
| Liabeuf, S | 1 |
| Stengel, B | 1 |
| Harambat, J | 1 |
| Leffondré, K | 1 |
| Haruyama, N | 1 |
| Nakayama, M | 3 |
| Fukui, A | 1 |
| Yoshitomi, R | 1 |
| Tsuruya, K | 2 |
| Nakano, T | 1 |
| Kitazono, T | 2 |
| Pan, M | 2 |
| You, X | 2 |
| Lin, F | 1 |
| Lu, G | 1 |
| Ambarsari, CG | 1 |
| Cahyadi, D | 1 |
| Sari, L | 1 |
| Satria, O | 1 |
| Sahli, F | 1 |
| Darmadi, TL | 1 |
| Kadaristiana, A | 1 |
| Dong, ZX | 1 |
| Tian, M | 1 |
| Li, H | 1 |
| Wu, Y | 2 |
| Du, XG | 1 |
| Dong, JW | 1 |
| Xiao, HH | 1 |
| Dong, LP | 1 |
| Song, XH | 1 |
| Han, Y | 1 |
| Song, X | 1 |
| Zhang, W | 2 |
| Li, J | 1 |
| Tu, Y | 1 |
| Chang, W | 1 |
| Yoshida, H | 1 |
| Inaguma, D | 1 |
| Koshi-Ito, E | 1 |
| Ogata, S | 1 |
| Kitagawa, A | 1 |
| Takahashi, K | 1 |
| Koide, S | 1 |
| Hayashi, H | 1 |
| Hasegawa, M | 1 |
| Yuzawa, Y | 1 |
| Tsuboi, N | 1 |
| Kim, K | 1 |
| Go, S | 1 |
| Son, HE | 1 |
| Ryu, JY | 1 |
| Lee, H | 2 |
| Heo, NJ | 1 |
| Chin, HJ | 1 |
| Park, JH | 1 |
| Wang, W | 2 |
| Liu, W | 1 |
| Zhao, Z | 1 |
| Zhao, Y | 2 |
| Zhao, C | 1 |
| Yano, J | 1 |
| Ito, S | 3 |
| Kodama, G | 1 |
| Nakayama, Y | 1 |
| Kaida, Y | 1 |
| Yokota, Y | 1 |
| Kinoshita, Y | 2 |
| Tashiro, K | 1 |
| Fukami, K | 1 |
| Doualla, M | 1 |
| Nkeck, JR | 1 |
| Halle, MP | 1 |
| Kamdem, F | 1 |
| Agouak, AI | 1 |
| Essouma, M | 1 |
| Lobe, YB | 1 |
| Ashuntantang, G | 1 |
| Russo, E | 1 |
| Drovandi, S | 1 |
| Salvidio, G | 1 |
| Verzola, D | 1 |
| Esposito, P | 1 |
| Garibotto, G | 1 |
| Viazzi, F | 1 |
| Yang, Y | 3 |
| Qin, X | 1 |
| Li, Y | 2 |
| Yang, S | 1 |
| Chen, J | 1 |
| He, Y | 1 |
| Lin, Z | 1 |
| Kong, Y | 1 |
| Lu, Y | 1 |
| Wan, Q | 1 |
| Wang, Q | 1 |
| Huang, S | 1 |
| Liu, A | 1 |
| Liu, F | 1 |
| Hou, FF | 1 |
| Liang, M | 1 |
| Inaba, M | 2 |
| Kumeda, Y | 1 |
| Yamada, S | 1 |
| Toi, N | 1 |
| Hamai, C | 1 |
| Noguchi, K | 1 |
| Yasuda, E | 1 |
| Furumitsu, Y | 1 |
| Emoto, M | 2 |
| Ohno, Y | 2 |
| Mohammed, A | 1 |
| Marie, MA | 1 |
| Abdulazim, DO | 1 |
| Hassan, M | 1 |
| Shaker, O | 1 |
| Ayeldeen, G | 1 |
| Salem, MM | 1 |
| Sharaf El Din, UA | 1 |
| Wen, L | 1 |
| Yang, H | 1 |
| Ma, L | 1 |
| Fu, P | 1 |
| Wang, R | 2 |
| An, D | 1 |
| Ma, P | 1 |
| Guo, Y | 1 |
| Tang, L | 3 |
| Watanabe, K | 2 |
| Yamamoto, T | 2 |
| Yamada, G | 1 |
| Sato, H | 2 |
| Miyazaki, M | 1 |
| Longenecker, JC | 1 |
| Waheed, S | 1 |
| Bandak, G | 1 |
| Murakami, CA | 1 |
| McMahon, BA | 1 |
| Gelber, AC | 1 |
| Atta, MG | 1 |
| Hsieh, YP | 2 |
| Chang, CC | 2 |
| Kor, CT | 2 |
| Wen, YK | 2 |
| Chiu, PF | 2 |
| Lin, CC | 2 |
| Alshahawey, M | 1 |
| Shahin, SM | 1 |
| Elsaid, TW | 1 |
| Sabri, NA | 1 |
| Rutherford, E | 1 |
| Stewart, G | 1 |
| Houston, JG | 1 |
| Jardine, AG | 1 |
| Mark, PB | 1 |
| Struthers, AD | 1 |
| Zakaria, H | 1 |
| Mostafa, TM | 1 |
| El-Azab, GA | 1 |
| Abd El Wahab, AM | 1 |
| Elshahawy, H | 1 |
| Sayed-Ahmed, NA | 1 |
| Ishii, T | 1 |
| Taguri, M | 1 |
| Tamura, K | 1 |
| Oyama, K | 1 |
| Sampson, AL | 1 |
| Singer, RF | 1 |
| Walters, GD | 1 |
| Su, X | 1 |
| Xu, B | 1 |
| Yan, B | 1 |
| Qiao, X | 1 |
| Wang, L | 1 |
| Nakatani, A | 1 |
| Nakatani, S | 1 |
| Ishimura, E | 1 |
| Murase, T | 1 |
| Nakamura, T | 1 |
| Sakura, M | 1 |
| Tateishi, Y | 1 |
| Tsuda, A | 1 |
| Kurajoh, M | 1 |
| Mori, K | 1 |
| Kim, SJ | 2 |
| Jud, P | 1 |
| Verheyen, N | 1 |
| Fruhwald, F | 1 |
| Iseki, K | 2 |
| Zhou, Q | 1 |
| Zheng, S | 1 |
| Xu, F | 2 |
| Li, Z | 2 |
| Zhou, Z | 2 |
| Mazidi, M | 1 |
| Shivappa, N | 1 |
| Wirth, MD | 1 |
| Hebert, JR | 1 |
| Kengne, AP | 1 |
| Xie, J | 1 |
| Field, C | 1 |
| Block, C | 1 |
| Taylor, T | 1 |
| Murea, M | 2 |
| Tucker, BM | 1 |
| Zhu, B | 1 |
| Yu, DR | 1 |
| Lv, JC | 1 |
| Lin, Y | 2 |
| Li, Q | 1 |
| Yin, JZ | 1 |
| Du, YY | 1 |
| Tang, XL | 1 |
| Mao, LC | 1 |
| Li, QF | 1 |
| Sun, Y | 1 |
| Liu, L | 1 |
| Li, XF | 1 |
| Fei, D | 1 |
| Wei, XY | 1 |
| Zhu, CF | 1 |
| Cheng, XX | 1 |
| Chen, HY | 1 |
| Wang, YJ | 1 |
| Martin-Higueras, C | 1 |
| Ludwig-Portugall, I | 1 |
| Hoppe, B | 1 |
| Kurts, C | 1 |
| Liu, X | 1 |
| Wu, J | 1 |
| Wu, H | 1 |
| Yi, C | 1 |
| Huang, F | 1 |
| Yu, X | 1 |
| Andrews, ES | 1 |
| Perrenoud, L | 1 |
| Nowak, KL | 1 |
| You, Z | 1 |
| Pasch, A | 1 |
| Chonchol, M | 2 |
| Kendrick, J | 1 |
| Jalal, D | 2 |
| Pilemann-Lyberg, S | 1 |
| Hansen, TW | 1 |
| Tofte, N | 1 |
| Winther, SA | 1 |
| Theilade, S | 1 |
| Ahluwalia, TS | 1 |
| Rossing, P | 2 |
| Toida, T | 1 |
| Sato, Y | 1 |
| Komatsu, H | 1 |
| Kitamura, K | 1 |
| Fujimoto, S | 1 |
| Lai, S | 2 |
| Mittherhofer, AP | 1 |
| Cianci, R | 1 |
| Riviello, L | 1 |
| Vocaturi, M | 1 |
| Mastroluca, D | 1 |
| Ciccariello, M | 1 |
| Von Heland, M | 1 |
| Ricciuti, GP | 1 |
| Salciccia, S | 1 |
| Mazzaferro, S | 1 |
| Duan, CY | 1 |
| Han, J | 1 |
| Zhang, CY | 1 |
| Wu, K | 1 |
| Gajjala, PR | 1 |
| Bruck, H | 1 |
| Noels, H | 1 |
| Heinze, G | 1 |
| Ceccarelli, F | 1 |
| Kribben, A | 1 |
| Saez-Rodriguez, J | 1 |
| Marx, N | 1 |
| Zidek, W | 1 |
| Jankowski, J | 1 |
| Jankowski, V | 1 |
| Alam, S | 1 |
| Hussain, A | 1 |
| Daiwajna, R | 1 |
| Tan, J | 1 |
| Feng, S | 1 |
| Jiang, L | 1 |
| Shi, Y | 1 |
| Shen, H | 1 |
| Shi, X | 1 |
| Jin, D | 1 |
| Zeng, Y | 1 |
| Wang, Z | 2 |
| Sieńko, J | 1 |
| Kotowski, M | 1 |
| Safranow, K | 2 |
| Paczkowska, E | 1 |
| Wojciuk, B | 1 |
| Piątek, J | 1 |
| Ossowski, A | 1 |
| Wiśniewska, M | 1 |
| Ostrowski, M | 1 |
| Jasiczek, A | 1 |
| Machaliński, B | 1 |
| Zhang, S | 1 |
| Ren, L | 1 |
| Zhang, H | 2 |
| Bai, X | 1 |
| Miyaoka, T | 1 |
| Mochizuki, T | 1 |
| Takei, T | 2 |
| Tsuchiya, K | 1 |
| Nitta, K | 2 |
| Griffin, B | 1 |
| Lightstone, L | 1 |
| Dahle, DO | 2 |
| Jenssen, T | 2 |
| Holdaas, H | 2 |
| Leivestad, T | 1 |
| Vårdal, M | 1 |
| Mjøen, G | 2 |
| Reisaeter, AV | 1 |
| Toft, I | 1 |
| Hartmann, A | 2 |
| Cheng, P | 1 |
| Xia, Y | 1 |
| Peng, C | 1 |
| Dziuba, J | 1 |
| Alperin, P | 1 |
| Racketa, J | 1 |
| Iloeje, U | 1 |
| Goswami, D | 1 |
| Hardy, E | 1 |
| Perlstein, I | 1 |
| Grossman, HL | 1 |
| Cohen, M | 1 |
| Boban, M | 1 |
| Kocic, G | 1 |
| Radenkovic, S | 1 |
| Pavlovic, R | 1 |
| Cvetkovic, T | 1 |
| Deljanin-Ilic, M | 1 |
| Ilic, S | 1 |
| Bobana, MD | 1 |
| Djindjic, B | 1 |
| Stojanovic, D | 1 |
| Sokolovic, D | 1 |
| Jevtovic-Stoimenov, T | 1 |
| Hart, A | 1 |
| Jackson, S | 1 |
| Kasiske, BL | 1 |
| Mauer, MS | 1 |
| Najafian, B | 1 |
| Matas, AJ | 1 |
| Spong, R | 1 |
| Ibrahim, HN | 1 |
| Müller-Deile, J | 1 |
| Lichtinghagen, R | 2 |
| Haller, H | 2 |
| Schmitt, R | 2 |
| Gouri, A | 1 |
| Dekaken, A | 1 |
| Bentorki, AA | 1 |
| Touaref, A | 1 |
| Yakhlef, A | 1 |
| Kouicem, N | 1 |
| Zhou, C | 1 |
| Ding, Y | 1 |
| Du, L | 1 |
| Hou, C | 1 |
| Lu, D | 1 |
| Hao, L | 1 |
| Lv, W | 2 |
| Bjornstad, P | 1 |
| Cherney, D | 1 |
| Maahs, DM | 1 |
| Al Wakeel, JS | 1 |
| Asberg, A | 1 |
| Soveri, I | 1 |
| Holme, I | 1 |
| Eide, IA | 1 |
| Pihlstrøm, H | 1 |
| Dörje, C | 1 |
| Halden, TA | 1 |
| Nasri, H | 1 |
| Baradaran, A | 1 |
| Biniaz, V | 1 |
| Tayebi, A | 1 |
| Ebadi, A | 1 |
| Sadeghi Shermeh, M | 1 |
| Einollahi, B | 2 |
| Uchida, S | 2 |
| Takahashi, M | 1 |
| Sugawara, M | 1 |
| Saito, T | 1 |
| Nakai, K | 1 |
| Fujita, M | 1 |
| Mochizuki, K | 1 |
| Shin, I | 1 |
| Morita, T | 1 |
| Hikita, T | 1 |
| Itakura, H | 1 |
| Takahashi, Y | 1 |
| Mizuno, S | 1 |
| Ito, K | 1 |
| Ito, T | 1 |
| Soma, M | 1 |
| Elsherbiny, HE | 1 |
| Alexander, MP | 1 |
| Kremers, WK | 1 |
| Park, WD | 1 |
| Poggio, ED | 1 |
| Prieto, M | 1 |
| Lieske, JC | 1 |
| Rule, AD | 1 |
| Moriyama, T | 1 |
| Itabashi, M | 1 |
| Kataoka, H | 1 |
| Sato, M | 1 |
| Shimizu, A | 1 |
| Iwabuchi, Y | 1 |
| Nishida, M | 1 |
| Uchida, K | 1 |
| Prejbisz, A | 1 |
| Sellin, L | 1 |
| Szwench-Pietrasz, E | 1 |
| Woznowski, M | 1 |
| Michałowska, I | 1 |
| Blondin, D | 1 |
| Sajnaga, D | 1 |
| Epplen, JT | 1 |
| Litwin, M | 1 |
| Dekomien, G | 1 |
| Januszewicz, M | 1 |
| Helmchen, U | 1 |
| Matuszkiewicz-Rowińska, J | 1 |
| Adamczak, M | 1 |
| Więcek, A | 1 |
| Januszewicz, A | 1 |
| Rump, LC | 1 |
| Bleyer, AJ | 2 |
| Wright, D | 1 |
| Alcorn, H | 1 |
| Schievink, B | 1 |
| de Zeeuw, D | 1 |
| Parving, HH | 1 |
| Lambers Heerspink, HJ | 1 |
| Gupta, S | 1 |
| Yui, JC | 1 |
| Xu, D | 1 |
| Fitzhugh, CD | 1 |
| Clark, C | 1 |
| Siddiqui, S | 1 |
| Conrey, AK | 1 |
| Kato, GJ | 1 |
| Minniti, CP | 1 |
| Eloot, S | 1 |
| Van Biesen, W | 1 |
| Axelsen, M | 2 |
| Pedersen, RS | 2 |
| Heaf, JG | 2 |
| Kanji, T | 1 |
| Gandhi, M | 1 |
| Clase, CM | 1 |
| Yang, R | 1 |
| Yngman-Uhlin, P | 1 |
| Fernström, A | 1 |
| Jiang, MY | 1 |
| Hwang, JC | 1 |
| Lu, YH | 1 |
| Wang, CT | 1 |
| He, L | 2 |
| Huang, D | 1 |
| Lei, S | 1 |
| Gao, J | 1 |
| Balzer, MS | 1 |
| Gross, MM | 1 |
| Chang, WX | 1 |
| Ota, T | 1 |
| Tamura, Y | 1 |
| Shiraishi, T | 1 |
| Kumagai, T | 1 |
| Shibata, S | 1 |
| Fujigaki, Y | 1 |
| Hosoyamada, M | 1 |
| Kaneko, K | 1 |
| Shen, ZY | 1 |
| Fujimori, S | 2 |
| Roncal-Jimenez, CA | 1 |
| García-Trabanino, R | 1 |
| Wesseling, C | 1 |
| Johnson, RJ | 5 |
| Demirtas, L | 1 |
| Turkmen, K | 1 |
| Buyuklu, M | 1 |
| Kocyigit, I | 1 |
| Orscelik, O | 1 |
| Kanbay, M | 3 |
| Afsar, B | 1 |
| Siriopol, D | 1 |
| Unal, HU | 1 |
| Karaman, M | 1 |
| Saglam, M | 2 |
| Eyileten, T | 1 |
| Gezer, M | 1 |
| Verim, S | 1 |
| Oguz, Y | 1 |
| Vural, A | 1 |
| Ortiz, A | 1 |
| Covic, A | 2 |
| Yilmaz, MI | 2 |
| Kim, MJ | 1 |
| Mayr, M | 1 |
| Beberashvili, I | 1 |
| Erlich, A | 1 |
| Azar, A | 1 |
| Sinuani, I | 1 |
| Feldman, L | 1 |
| Gorelik, O | 1 |
| Stav, K | 1 |
| Efrati, S | 1 |
| Lai, C | 1 |
| Aceto, P | 1 |
| Luciani, M | 1 |
| Fazzari, E | 1 |
| Cesari, V | 1 |
| Luciano, S | 1 |
| Fortini, A | 1 |
| Berloco, D | 1 |
| Canulla, F | 1 |
| Calia, R | 1 |
| Bae, E | 1 |
| Cho, HJ | 1 |
| Shin, N | 1 |
| Kim, SM | 1 |
| Yang, SH | 1 |
| Kim, DK | 2 |
| Kim, YL | 1 |
| Kang, SW | 2 |
| Yang, CW | 1 |
| Kim, NH | 1 |
| Kim, YS | 1 |
| Courbebaisse, M | 1 |
| Prot-Bertoye, C | 1 |
| Bertocchio, JP | 1 |
| Baron, S | 1 |
| Maruani, G | 1 |
| Briand, S | 1 |
| Daudon, M | 1 |
| Houillier, P | 1 |
| Hu, Q | 1 |
| Shen, P | 1 |
| Yuan, G | 1 |
| Zhou, Y | 1 |
| Chai, H | 1 |
| Matsukuma, Y | 1 |
| Masutani, K | 1 |
| Tanaka, S | 2 |
| Tsuchimoto, A | 1 |
| Fujisaki, K | 1 |
| Torisu, K | 1 |
| Katafuchi, R | 1 |
| Hirakata, H | 1 |
| Gluba-Brzozka, A | 1 |
| Franczyk, B | 1 |
| Bartnicki, P | 1 |
| Rysz-Gorzyn Ska, M | 1 |
| Rysz, J | 1 |
| Hung, CC | 1 |
| Lin, HY | 1 |
| Lee, JJ | 1 |
| Lim, LM | 1 |
| Chiu, YW | 1 |
| Chiang, HP | 1 |
| Hwang, SJ | 1 |
| Chen, HC | 2 |
| Shu, D | 1 |
| Su, Z | 1 |
| Ding, X | 3 |
| Lv, Y | 1 |
| Lin, H | 1 |
| Huang, P | 1 |
| Hünkerler, Z | 1 |
| Köken, T | 1 |
| Koca, B | 1 |
| Kahraman, A | 1 |
| Hsu, WL | 1 |
| Li, SY | 1 |
| Liu, JS | 1 |
| Huang, PH | 1 |
| Lin, SJ | 1 |
| Hsu, CC | 1 |
| Lin, YP | 1 |
| Tarng, DC | 1 |
| Ma, J | 1 |
| Dou, Y | 1 |
| Thijssen, S | 1 |
| Williams, S | 1 |
| Kuntsevich, V | 1 |
| Ouellet, G | 1 |
| Wong, MM | 1 |
| Persic, V | 1 |
| Kruse, A | 1 |
| Rosales, L | 1 |
| Wang, Y | 3 |
| Levin, NW | 2 |
| Kotanko, P | 4 |
| Georgatzakou, HT | 1 |
| Tzounakas, VL | 1 |
| Kriebardis, AG | 1 |
| Velentzas, AD | 1 |
| Papageorgiou, EG | 1 |
| Voulgaridou, AI | 1 |
| Kokkalis, AC | 1 |
| Antonelou, MH | 1 |
| Papassideri, IS | 1 |
| Nitschke, M | 1 |
| Meier, M | 1 |
| Steinhoff, J | 1 |
| Dudarev, MV | 1 |
| Pimenov, LT | 1 |
| Blicharz, TM | 1 |
| Rissin, DM | 1 |
| Bowden, M | 1 |
| Hayman, RB | 1 |
| DiCesare, C | 1 |
| Bhatia, JS | 1 |
| Grand-Pierre, N | 1 |
| Siqueira, WL | 1 |
| Helmerhorst, EJ | 1 |
| Loscalzo, J | 1 |
| Oppenheim, FG | 1 |
| Walt, DR | 1 |
| Lee, SM | 1 |
| Lee, AL | 1 |
| Winters, TJ | 1 |
| Tam, E | 1 |
| Jaleel, M | 1 |
| Stenvinkel, P | 1 |
| Fukunaga, N | 1 |
| Anan, F | 1 |
| Kaneda, K | 1 |
| Nawata, T | 1 |
| Saikawa, T | 1 |
| Yoshimatsu, H | 1 |
| Tang, Z | 1 |
| Cheng, LT | 1 |
| Wang, T | 1 |
| Xiong, W | 1 |
| Jiang, Z | 1 |
| Hsu, CY | 1 |
| Iribarren, C | 1 |
| McCulloch, CE | 1 |
| Darbinian, J | 1 |
| Go, AS | 1 |
| Ohno, I | 3 |
| Yamaguchi, Y | 1 |
| Saikawa, H | 2 |
| Uetake, D | 2 |
| Hikita, M | 1 |
| Okabe, H | 1 |
| Ichida, K | 2 |
| Hosoya, T | 5 |
| Madero, M | 1 |
| Sarnak, MJ | 1 |
| Wang, X | 1 |
| Greene, T | 1 |
| Beck, GJ | 1 |
| Kusek, JW | 1 |
| Collins, AJ | 1 |
| Levey, AS | 1 |
| Menon, V | 1 |
| Edwards, NL | 1 |
| Min, SI | 1 |
| Yun, IJ | 1 |
| Kang, JM | 1 |
| Park, YJ | 1 |
| Min, SK | 1 |
| Ahn, C | 1 |
| Ha, J | 1 |
| Park, JT | 1 |
| Chang, TI | 1 |
| Kim, HW | 1 |
| Chang, JH | 1 |
| Park, SY | 1 |
| Kim, E | 1 |
| Han, DS | 1 |
| Yoo, TH | 1 |
| Shahbazian, H | 1 |
| Zand Moghadam, A | 1 |
| Ehsanpour, A | 1 |
| Khazaali, M | 1 |
| Shimoyama, Y | 1 |
| Taki, K | 1 |
| Mitsuda, Y | 1 |
| Tsuruta, Y | 1 |
| Hamajima, N | 1 |
| Niwa, T | 1 |
| Turgut, F | 2 |
| Kasapoğlu, B | 1 |
| Mir, S | 1 |
| Yavascan, O | 1 |
| Mutlubas, F | 1 |
| Berdeli, A | 1 |
| Sen, S | 1 |
| Shelmadine, B | 1 |
| Bowden, RG | 1 |
| Wilson, RL | 1 |
| Beavers, D | 1 |
| Hartman, J | 1 |
| Caussé, E | 2 |
| Ribes, D | 1 |
| Longlune, N | 1 |
| Kamar, N | 1 |
| Durand, D | 1 |
| Salvayre, R | 2 |
| Rostaing, L | 1 |
| Olivero, JJ | 2 |
| Nguyen, PT | 1 |
| Borazan, A | 1 |
| Binici, DN | 1 |
| Yiğiner, O | 1 |
| Ozçelik, F | 1 |
| Aparci, M | 1 |
| Işilak, Z | 1 |
| Uz, O | 1 |
| Mumtaz, A | 1 |
| Anees, M | 1 |
| Bilal, M | 1 |
| Ibrahim, M | 1 |
| Ren, H | 1 |
| Chen, N | 1 |
| Piret, SE | 1 |
| Danoy, P | 1 |
| Dahan, K | 2 |
| Reed, AA | 1 |
| Pryce, K | 1 |
| Wong, W | 1 |
| Torres, RJ | 3 |
| Puig, JG | 7 |
| Müller, T | 1 |
| Lhotta, K | 3 |
| Devuyst, O | 2 |
| Brown, MA | 2 |
| Thakker, RV | 2 |
| Akl, K | 1 |
| Chen, Y | 2 |
| Teng, J | 2 |
| Zou, J | 2 |
| Zhong, Y | 1 |
| Fang, Y | 1 |
| Liu, Z | 2 |
| Xu, S | 2 |
| Shen, B | 2 |
| Ben-Dov, IZ | 1 |
| Kark, JD | 1 |
| Satirapoj, B | 1 |
| Supasyndh, O | 1 |
| Nata, N | 1 |
| Phulsuksombuti, D | 1 |
| Utennam, D | 1 |
| Kanjanakul, I | 1 |
| Choovichian, P | 1 |
| Duangurai, K | 1 |
| Lin, YF | 1 |
| Chien, CT | 1 |
| Kan, WC | 1 |
| Chen, YM | 1 |
| Chu, TS | 1 |
| Hung, KY | 2 |
| Tsai, TJ | 1 |
| Wu, KD | 1 |
| Wu, MS | 1 |
| Badve, SV | 1 |
| Brown, F | 1 |
| Hawley, CM | 1 |
| Johnson, DW | 1 |
| Kanellis, J | 1 |
| Rangan, GK | 1 |
| Perkovic, V | 1 |
| Keller, DL | 1 |
| Sonmez, A | 1 |
| Cakir, E | 1 |
| Yenicesu, M | 1 |
| Sonoda, H | 1 |
| Takase, H | 1 |
| Dohi, Y | 1 |
| Kimura, G | 1 |
| Kalantar, E | 1 |
| Khalili, N | 1 |
| Hossieni, MS | 1 |
| Rostami, Z | 1 |
| Silverstein, DM | 1 |
| Srivaths, PR | 1 |
| Mattison, P | 1 |
| Upadhyay, K | 1 |
| Midgley, L | 1 |
| Moudgil, A | 1 |
| Goldstein, SL | 1 |
| Feig, DI | 1 |
| Adeva, MM | 1 |
| Souto, G | 1 |
| Portugal-Cohen, M | 1 |
| Oron, M | 1 |
| Ma'or, Z | 1 |
| Boaz, M | 1 |
| Shtendik, L | 1 |
| Biro, A | 1 |
| Cernes, R | 1 |
| Barnea, Z | 1 |
| Kazir, Z | 1 |
| Kohen, R | 1 |
| Hurtes, X | 1 |
| Meria, P | 1 |
| Dhaun, N | 1 |
| Johnston, NR | 1 |
| Goddard, J | 1 |
| Webb, DJ | 1 |
| Martí del Moral, L | 1 |
| Agil, A | 1 |
| Navarro-Alarcón, M | 1 |
| López-Ga de la Serrana, H | 1 |
| Palomares-Bayo, M | 1 |
| Oliveras-López, MJ | 1 |
| Doria, A | 1 |
| Krolewski, AS | 1 |
| Fuldeore, MJ | 1 |
| Riedel, AA | 1 |
| Zarotsky, V | 1 |
| Pandya, BJ | 1 |
| Dabbous, O | 1 |
| Krishnan, E | 1 |
| Bollée, G | 1 |
| Flamant, M | 1 |
| Morinière, V | 1 |
| Pawtowski, A | 1 |
| Heidet, L | 1 |
| Lacombe, D | 1 |
| Pirson, Y | 1 |
| Antignac, C | 1 |
| Knebelmann, B | 1 |
| Sahin, E | 1 |
| Goçmen, AY | 1 |
| Gümüşlü, S | 1 |
| Sahin, M | 1 |
| Koçak, H | 1 |
| Tuncer, M | 1 |
| Zoppini, G | 1 |
| Targher, G | 1 |
| Ortalda, V | 2 |
| Abaterusso, C | 1 |
| Pichiri, I | 1 |
| Negri, C | 1 |
| Bonora, E | 1 |
| Xing, RL | 1 |
| Meng, DM | 1 |
| Ren, W | 1 |
| Ooyama, K | 1 |
| Ooyama, H | 1 |
| Moromizato, H | 1 |
| Gibson, T | 2 |
| Razeghi, E | 1 |
| Heydarian, P | 1 |
| Heydari, M | 1 |
| Filiopoulos, V | 1 |
| Hadjiyannakos, D | 1 |
| Vlassopoulos, D | 1 |
| Zinellu, A | 1 |
| Sotgia, S | 1 |
| Loriga, G | 1 |
| Deiana, L | 1 |
| Satta, AE | 1 |
| Carru, C | 1 |
| Lai, JY | 1 |
| Atzmon, G | 1 |
| Melamed, ML | 1 |
| Hostetter, TH | 1 |
| Crandall, JP | 1 |
| Barzilai, N | 1 |
| Bitzer, M | 1 |
| Caliskan, Y | 1 |
| Ozkok, A | 1 |
| Akagun, T | 1 |
| Alpay, N | 1 |
| Guz, G | 1 |
| Polat, N | 1 |
| Tufan, F | 1 |
| Ecder, T | 1 |
| Bozfakioglu, S | 1 |
| Liu, H | 1 |
| Ge, Y | 1 |
| Xu, Y | 1 |
| Cao, X | 1 |
| Antunovic, T | 1 |
| Stefanovic, A | 1 |
| Ratkovic, M | 1 |
| Gledovic, B | 1 |
| Gligorovic-Barhanovic, N | 1 |
| Bozovic, D | 1 |
| Ivanisevic, J | 1 |
| Prostran, M | 1 |
| Stojanov, M | 1 |
| Sundy, JS | 1 |
| Suzuki, K | 1 |
| Konta, T | 1 |
| Kudo, K | 1 |
| Ikeda, A | 1 |
| Ichikawa, K | 1 |
| Ueno, Y | 1 |
| Kato, T | 2 |
| Kayama, T | 1 |
| Kubota, I | 1 |
| Zou, C | 1 |
| Wu, YC | 1 |
| Lin, QZ | 1 |
| Helal, I | 1 |
| McFann, K | 1 |
| Reed, B | 1 |
| Yan, XD | 1 |
| Schrier, RW | 2 |
| Fick-Brosnahan, GM | 1 |
| Cheng, GY | 1 |
| Liu, DW | 1 |
| Zhang, N | 1 |
| Zhao, ZZ | 1 |
| Liu, ZS | 1 |
| Lobo, JC | 1 |
| Stockler-Pinto, MB | 1 |
| da Nóbrega, AC | 1 |
| Carraro-Eduardo, JC | 1 |
| Mafra, D | 1 |
| Mandell, BF | 1 |
| Mavromatidis, K | 1 |
| Magoula, I | 2 |
| Tsapas, G | 2 |
| Stacey, JM | 1 |
| Turner, JJ | 1 |
| Harding, B | 1 |
| Nesbit, MA | 1 |
| Ferraro, B | 1 |
| Galli, F | 1 |
| Frei, B | 1 |
| Kingdon, E | 1 |
| Canestrari, F | 1 |
| Rice-Evans, C | 1 |
| Buoncristiani, U | 1 |
| Davenport, A | 2 |
| Moore, KP | 1 |
| Woodard, AS | 1 |
| Shihabi, Z | 1 |
| Sandhu, J | 1 |
| Zhu, H | 1 |
| Satko, SG | 1 |
| Weller, N | 1 |
| Deterding, E | 1 |
| McBride, D | 1 |
| Gorry, MC | 1 |
| Xu, L | 1 |
| Ganier, D | 1 |
| Hart, TC | 1 |
| Malliaraki, N | 1 |
| Mpliamplias, D | 1 |
| Kampa, M | 1 |
| Perakis, K | 1 |
| Margioris, AN | 1 |
| Castanas, E | 1 |
| CANER, JE | 1 |
| DECKER, JL | 1 |
| MAHER, JF | 1 |
| FREEMAN, RB | 1 |
| SCHREINER, GE | 1 |
| SHAW, AB | 1 |
| BAZZARD, FJ | 1 |
| BOOTH, EM | 1 |
| NILWARANGKUR, S | 1 |
| BERLYNE, GM | 2 |
| Hsu, SP | 1 |
| Pai, MF | 1 |
| Peng, YS | 1 |
| Chiang, CK | 1 |
| Ho, TI | 1 |
| Sanaka, T | 1 |
| Akizawa, T | 1 |
| Koide, K | 1 |
| Koshikawa, S | 1 |
| Garcia, CD | 1 |
| Henry, CS | 2 |
| Khan, SR | 1 |
| Ikemiya, Y | 1 |
| Inoue, T | 1 |
| Iseki, C | 1 |
| Kinjo, K | 1 |
| Takishita, S | 1 |
| Vogt, B | 1 |
| Gugger, M | 1 |
| Frey, FJ | 1 |
| Palmer, BF | 1 |
| Garg, JP | 1 |
| Chasan-Taber, S | 1 |
| Blair, A | 1 |
| Plone, M | 1 |
| Bommer, J | 1 |
| Raggi, P | 1 |
| Chertow, GM | 1 |
| Segal, MS | 1 |
| Srinivas, T | 1 |
| Ejaz, A | 1 |
| Mu, W | 1 |
| Roncal, C | 1 |
| Sánchez-Lozada, LG | 1 |
| Gersch, M | 1 |
| Rodriguez-Iturbe, B | 1 |
| Kang, DH | 1 |
| Acosta, JH | 1 |
| Lucchi, L | 1 |
| Banni, S | 1 |
| Iannone, A | 1 |
| Melis, MP | 1 |
| Carta, G | 1 |
| Murru, E | 1 |
| Cordeddu, L | 1 |
| Stipo, L | 1 |
| Uggeri, S | 1 |
| Gatti, V | 1 |
| Malaguti, V | 1 |
| Albertazzi, A | 3 |
| Saxena, R | 1 |
| Loghmanee, F | 1 |
| Durmus, A | 1 |
| Dogan, E | 1 |
| Erkoc, R | 1 |
| Sayarlioglu, H | 1 |
| Topal, C | 1 |
| Dilek, I | 1 |
| Enomoto, A | 1 |
| Endou, H | 1 |
| Siu, YP | 1 |
| Leung, KT | 1 |
| Tong, MK | 1 |
| Kwan, TH | 1 |
| Davies, PM | 2 |
| Fairbanks, LD | 2 |
| Bending, MR | 1 |
| Simmonds, HA | 8 |
| Caravaca, F | 1 |
| Martín, MV | 1 |
| Barroso, S | 1 |
| Cancho, B | 1 |
| Arrobas, M | 1 |
| Luna, E | 1 |
| Sánchez-Casado, E | 1 |
| Alappatt, C | 1 |
| Clayburne, G | 1 |
| Schumacher, R | 1 |
| Caldas, CA | 1 |
| Fuller, R | 1 |
| Toprak, O | 1 |
| Cirit, M | 1 |
| Yesil, M | 1 |
| Bayata, S | 1 |
| Tanrisev, M | 1 |
| Varol, U | 1 |
| Ersoy, R | 1 |
| Esi, E | 1 |
| Pradelles, A | 1 |
| Dirat, B | 1 |
| Negre-Salvayre, A | 1 |
| Couderc, F | 1 |
| Zhu, BL | 1 |
| Ishikawa, T | 1 |
| Michiue, T | 1 |
| Li, DR | 1 |
| Quan, L | 1 |
| Oritani, S | 1 |
| Maeda, H | 1 |
| Soska, V | 1 |
| Ciz, M | 1 |
| Kubala, L | 1 |
| Sobotova, D | 1 |
| Lojek, A | 1 |
| Terawaki, H | 1 |
| Nakayama, K | 1 |
| Matsuyama, Y | 1 |
| Sato, T | 1 |
| Era, S | 1 |
| de Groot, K | 1 |
| Sabbatini, M | 1 |
| Pisani, A | 1 |
| Crispo, A | 1 |
| Ragosta, A | 1 |
| Gallo, R | 1 |
| Pota, A | 1 |
| Serio, V | 1 |
| Tripepi, G | 1 |
| Cianciaruso, B | 1 |
| Barisić, I | 1 |
| Ljutić, D | 1 |
| Vlak, T | 1 |
| Bekavac, J | 1 |
| Janković, S | 1 |
| Peterson, JM | 1 |
| Butani, L | 1 |
| Bibi, G | 1 |
| Green, Y | 1 |
| Nagler, RM | 1 |
| Kudo, E | 1 |
| Itakura, M | 1 |
| Sestigiani, E | 1 |
| Mandreoli, M | 1 |
| Guardigli, M | 1 |
| Roda, A | 1 |
| Ramazzotti, E | 1 |
| Boni, P | 1 |
| Santoro, A | 1 |
| Angelopoulos, B | 1 |
| Vlassopoulos, C | 1 |
| Kalos, A | 1 |
| Posey, RE | 1 |
| Ritchie, EB | 1 |
| Dimopoulos, C | 1 |
| Chinaris, L | 1 |
| Olmer, M | 2 |
| Lafon, J | 1 |
| James, DR | 1 |
| Price, CP | 1 |
| Hosokawa, S | 1 |
| Kohira, S | 1 |
| Nishio, T | 1 |
| Tomoyoshi, T | 1 |
| Guyon, B | 1 |
| Ory, JP | 1 |
| Delacour, JL | 1 |
| Wagschal, G | 1 |
| Daoudal, P | 1 |
| Taraba, I | 1 |
| Balás, AE | 1 |
| Fazakas, L | 1 |
| Hering, A | 1 |
| Török, K | 1 |
| Gardner, DL | 1 |
| Kjellstrand, CM | 1 |
| Hassler, CR | 1 |
| Fink, DJ | 1 |
| Emmerling, DC | 1 |
| Ryabov, SI | 1 |
| Shostka, GD | 1 |
| Lukichev, BG | 2 |
| Strelko, VV | 1 |
| Spiridonov, VN | 1 |
| Kartel, NT | 1 |
| Scherbitsky, AB | 1 |
| Hautmann, R | 1 |
| Gruskin, AB | 1 |
| Rosenblum, H | 1 |
| Baluarte, HJ | 1 |
| Morgenstern, BZ | 1 |
| Polinsky, MS | 1 |
| Perlman, SA | 1 |
| Batch, JA | 1 |
| Riek, RP | 1 |
| Gordon, RB | 1 |
| Burke, JR | 1 |
| Emmerson, BT | 6 |
| Karátson, A | 1 |
| Gróf, J | 1 |
| Gofman, L | 1 |
| Rácz, L | 1 |
| Hoffmann, L | 1 |
| Esther, G | 1 |
| Neumann, J | 1 |
| Serfling, D | 1 |
| Bast, R | 1 |
| Capodicasa, G | 2 |
| De Santo, NG | 2 |
| Vaccaro, F | 2 |
| Manzo, M | 1 |
| Maione, S | 1 |
| Capasso, G | 1 |
| Giordano, C | 2 |
| Popławski, A | 1 |
| Saito, A | 4 |
| Ogawa, H | 1 |
| Takagi, T | 1 |
| Ohta, K | 2 |
| Akasu, H | 1 |
| Kawai, S | 1 |
| Kubotsu, A | 1 |
| Rotés Querol, J | 1 |
| Eisalo, A | 1 |
| Tötterman, KJ | 1 |
| Haapanen, E | 1 |
| Henderson, LW | 1 |
| Sanfelippo, ML | 1 |
| Stone, RA | 1 |
| Bagdade, JD | 1 |
| Lantz, B | 1 |
| Wajcman, H | 1 |
| Beaufils, M | 1 |
| Meyrier, A | 1 |
| Labie, D | 1 |
| Assan, R | 1 |
| Beck, LH | 1 |
| Vitali, C | 1 |
| Pasero, G | 1 |
| Clerico, A | 1 |
| Riente, L | 1 |
| Molea, N | 1 |
| Pilo, A | 1 |
| Mariani, G | 1 |
| Bianchi, R | 1 |
| Larsson, R | 1 |
| Bodemar, G | 1 |
| Kågedal, B | 1 |
| Walan, A | 1 |
| Fer, MF | 1 |
| McKinney, TD | 1 |
| Richardson, RL | 1 |
| Hande, KR | 1 |
| Oldham, RK | 1 |
| Greco, FA | 1 |
| Revúsová, V | 1 |
| Zvara, Z | 1 |
| Krídl, J | 1 |
| Borosová, E | 1 |
| Pribylincová, V | 1 |
| Reznicek, J | 1 |
| Gratzlová, J | 1 |
| Rouault, T | 1 |
| Caldwell, DS | 1 |
| Holmes, EW | 1 |
| Galione, A | 1 |
| Bellavia, C | 1 |
| Annaloro, R | 1 |
| Picone, F | 1 |
| Vinti, V | 1 |
| Davi, G | 1 |
| Rapisarda, LM | 1 |
| Bastecká, D | 1 |
| Erben, J | 1 |
| Smahelová, A | 1 |
| Pogglitsch, H | 1 |
| Kleint, V | 1 |
| Stradtmann, H | 1 |
| Klinger, H | 1 |
| Palm, B | 1 |
| Frenkel, I | 1 |
| Warren, DJ | 1 |
| Naik, RB | 1 |
| Heine, W | 1 |
| Peine, D | 1 |
| Stolpe, HJ | 1 |
| Stefoni, S | 1 |
| Feliciangeli, G | 1 |
| Coli, L | 1 |
| Scolari, MP | 1 |
| Bonomini, V | 1 |
| Rico, H | 1 |
| Huertas, R | 1 |
| Cruceira, A | 1 |
| del Rio, A | 1 |
| Piliaev, VG | 1 |
| Elion, GB | 1 |
| Benezra, FM | 1 |
| Beardmore, TD | 1 |
| Kelley, WN | 2 |
| Nishioka, N | 1 |
| Mikanagi, K | 1 |
| Thiele, P | 1 |
| Schröder, HE | 1 |
| Yatzidis, H | 1 |
| Petucci, CJ | 1 |
| Kantes, HL | 1 |
| Strein, TG | 1 |
| Veening, H | 1 |
| Jackson, P | 1 |
| Loughrey, CM | 1 |
| Lightbody, JH | 1 |
| McNamee, PT | 1 |
| Young, IS | 1 |
| Kirschbaum, B | 1 |
| Reiter, L | 1 |
| Edmonds, J | 1 |
| Hatch, M | 3 |
| Vaziri, ND | 4 |
| Lin, JL | 2 |
| Huang, PT | 1 |
| Jones, SR | 1 |
| Goel, S | 1 |
| Astley, JP | 1 |
| Hartog, M | 1 |
| Ifudu, O | 1 |
| Tan, CC | 1 |
| Dulin, AL | 1 |
| Delano, BG | 1 |
| Friedman, EA | 1 |
| Nami, R | 1 |
| Martinelli, M | 1 |
| Buracchi, P | 1 |
| Lucani, B | 1 |
| Panza, F | 1 |
| Pavese, G | 1 |
| Carletti, F | 1 |
| Saia, F | 1 |
| Gennari, C | 1 |
| Vanholder, R | 1 |
| Patel, S | 1 |
| Hsu, CH | 1 |
| Daniewska-Michalska, D | 1 |
| Motyl, T | 1 |
| Gellert, R | 1 |
| Kukulska, W | 1 |
| Podgurniak, M | 1 |
| Opechowska-Pacocha, E | 1 |
| Ostrowski, K | 1 |
| Tanaka, Y | 3 |
| Shibata, R | 1 |
| Sakamoto, K | 1 |
| Matsuda, O | 1 |
| Otsuka, M | 1 |
| Yamada, T | 1 |
| Tomita, K | 1 |
| Marumo, F | 2 |
| Miranda, ME | 1 |
| Mateos, FA | 5 |
| Picazo, ML | 1 |
| Jiménez, ML | 2 |
| Calvin, TS | 1 |
| Gil, AA | 1 |
| Chen, CY | 1 |
| Chen, CS | 1 |
| Freel, RW | 2 |
| Shahinfar, S | 1 |
| Hisatome, I | 1 |
| Kosaka, H | 1 |
| Ohtahara, K | 1 |
| Tsuboi, M | 1 |
| Manabe, I | 1 |
| Ohtahara, A | 1 |
| Sawaguchi, M | 1 |
| Igawa, O | 1 |
| Fujimoto, Y | 1 |
| Yoshida, A | 1 |
| Takeda, A | 1 |
| Shigemasa, C | 1 |
| Okada, K | 1 |
| Urae, J | 1 |
| Takahashi, S | 1 |
| Ha, TK | 1 |
| Sattar, N | 1 |
| Talwar, D | 1 |
| Cooney, J | 1 |
| Simpson, K | 1 |
| O'Reilly, DS | 1 |
| Lean, ME | 1 |
| Riabov, SI | 1 |
| Panina, II | 1 |
| Klechikov, VZ | 1 |
| Lisochkin, BG | 1 |
| Bertolo, MB | 1 |
| Costallat, LT | 1 |
| Miranda-Carús, E | 1 |
| Sanz, AG | 1 |
| Herrero, E | 1 |
| Ramos, T | 1 |
| Herzog, W | 1 |
| Deter, HC | 1 |
| Fiehn, W | 1 |
| Petzold, E | 1 |
| Nickeleit, V | 1 |
| Mihatsch, MJ | 1 |
| Laine, J | 1 |
| Jalanko, H | 1 |
| Leijala, M | 1 |
| Sairanen, H | 1 |
| Holmberg, C | 1 |
| Sancho, T | 1 |
| Buño, A | 1 |
| de Miguel, E | 2 |
| Gil, A | 1 |
| Grahame, R | 2 |
| McBride, MB | 2 |
| Marsh, FP | 1 |
| Reiter, S | 1 |
| Engelleiter, R | 1 |
| Proske, H | 1 |
| Müller, A | 1 |
| van der Woude, FJ | 1 |
| Duley, JA | 1 |
| Gruber, J | 1 |
| Sgonc, R | 1 |
| Fend, F | 1 |
| König, P | 1 |
| Rigden, S | 1 |
| Haycock, GB | 1 |
| Dalton, N | 1 |
| Van't Hoff, W | 1 |
| Rees, L | 1 |
| Raman, GV | 1 |
| Moro, F | 1 |
| Ogg, CS | 1 |
| Cameron, JS | 3 |
| Steele, TH | 3 |
| Hottelart, C | 1 |
| el Esper, N | 1 |
| Achard, JM | 1 |
| Pruna, A | 1 |
| Fournier, A | 1 |
| Nguyen-Khoa, T | 1 |
| Witko-Sarsat, V | 1 |
| Thévenin, M | 1 |
| Touam, M | 1 |
| Lambrey, G | 1 |
| Lacour, B | 1 |
| Drüeke, TB | 1 |
| Descamps-Latscha, B | 1 |
| Zweers, MM | 1 |
| de Waart, DR | 1 |
| Smit, W | 1 |
| Struijk, DG | 1 |
| Krediet, RT | 1 |
| Martínez, M | 1 |
| Vayá, A | 1 |
| Alvariño, J | 1 |
| Barberá, JL | 1 |
| Ramos, D | 1 |
| López, A | 1 |
| Aznar, J | 1 |
| Syrjänen, J | 1 |
| Mustonen, J | 1 |
| Pasternack, A | 1 |
| Schreiner, O | 1 |
| Wandel, E | 1 |
| Himmelsbach, F | 1 |
| Galle, PR | 1 |
| Märker-Hermann, E | 1 |
| Clermont, G | 1 |
| Lecour, S | 1 |
| Lahet, J | 1 |
| Siohan, P | 1 |
| Vergely, C | 1 |
| Chevet, D | 1 |
| Rifle, G | 1 |
| Rochette, L | 1 |
| Naruszewicz, M | 1 |
| Klinke, M | 1 |
| Dziewanowski, K | 1 |
| Staniewicz, A | 1 |
| Bukowska, H | 1 |
| Zefirova, GS | 1 |
| Zakutniaia, VN | 1 |
| Bufakhreddin, S | 1 |
| Plevako, VA | 1 |
| Burmistrova, NL | 1 |
| Nakayama, H | 1 |
| Akiyama, S | 1 |
| Inagaki, M | 1 |
| Gotoh, Y | 1 |
| Oguchi, K | 1 |
| Palamarchuk, MI | 1 |
| Kozlovskaia, LV | 1 |
| Balkarov, IM | 1 |
| Mora-Macía, J | 1 |
| Cases, A | 1 |
| Calero, F | 1 |
| Barceló, P | 1 |
| Clark, EA | 1 |
| Fanguy, JC | 1 |
| Yu, CC | 1 |
| Lin-Tan, DT | 1 |
| Ho, HH | 1 |
| Grzegorzewska, AE | 1 |
| Antczak-Jedrzejczak, D | 1 |
| Leander, M | 1 |
| Mariak, I | 1 |
| Augoustides-Savvopoulou, P | 1 |
| Papachristou, F | 1 |
| Dimitrakopoulos, K | 1 |
| Marinaki, AM | 1 |
| Gröbner, W | 1 |
| Erdoğan, C | 1 |
| Unlüçerçi, Y | 1 |
| Türkmen, A | 1 |
| Kuru, A | 1 |
| Cetin, O | 1 |
| Bekpinar, S | 1 |
| Gebetsroither, E | 1 |
| Skrabal, F | 1 |
| Weinman, EJ | 1 |
| de Vries, A | 1 |
| Sperling, O | 1 |
| Quellhorst, E | 1 |
| Schuenemann, B | 1 |
| Borghardt, J | 1 |
| Chodorowski, Z | 1 |
| Man, NK | 1 |
| Funck-Brentano, JL | 2 |
| Didier, M | 1 |
| Lundberg, WB | 1 |
| Cadman, ED | 1 |
| Finch, SC | 1 |
| Capizzi, RL | 1 |
| Boda, D | 1 |
| Gál, G | 1 |
| Eck, E | 1 |
| Kiss, E | 1 |
| Westberg, NG | 1 |
| Rosén, E | 1 |
| Waldenström, J | 1 |
| Bataille, R | 1 |
| Donadio, D | 1 |
| Morlock, G | 1 |
| Rosenberg, F | 1 |
| Blotman, F | 1 |
| Sany, J | 1 |
| Simon, L | 3 |
| Izarn, P | 1 |
| Serre, H | 3 |
| Johnson, WJ | 1 |
| O'Duffy, JD | 1 |
| Barbour, GL | 1 |
| Joe, C | 1 |
| Patterson, RM | 1 |
| Burian, AE | 1 |
| Dobrova, AS | 1 |
| Chang, TM | 6 |
| Chirito, E | 2 |
| Barre, P | 1 |
| Cole, C | 2 |
| Lister, C | 1 |
| Resurreccion, E | 1 |
| Auer, L | 1 |
| Holzer, H | 1 |
| Tritthart, H | 1 |
| Gell, G | 1 |
| Bank, N | 1 |
| Lief, PD | 1 |
| Piczon, O | 1 |
| Leski, M | 1 |
| Joliat, A | 1 |
| Massola, VC | 1 |
| Sabbaga, E | 1 |
| Teehan, BP | 1 |
| Smith, LJ | 1 |
| Hartigan, MF | 1 |
| Griesemer, GA | 1 |
| Gilgore, GS | 1 |
| Sigler, MH | 1 |
| Yü, TF | 1 |
| Bec, Ph | 1 |
| Pujo, JM | 1 |
| Suc, JM | 1 |
| Balcke, P | 1 |
| Schmidt, P | 2 |
| Zazgornik, J | 1 |
| Kopsa, H | 1 |
| Pils, P | 1 |
| Chanard, J | 1 |
| Kamoun, P | 1 |
| Pleau, JM | 1 |
| Brami, M | 1 |
| Brunois, JP | 1 |
| Kunitomo, T | 1 |
| Lowrie, EG | 1 |
| Kumazawa, S | 1 |
| O'Brien, M | 1 |
| Lazarus, JM | 1 |
| Gottlieb, MN | 1 |
| Merrill, JP | 2 |
| Malchesky, PS | 1 |
| Nosé, Y | 2 |
| Bluestone, R | 2 |
| Waisman, J | 1 |
| Klinenberg, JR | 1 |
| Erzsébet, H | 1 |
| István, H | 1 |
| Gejyo, F | 1 |
| Ikenaka, T | 1 |
| Lebek, R | 1 |
| Sobczyk, J | 1 |
| Twardowski, Z | 1 |
| Yolken, RH | 1 |
| Miller, DR | 1 |
| Maeda, K | 2 |
| Manji, T | 1 |
| Kawaguchi, S | 1 |
| Warembourg, H | 1 |
| Stalnikiewicz, G | 1 |
| Giovannetti, S | 2 |
| Barsotti, G | 1 |
| Ravera, R | 1 |
| Potaux, L | 1 |
| Aparicio, M | 1 |
| Maurel, C | 1 |
| Ruedas, ME | 1 |
| Martin-Dupont, Cl | 1 |
| Row, PG | 1 |
| Sorensen, LB | 2 |
| Levinson, DJ | 1 |
| Rieselbach, RE | 2 |
| Barre, B | 1 |
| Hewish, M | 1 |
| Llach, F | 1 |
| Franklin, SS | 1 |
| Maxwell, MH | 3 |
| Vendl, L | 2 |
| Oreopoulos, DG | 1 |
| Walker, D | 1 |
| Akriotis, DJ | 1 |
| Roncari, DA | 1 |
| Husdan, H | 1 |
| Symvoulidis, A | 1 |
| Deveber, GA | 1 |
| Rapoport, A | 1 |
| Reid, DB | 1 |
| Fröhling, P | 1 |
| Vetter, K | 1 |
| Kaschube, I | 1 |
| Yukawa, S | 1 |
| Tone, Y | 1 |
| Sonobe, M | 1 |
| Maeda, T | 1 |
| Mimura, K | 1 |
| Mune, M | 1 |
| Fujiwara, S | 1 |
| Tsujimoto, K | 1 |
| Maeshima, E | 1 |
| Saika, Y | 1 |
| Marangoni, R | 1 |
| Savino, R | 1 |
| Colombo, R | 1 |
| Cimino, R | 1 |
| Civardi, F | 1 |
| Wernick, R | 1 |
| Winkler, C | 1 |
| Campbell, S | 1 |
| Shirai, D | 1 |
| Kajimoto, Y | 1 |
| Ochi, S | 1 |
| Wada, A | 1 |
| Yano, F | 1 |
| Izumi, M | 1 |
| Fujita, Y | 1 |
| Nakahama, H | 1 |
| Tabe, A | 1 |
| Hayashi, T | 1 |
| Sakai, O | 1 |
| Caimi, G | 1 |
| Lo Presti, R | 1 |
| Miranda Carús, ME | 1 |
| Luz Picazo, M | 1 |
| López Jiménez, M | 1 |
| Ortíz Vázquez, J | 1 |
| Miskowiak, J | 1 |
| Michán, AD | 1 |
| Pérez de Ayala, C | 1 |
| Capitán, CF | 1 |
| Gijón, JB | 1 |
| Fushimi, K | 1 |
| Shichiri, M | 1 |
| Venkataseshan, VS | 1 |
| Feingold, R | 1 |
| Dikman, S | 1 |
| Churg, J | 1 |
| Grzegorzewska, A | 2 |
| Antoniewicz, K | 1 |
| Kuźniak, J | 1 |
| Zawadzka, E | 1 |
| Taş, S | 1 |
| Zein el Din, RR | 1 |
| Foreman, JW | 1 |
| Yudkoff, M | 1 |
| Lai, YH | 1 |
| Tsai, CY | 1 |
| Tsai, JH | 1 |
| Okafuji, K | 1 |
| Shinohara, K | 1 |
| Vanag, IG | 1 |
| Shamovskiĭ, GG | 1 |
| Shelpakova, OL | 1 |
| Nakamura, R | 1 |
| Kano, S | 1 |
| Ohtake, T | 1 |
| Hosoda, Y | 1 |
| Saruta, T | 1 |
| Vargemezis, V | 1 |
| Pasadakis, P | 1 |
| Thodis, E | 1 |
| Hasegawa, T | 1 |
| Kuroda, M | 1 |
| Stiefel, M | 1 |
| Verberckmoes, R | 1 |
| Ritz, E | 1 |
| Weidmann, P | 1 |
| Gnädinger, MP | 1 |
| Schohn, D | 1 |
| Riesen, W | 1 |
| Jahn, H | 1 |
| Coutellier, P | 1 |
| Delgrange, B | 1 |
| Coratelli, P | 1 |
| Buongiorno, E | 1 |
| Giannattasio, M | 1 |
| Passavanti, G | 1 |
| Mejías, E | 1 |
| Navas, J | 1 |
| Lluberes, R | 1 |
| Martínez-Maldonado, M | 1 |
| Pewsner, D | 1 |
| Bachmann, C | 1 |
| Müller, U | 1 |
| Hoyer, PF | 1 |
| Lee, IJ | 1 |
| Oemar, BS | 1 |
| Krohn, HP | 1 |
| Offner, G | 1 |
| Brodehl, J | 1 |
| Vree, TB | 1 |
| Martea, M | 1 |
| Tiggeler, RG | 1 |
| Hekster, YA | 1 |
| Hafkenscheid, JC | 1 |
| Kult, J | 1 |
| Häcker, W | 1 |
| Glocke, M | 1 |
| Ikeda, H | 1 |
| Kono, H | 1 |
| Miyahara, T | 1 |
| Forêt, M | 1 |
| Hachache, T | 1 |
| Alibeu, C | 1 |
| Kuentz, F | 1 |
| Meftahi, H | 1 |
| Hölzel, WG | 1 |
| Rugiu, C | 1 |
| Oldrizzi, L | 1 |
| Lupo, A | 1 |
| Valvo, E | 1 |
| Loschiavo, C | 1 |
| Tessitore, N | 1 |
| Gammaro, L | 1 |
| Fabris, A | 1 |
| Panzetta, G | 1 |
| Antonov, S | 1 |
| Kiriakov, Z | 1 |
| Kuleva, V | 1 |
| Krivoshiev, S | 1 |
| Velkovski, Ts | 1 |
| Dykman, D | 1 |
| Simon, EE | 1 |
| Garyfallos, A | 1 |
| Alessandri, C | 1 |
| Violi, F | 1 |
| Bonavita, MS | 1 |
| Weinberger, A | 1 |
| Agudelo, CA | 1 |
| Schumacher, HR | 1 |
| Bonner, J | 1 |
| Pinkhas, J | 1 |
| Flöge, J | 1 |
| Stannat, S | 1 |
| Bahlmann, J | 1 |
| Kühn, KW | 1 |
| Koch, KM | 1 |
| Jacobs, C | 1 |
| Sari, R | 1 |
| Wehle, B | 1 |
| Oja-Pettersson, K | 1 |
| Schyllert, B | 1 |
| Diehl, U | 1 |
| Bergström, J | 1 |
| Nielsen, B | 1 |
| Petersen, B | 1 |
| Post, L | 1 |
| Morris, GS | 1 |
| Rodriguez-Segade, S | 1 |
| Alonso de la Peña, C | 1 |
| Paz, M | 1 |
| Novoa, D | 1 |
| Romero, R | 1 |
| Arcocha, V | 1 |
| Del Rio, R | 1 |
| Murisasco, A | 1 |
| Baz, M | 1 |
| Boobes, Y | 1 |
| Bertocchio, P | 1 |
| el Mehdi, M | 1 |
| Durand, C | 1 |
| Reynier, JP | 1 |
| Ragon, A | 1 |
| Phanichphant, S | 1 |
| Govithrapong, P | 1 |
| Morachiello, P | 1 |
| Coli, U | 1 |
| Landini, S | 1 |
| Fracasso, A | 1 |
| Righetto, F | 1 |
| Scanferla, F | 1 |
| Bazzato, G | 1 |
| Lenert, P | 1 |
| Drazen, F | 1 |
| Tepavcević, P | 1 |
| Pejin, D | 1 |
| Curić, S | 1 |
| Ilić, V | 1 |
| Uzurov, V | 1 |
| Popowić, S | 1 |
| Zupunski, A | 1 |
| Djisalov, M | 1 |
| Ruiz, M | 1 |
| Furió Bacete, V | 1 |
| Juárez Centeno, D | 1 |
| Tennyson, TE | 1 |
| Brown, WS | 1 |
| Jennison, JH | 1 |
| Reubi, F | 1 |
| Dotchev, D | 1 |
| Hungerland, H | 1 |
| Liappis, N | 1 |
| Oyanagi, K | 1 |
| Migchelsen, M | 1 |
| Coffey, JF | 2 |
| Stark, A | 1 |
| Watschinger, B | 1 |
| Pasero, GP | 1 |
| Ciompi, MI | 1 |
| Delbarre, F | 1 |
| Braun, S | 1 |
| Saint-Georges-Chaumet, F | 1 |
| Fine, RN | 1 |
| De Palma, JR | 1 |
| Lieberman, E | 1 |
| Donnell, GN | 1 |
| Gordon, A | 2 |
| Claustre, J | 2 |
| Hartenbower, DL | 1 |
| Coburn, JW | 1 |
| Cambi, V | 1 |
| Svazzi, G | 1 |
| Arisi, L | 1 |
| Buzio, C | 1 |
| Dall'Aglio, P | 1 |
| Rossi, E | 1 |
| Migone, L | 2 |
| Fuss, M | 1 |
| Van Landuyt, P | 1 |
| Weiser, M | 1 |
| Fontinoy, N | 1 |
| Kuruvila, KC | 1 |
| Cadnapaphornchai, P | 1 |
| Leasor, G | 1 |
| Popovtzer, M | 1 |
| Alfrey, A | 1 |
| Ota, K | 1 |
| Shimoji, T | 1 |
| Amano, I | 1 |
| Zimmermann, E | 1 |
| Garrick, R | 1 |
| Ewan, CE | 1 |
| Bauer, GE | 1 |
| Neale, FC | 1 |
| Grams, RR | 1 |
| Johnson, EA | 1 |
| Benson, ES | 1 |
| Falls, WF | 1 |
| Randall, RE | 1 |
| Sommers, SC | 1 |
| Stacy, WK | 1 |
| Larkin, EG | 1 |
| Still, WJ | 1 |
| Asch, L | 1 |
| Boine, L | 1 |
| Ueda, Y | 1 |
| Ogura, Y | 1 |
| Yamamoto, M | 1 |
| Danovitch, GM | 2 |
| Dumas, R | 1 |
| Castel, J | 1 |
| Jean, R | 1 |
| Buckalew, VM | 1 |
| Someren, A | 1 |
| Armbruster, KF | 1 |
| Ing, TS | 1 |
| Kark, RM | 1 |
| Urakabe, S | 1 |
| Nakata, K | 1 |
| Orita, Y | 1 |
| Ando, A | 1 |
| Uasa, S | 1 |
| Suzuki, Y | 1 |
| Mimura, N | 1 |
| Becker, JA | 1 |
| Kinkhabwala, M | 1 |
| Zolan, S | 1 |
| Prakash, R | 1 |
| Wegner, S | 1 |
| Gonda, A | 2 |
| Dirks, JH | 2 |
| Lee-Burns, T | 1 |
| Brogard, JM | 2 |
| Frankhauser, J | 1 |
| Stahl, A | 2 |
| Lock, JP | 1 |
| Castro, GA | 1 |
| Pechet, LN | 1 |
| Snyder, LM | 1 |
| Jelińska, S | 1 |
| Swiderska-Kulikowa, B | 1 |
| Grantham, JJ | 1 |
| Irwin, RL | 1 |
| Qualizza, PB | 1 |
| Tucker, DR | 1 |
| Whittier, FC | 1 |
| Rieger, J | 1 |
| Fernandez, E | 1 |
| Girndt, J | 1 |
| Köthe, E | 1 |
| Scheler, F | 1 |
| Charbonnet, F | 1 |
| Rossier, J | 1 |
| Perlman, LV | 1 |
| Kennedy, BW | 1 |
| Hayner, NS | 1 |
| Basu, TK | 1 |
| Stein, RM | 1 |
| Kuntzinger, H | 1 |
| Chang, GN | 1 |
| Fam, A | 1 |
| Little, AH | 1 |
| Malkin, A | 1 |
| Kolton, B | 1 |
| Pedersen, J | 1 |
| Postlethwaite, AE | 1 |
| Gutman, RA | 1 |
| Abe, H | 1 |
| Furukawa, T | 1 |
| Hayashi, R | 1 |
| Muiesan, G | 1 |
| Motolese, M | 1 |
| Petz, E | 1 |
| Todisco, T | 1 |
| Anderton, JL | 1 |
| Kincaid-Smith, P | 1 |
| Bianchi Porro, G | 2 |
| Petrillo, M | 1 |
| Bianchessi, M | 2 |
| Mertz, DP | 4 |
| Weinberger, J | 1 |
| Balasse-Ketelbant, P | 1 |
| Hirszel, P | 1 |
| Louyot, P | 1 |
| Pourel, J | 1 |
| Gaucher, A | 1 |
| Montet, Y | 1 |
| Lagrue, G | 3 |
| Ménard, J | 2 |
| Safar, M | 1 |
| Schlotterer, P | 1 |
| Oliver-Martin, F | 1 |
| Kazandjian, M | 1 |
| Milliez, P | 1 |
| Malave, N | 2 |
| Better, OS | 1 |
| Greenbaum, MA | 1 |
| Marantz, LB | 1 |
| Gral, T | 1 |
| Malchesky, P | 1 |
| Nakamoto, S | 1 |
| Popowniak, K | 1 |
| Myers, CH | 1 |
| Weseley, CH | 1 |
| Schmitt, GW | 1 |
| Shalhoub, RJ | 1 |
| Austin, C | 1 |
| Bowie, EA | 1 |
| North, JD | 1 |
| Ryckewaert, A | 1 |
| Weiss, S | 1 |
| Fankhauser, S | 1 |
| Mirosch, W | 1 |
| Douglas, JB | 1 |
| Canlorbe, P | 1 |
| Busuttil, R | 1 |
| Urso, L | 1 |
| Mioli, V | 2 |
| Martinelli, G | 1 |
| Bossini, A | 2 |
| De Martino Rosaroll, G | 1 |
| Lejeune, E | 1 |
| Tolot, F | 1 |
| Meunier, P | 1 |
| Cagli, V | 2 |
| Werning, C | 1 |
| Siegenthaler, W | 1 |
| Ruotolo, V | 1 |
| Bologna, E | 1 |
| Metaxas, P | 1 |
| Papadimitriou, M | 1 |
| Papapostolou, C | 1 |
| Valtis, DJ | 1 |
| Balestri, PL | 1 |
| Biagini, M | 1 |
| Menichini, G | 1 |
| Rindi, P | 1 |
| Scott, JT | 1 |
| Schang, AM | 1 |
| Coumaros, C | 1 |
| Ravera, M | 1 |
| Ugo, C | 1 |
| Knowles, BR | 1 |
| Morelli, OH | 1 |
| Moledo, LI | 1 |
| Alanis, E | 1 |
| Gaston, OL | 1 |
| Terzaghi, O | 1 |
| Rastogi, SP | 1 |
| Volans, G | 1 |
| Elliott, RW | 1 |
| Eccleston, DW | 1 |
| Ashcroft, R | 1 |
| Webster, D | 1 |
| Kerr, DN | 1 |
| Ponticelli, C | 1 |
| Locatelli, F | 1 |
| Graziani, G | 1 |
| Zucchelli, P | 2 |
| Petrella, A | 1 |
| Fusaroli, M | 2 |
| Sasdelli, M | 2 |
| Melica, A | 1 |
| Schindera, F | 2 |
| Hampers, CL | 1 |
| Bailey, GL | 1 |
| Hager, EB | 1 |
| Vandam, LD | 1 |
| Ostberg, Y | 1 |
| Lilis, R | 1 |
| Gavrilescu, N | 1 |
| Nestorescu, B | 1 |
| Dumitriu, C | 1 |
| Roventa, A | 1 |
| Vangelista, A | 1 |
| Philippson, C | 1 |
| Liebig, J | 1 |
| Howorth, PJ | 1 |
| Zilva, JF | 1 |
| Miller, FW | 1 |
| Clark, JE | 1 |
| Jones, CP | 1 |
| Smeltzer, KL | 1 |
| Bluemle, LW | 1 |
| Klütsch, K | 2 |
| Grosswendt, J | 1 |
| Scheitza, E | 1 |
| Heidland, A | 2 |
| Fischer, V | 1 |
| Gekle, D | 1 |
| Tiegerman, T | 1 |
| Pompilian, V | 1 |
| Grimberg, L | 1 |
| Petrescu, C | 1 |
| Ambruş, I | 1 |
| Plătică, O | 1 |
| Tagliabue, M | 1 |
| Zacharia, S | 1 |
| Zacharia, D | 1 |
| Borghetti, A | 1 |
| Shelp, WD | 1 |
| Mayrhofer, E | 1 |
| Kotzaurek, R | 1 |
| Moskowitz, RW | 1 |
| Vertes, V | 1 |
| Schwartz, A | 1 |
| Marshall, G | 1 |
| Friedman, B | 1 |
| Young, GA | 1 |
| Parsons, FM | 2 |
| Sarre, H | 1 |
| Richet, G | 1 |
| Leroux-Robert, C | 1 |
| Podevin, R | 1 |
| Amiel, C | 1 |
| Rapado, A | 1 |
| Abrahams, OL | 1 |
| Sjöberg, KH | 1 |
| Miller, JH | 1 |
| Gipstein, R | 1 |
| Margules, R | 1 |
| Schwartz, M | 1 |
| Rubini, ME | 1 |
| Zarembski, PM | 1 |
| Hodgkinson, A | 1 |
| Alwall, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Allopurinol in the Treatment of Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Treated by Either PCI or CABG: Pilot Study[NCT03700645] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-12-01 | Not yet recruiting | ||
| Clinical and Biochemical Effects of Multipass Hemodialysis[NCT01267760] | Phase 2 | 12 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| Study Protocol for a Prospective Observational Study Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation[NCT04017806] | 60 participants (Anticipated) | Observational | 2018-09-19 | Recruiting | |||
| Study on the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention[NCT03425708] | Phase 4 | 400 participants (Anticipated) | Interventional | 2017-01-01 | Recruiting | ||
| Alkaline Diet for Insulin Sensitivity[NCT02501343] | 32 participants (Actual) | Interventional | 2015-03-31 | Completed | |||
| Value of Uric Acid as Early Predictor of Lupus Nephritis in Assiut University Hospital[NCT05402735] | 100 participants (Anticipated) | Observational | 2022-06-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
46 reviews available for uric acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy.
Topics: Acute Kidney Injury; Animals; Cytokines; Diabetic Nephropathies; Humans; Hyperuricemia; Inflammasome | 2021 |
Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.
Topics: Cardiovascular Diseases; Creatinine; Disease Progression; Glomerular Filtration Rate; Humans; Hyperu | 2017 |
Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.
Topics: Humans; Kidney Failure, Chronic; Uric Acid | 2017 |
The physiology of uric acid and the impact of end-stage kidney disease and dialysis.
Topics: Female; Humans; Hyperuricemia; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Prognosis; Renal | 2019 |
Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
Topics: Adolescent; Adult; Animals; Calcium Oxalate; Child; Child, Preschool; Disease Models, Animal; Humans | 2019 |
Renoprotective strategies in lupus nephritis: beyond immunosuppression.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Disease Progression; Dyslipidemias; Humans; | 2013 |
Early diabetic nephropathy in type 1 diabetes: new insights.
Topics: Angiotensin II Type 2 Receptor Blockers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease | 2014 |
Aggravation of immunoglobulin a nephropathy by hyperuricemia: a mini-review on current findings and new concepts.
Topics: Allopurinol; Disease Progression; Glomerulonephritis, IGA; Gout Suppressants; Humans; Hyperuricemia; | 2014 |
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.
Topics: Cardiovascular Diseases; Creatinine; Disease Progression; Glomerular Filtration Rate; Gout Suppressa | 2015 |
Mesoamerican Nephropathy or Global Warming Nephropathy?
Topics: Adult; Agricultural Workers' Diseases; Aldehyde Reductase; Central America; Creatinine; Dehydration; | 2016 |
[Nephrolithiasis of adult: From mechanisms to preventive medical treatment].
Topics: Adult; Calcium, Dietary; France; Humans; Kidney Calculi; Kidney Failure, Chronic; Nephrolithiasis; R | 2017 |
The role of hyperuricemia in vascular disorders.
Topics: Animals; Biological Evolution; Cardiovascular Diseases; Disease Models, Animal; Humans; Hypertension | 2009 |
Chronic kidney disease: a marker of cardiovascular disease.
Topics: Albuminuria; Anemia; Biomarkers; Blood Urea Nitrogen; Cardiovascular Diseases; Creatinine; Glomerula | 2009 |
Challenges of conducting a trial of uric-acid-lowering therapy in CKD.
Topics: Allopurinol; Gout Suppressants; Humans; Hyperuricemia; Kidney Failure, Chronic; Randomized Controlle | 2011 |
Diet-induced metabolic acidosis.
Topics: Acid-Base Equilibrium; Acidosis; Bicarbonates; Biomarkers; Cardiovascular Diseases; Citric Acid; Die | 2011 |
[Hyperuricemia and uro-nephrological disorders].
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diagnosis, Differential; Humans; Hypertension; H | 2011 |
Hyperuricemia, gout and the kidney.
Topics: Gout; Humans; Hyperuricemia; Kidney Failure, Chronic; Uric Acid | 2012 |
New insights into uric acid effects on the progression and prognosis of chronic kidney disease.
Topics: Animals; Biomarkers; Disease Progression; Humans; Hyperuricemia; Kidney Failure, Chronic; Prognosis; | 2012 |
The rheumatology of gout.
Topics: Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; Uric Acid | 2012 |
Advanced kidney failure and hyperuricemia.
Topics: Gout; Humans; Hyperuricemia; Kidney Failure, Chronic; Renal Dialysis; Uric Acid | 2012 |
Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies.
Topics: Animals; Calcium Oxalate; Calcium Phosphates; Crystallization; Humans; Kidney Failure, Chronic; Tiss | 2004 |
[Purine metabolism in patients with renal failure].
Topics: Allopurinol; Antimetabolites; Glomerulonephritis; Humans; Hyperuricemia; Hypoxanthine; Kidney; Kidne | 2004 |
Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?
Topics: Disease Progression; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; | 2005 |
Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.
Topics: Acute Kidney Injury; Animals; Carnitine; Carrier Proteins; Free Radical Scavengers; Humans; Kidney F | 2005 |
[Uromodulin mutation and hyperuricemia].
Topics: Animals; Humans; Hyperuricemia; Kidney Failure, Chronic; Kidney Tubules, Proximal; Mucoproteins; Mut | 2008 |
[Renal failure caused by non-steroid anti-inflammatory agents].
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Drug Interactions; Glomerulonephritis; Humans; Hy | 1983 |
Cancer and the kidney: complications of neoplasms.
Topics: Amyloidosis; Antineoplastic Agents; Disseminated Intravascular Coagulation; Humans; Hypercalcemia; I | 1981 |
Uric acid nephropathy and end-stage renal disease--review of a non-disease.
Topics: Gout; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Uric Acid | 1997 |
Gout: new questions for an ancient disease.
Topics: Adult; Female; Gout; Humans; Kidney Failure, Chronic; Male; Microvascular Angina; Purine-Pyrimidine | 1998 |
Hyperuricemic nephropathies.
Topics: Humans; Kidney Diseases; Kidney Failure, Chronic; Uric Acid | 1999 |
Implications of disorders of purine metabolism for the kidney and the urinary tract.
Topics: Adenine Phosphoribosyltransferase; Allopurinol; Animals; Calcium; Gout; Humans; Hydrogen-Ion Concent | 1977 |
Uremic intoxication.
Topics: Amines; Animals; Creatinine; Dogs; Guanidines; Humans; Hydroxy Acids; Indican; Kidney Failure, Chron | 1975 |
Editorial: An evaluation of the pathogenesis of gouty kidney.
Topics: Gout; Humans; Hypoxanthine Phosphoribosyltransferase; Kidney; Kidney Diseases; Kidney Failure, Chron | 1975 |
Tophi as the initial manifestation of gout. Report of six cases and review of the literature.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Gout; Humans; Kidney Failure, Chronic; Male; Mi | 1992 |
[Physiopathological aspects of secondary hyperuricemia].
Topics: Acute Disease; Coronary Disease; Drug-Related Side Effects and Adverse Reactions; Fructose; Glycogen | 1991 |
[Is asymptomatic hyperuricemia in kidney-failure patients in need of therapy?].
Topics: Allopurinol; Gout; Humans; Kidney; Kidney Failure, Chronic; Uric Acid | 1989 |
[Conservative therapy of chronic renal failure].
Topics: Allopurinol; Aluminum; Anemia; Antihypertensive Agents; Blood Transfusion; Bone Diseases; Diet Thera | 1969 |
Hyperuricemia and gout.
Topics: Biological Transport; Carbohydrate Metabolism, Inborn Errors; Down Syndrome; Fructose; Glucosyltrans | 1969 |
[Hyperuricemia in childhood].
Topics: Anemia, Hemolytic; Child; Down Syndrome; Glycogen Storage Disease; Gout; Humans; Kidney Calculi; Kid | 1973 |
[Selection and administration of drugs on patients with chronic kidney failure].
Topics: Analgesics; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antihypertensive Agents; Barbiturates; Ca | 1972 |
Uric acid transport in renal failure. A review.
Topics: Absorption; Biological Transport; Depression, Chemical; Homeostasis; Humans; Kidney; Kidney Failure, | 1972 |
Renal manifestations of sickle cell disease.
Topics: Acid-Base Equilibrium; Age Factors; Anemia, Sickle Cell; Capillaries; Dilatation; Erythrocytes, Abno | 1974 |
[Renal insufficiency and amino acid: with special reference to essential amino acid therapy].
Topics: Adult; Amino Acids; Amino Acids, Essential; Diet Therapy; Dietary Proteins; Humans; Intestinal Absor | 1974 |
[Renal insufficiency and uric acid metabolism: harmful effect of uric acid and new interpretation of uric acid metabolism].
Topics: Female; Gout; Homeostasis; Humans; Kidney; Kidney Failure, Chronic; Male; Renal Dialysis; Uric Acid | 1974 |
[Abnormalities and interrelations of biochemical indicators in kidney failure].
Topics: Acid-Base Equilibrium; Acute Kidney Injury; Amino Acids; Blood Urea Nitrogen; Calcium; Carbohydrate | 1968 |
Diuretics. II. Clinical considerations.
Topics: Administration, Oral; Aminophylline; Ascites; Calcium; Carbohydrate Metabolism; Carbonic Anhydrase I | 1971 |
40 trials available for uric acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effect of Febuxostat on the Endothelial Dysfunction in Hemodialysis Patients: A Randomized, Placebo-Controlled, Double-Blinded Study.
Topics: Administration, Oral; Adult; Alanine Transaminase; Arginine; Aspartate Aminotransferases; C-Reactive | 2017 |
An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.
Topics: Allopurinol; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Gout | 2017 |
The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Alkaline Phosphatase; Antioxidants; Biomarkers; C-Reactive Protein; Calcium; Dietary Suppleme | 2017 |
Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Allopurinol; Carotid Intima-Media Thickness; Chronic Kidney Disease-Mineral | 2018 |
Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
Topics: Allografts; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Chronic Diseas | 2014 |
Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Ascorbic Acid; Creatinine; Dietary Supplements; Female; Humans; Hype | 2014 |
Effects of the N/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study).
Topics: Aged; Aged, 80 and over; Albuminuria; Amlodipine; Blood Pressure; Calcium Channel Blockers; Creatini | 2014 |
Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis.
Topics: Adult; Biomarkers; Drug Monitoring; Female; Gout Suppressants; Humans; Infusions, Intravenous; Kidne | 2015 |
The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers.
Topics: Adult; Aged; Albuminuria; Angiotensin Receptor Antagonists; Biomarkers; Biphenyl Compounds; Blood Pr | 2015 |
Lower serum uric acid level predicts mortality in dialysis patients.
Topics: Adult; Biomarkers; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pr | 2016 |
Uric acid and long-term outcomes in CKD.
Topics: Cardiovascular Diseases; Cause of Death; Confidence Intervals; Female; Follow-Up Studies; Glomerular | 2009 |
Pleiotropic effects of sevelamer beyond phosphate binding in end-stage renal disease patients: a randomized, open-label, parallel-group study.
Topics: Adult; Aged; Calcium; Chelating Agents; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Middl | 2011 |
Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.
Topics: Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Hypertension; Hyperurice | 2011 |
Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy.
Topics: Aged; Allantoin; Azetidines; Drug Administration Schedule; Drug Combinations; Ezetimibe; Female; Hum | 2012 |
[Effects of Chinese herbal enema therapy combined basic treatment on BUN, SCr, UA, and IS in chronic renal failure patients].
Topics: Adult; Aged; Blood Urea Nitrogen; Creatinine; Drugs, Chinese Herbal; Enema; Female; Humans; Integrat | 2012 |
Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
Topics: Aged; Blood Pressure; Blood Proteins; Blood Urea Nitrogen; Carbon; Cholesterol; Creatinine; Diabetic | 2004 |
Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
Topics: Aged; Biomarkers; Calcium; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Male; Middle Ag | 2005 |
Effect of valsartan on erythropoietin and hemoglobin levels in stage III-IV chronic kidney disease patients.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Urea N | 2005 |
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Topics: Adult; Aged; Allopurinol; Creatinine; Disease Progression; Enzyme Inhibitors; Female; Follow-Up Stud | 2006 |
Compositional and oxidative analysis in the saliva and serum of predialysis chronic kidney disease patients and end-stage renal failure patients on peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antioxidants; Blood Proteins; Female; Humans; Kidney Failu | 2008 |
Efficacy and (pharmaco)kinetics of one single dose of rasburicase in patients with chronic kidney disease.
Topics: Adult; Aged; Female; Humans; Hyperuricemia; Infusions, Intravenous; Kidney Failure, Chronic; Kidney | 2008 |
Tienilic acid in patients with impaired renal function.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Follow-Up Studies; Glycolates; Humans; Hypertension; | 1982 |
[Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency].
Topics: Aged; Creatinine; Cross-Over Studies; Female; Fenofibrate; Glomerular Filtration Rate; Humans; Hyper | 1999 |
Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin.
Topics: Adult; Arteriosclerosis; Cholesterol; Creatinine; Drug Therapy, Combination; Female; Fibrinogen; Fol | 2001 |
Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Creatinine; Diastole; Dis | 2001 |
Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout.
Topics: Adult; Aged; Body Burden; Chelating Agents; Cross-Sectional Studies; Edetic Acid; Female; Gout; Huma | 2001 |
[Hypouricemic effect of benzbromarone especially in kidney failure].
Topics: Adolescent; Adult; Aged; Benzbromarone; Benzofurans; Clinical Trials as Topic; Depression, Chemical; | 1978 |
Functional and morphological changes in refused Gambro-Lundia Nova dialyzers.
Topics: Clinical Trials as Topic; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Membranes, Artificia | 1975 |
[Benzbromarone in the treatment of hyperuricemias].
Topics: Adult; Aged; Benzofurans; Clinical Trials as Topic; Drug Evaluation; Drug Tolerance; Ethacrynic Acid | 1975 |
[Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias].
Topics: Acute Kidney Injury; Adult; Aged; Allantoin; Chemical Phenomena; Chemistry; Clinical Trials as Topic | 1975 |
Antihypertensive and hypouricaemic effects of nitrendipine in chronic renal failure.
Topics: Adult; Aged; Angiotensin II; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Age | 1989 |
Antihypertensive efficacy of enalapril maleate on impaired renal function.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diuretics; Enalapril; Fema | 1988 |
Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Creatinine; Diuretics; Double-Bl | 1988 |
Clinical features of patients with solitary kidneys.
Topics: Adult; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Hypertension; Kidney; Kidney Fai | 1986 |
[Clinical testing of the Bulgarian Diamex dialyzers].
Topics: Bulgaria; Clinical Trials as Topic; Creatinine; Humans; Kidney Failure, Chronic; Kidneys, Artificial | 1986 |
[Clinical trial of urate oxidase].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Diet, Reducing; Female; Gout; Humans; Kidney Fail | 1972 |
[Benziodarone in hyperuricemia due to renal insufficiency].
Topics: Acute Kidney Injury; Adult; Aged; Allopurinol; Benzofurans; Clinical Trials as Topic; Gout; Humans; | 1973 |
[Urate oxidase in pediatrics].
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Kidney Failure, Chron | 1973 |
The combination of guanethidine and hydrochlorothiazide in the treatment of arterial hypertension with and without renal failure.
Topics: Adult; Analysis of Variance; Blood Pressure; Clinical Trials as Topic; Creatine; Drug Synergism; Fem | 1968 |
[Distribution of electrolytes and substances normally contained in urine in the extracellular space under dialysis].
Topics: Ascitic Fluid; Creatinine; Electrolytes; Extracellular Space; Humans; Kidney Failure, Chronic; Nitra | 1968 |
424 other studies available for uric acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes.
Topics: Acute Kidney Injury; Aged; Asian People; China; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic | 2022 |
Urate-lowering therapy for patients with gout on hemodialysis.
Topics: Aged; Female; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Uric A | 2022 |
Patient profiles on outcomes in patients hospitalized for heart failure: a 10-year history of the Malaysian population.
Topics: Aged; Creatinine; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2022 |
Association of Uric Acid-Lowering Therapy With Incident Chronic Kidney Disease.
Topics: Albuminuria; Cohort Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Insuf | 2022 |
Boosted machine learning model for predicting intradialytic hypotension using serum biomarkers of nutrition.
Topics: Biomarkers; Humans; Hypotension; Kidney Failure, Chronic; Machine Learning; Malnutrition; Renal Dial | 2022 |
AMP-activated protein kinase α2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model.
Topics: AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Fibrosis; Hyperuricemia; Kidney; Kid | 2022 |
Treatment with Paracetamol Can Interfere with the Intradialytic Optical Estimation in Spent Dialysate of Uric Acid but Not of Indoxyl Sulfate.
Topics: Acetaminophen; Dialysis Solutions; Hemodiafiltration; Humans; Indican; Kidney Failure, Chronic; Rena | 2022 |
Semiquantitative assessment of
Topics: Alkaline Phosphatase; Calcitriol; Calcium; Creatinine; Cysteine Proteinase Inhibitors; Humans; Hyper | 2022 |
Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy.
Topics: Clinical Relevance; Disease Progression; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans | 2023 |
Correlation of serum omentin-1 level with clinical features and major adverse cardiac and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis.
Topics: C-Reactive Protein; Cholesterol; Humans; Inflammation; Kidney Failure, Chronic; Peritoneal Dialysis, | 2023 |
Longitudinal uric acid has nonlinear association with kidney failure and mortality in chronic kidney disease.
Topics: Aged; Female; Humans; Kidney Failure, Chronic; Male; Proportional Hazards Models; Renal Insufficienc | 2023 |
Sex differences in the association between urate metabolism and kidney outcomes in patients with chronic kidney disease.
Topics: Female; Humans; Kidney; Kidney Failure, Chronic; Male; Prospective Studies; Renal Insufficiency, Chr | 2023 |
Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy.
Topics: Adult; Biomarkers; Disease Progression; Female; Glomerular Filtration Rate; Glomerulonephritis, Memb | 2019 |
Late diagnosis of Lesch-Nyhan disease complicated with end-stage renal disease and tophi burst: a case report.
Topics: Adolescent; Allopurinol; Cerebral Palsy; Delayed Diagnosis; Exons; Gout Suppressants; Humans; Hypoxa | 2020 |
Association of Serum Uric Acid Concentration and Its Change with Cardiovascular Death and All-Cause Mortality.
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Female; Humans; Kaplan-Meier Estimate; Kidney Failur | 2020 |
The effects of depression and age on sleep disturbances in patients with non-dialysis stage 3-5 chronic kidney disease: a single-center study.
Topics: Adult; Age Factors; Aged; Cross-Sectional Studies; Depression; Dietary Proteins; Female; Glomerular | 2020 |
Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study.
Topics: Aged; Aged, 80 and over; Female; Humans; Hyperuricemia; Japan; Kidney Failure, Chronic; Male; Middle | 2020 |
Association between Serum Uric Acid Level and ESRD or Death in a Korean Population.
Topics: Adult; Aged; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Failure, Chro | 2020 |
High uric acid or low uric acid which is better for hemodialysis patients?
Topics: Humans; Kidney Failure, Chronic; Renal Dialysis; Uric Acid | 2020 |
Kinetics of Serum Carnitine Fractions in Patients with Chronic Kidney Disease Not on Dialysis.
Topics: Adult; Aged; Amino Acids; Carnitine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Fail | 2021 |
Assessment of the efficacy of hemodialysis on uric acid clearance in a sub-Saharan African population at the end stage kidney disease.
Topics: Adolescent; Adult; Aged; Cameroon; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal | 2020 |
Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy.
Topics: Adult; Aged; Arterioles; Biomarkers; Biopsy; Disease Progression; Female; Glomerulonephritis, IGA; H | 2020 |
Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Female; Follow-Up Studies; Humans; Hyperur | 2020 |
Association of higher arterial ketone body ratio (acetoacetate/β-hydroxybutyrate) with relevant nutritional marker in hemodialysis patients.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Aged; Biomarkers; Diabetes Mellitus, Type 2; Female; Humans; K | 2020 |
Serum Urate Lowering Therapy Using Allopurinol Improves Serum 25 Hydroxy Vitamin D in Stage 3-5 CKD Patients: A Pilot Study.
Topics: Adult; Allopurinol; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Gou | 2021 |
Clinicopathological characteristics and outcomes of anti-neutrophil cytoplasmic autoantibody-related renal vasculitis with hyperuricemia: a retrospective case-control study.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytopla | 2021 |
Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study.
Topics: Adult; Aged; Allopurinol; Antimetabolites; Female; Glomerular Filtration Rate; Humans; Hyperuricemia | 2021 |
Hyperuricemia after orthotopic liver transplantation: divergent associations with progression of renal disease, incident end-stage renal disease, and mortality.
Topics: Adult; Creatinine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hyperuricemia; I | 2017 |
Relationship between uric acid and technique failure in patients on continuous ambulatory peritoneal dialysis: a long-term observational cohort study.
Topics: Adult; Aged; Cohort Studies; Female; Humans; Hyperuricemia; Kidney Failure, Chronic; Longitudinal St | 2017 |
Evaluation of the Effectiveness of Xanthine Oxidoreductase Inhibitors on Haemodialysis Patients using a Marginal Structural Model.
Topics: Aged; Allopurinol; Cardiovascular Diseases; Enzyme Inhibitors; Febuxostat; Female; Gout Suppressants | 2017 |
Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.
Topics: Aged; Animals; Biomarkers; Blood Glucose; Chromatography, Liquid; Cross-Sectional Studies; Diabetes | 2017 |
Serum Uric Acid Levels and Kidney Transplant Outcomes: Cause, Consequence, or Confounded?
Topics: Glomerular Filtration Rate; Humans; Hyperuricemia; Kidney Failure, Chronic; Kidney Transplantation; | 2017 |
Multiple Chronic Gouty Tophi.
Topics: Aged; Arthritis, Gouty; Humans; Kidney Failure, Chronic; Male; Uric Acid | 2018 |
Significance of Hyperuricemia among Community-Based Screening Participants.
Topics: Disease Progression; Glomerular Filtration Rate; Humans; Hyperuricemia; Incidence; Japan; Kidney Fai | 2018 |
Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
Topics: Adult; Complement C3; Complement C4; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephri | 2018 |
Greater Dietary Inflammatory Index score is associated with higher likelihood of chronic kidney disease.
Topics: Adolescent; Adult; Albumins; Body Mass Index; Creatinine; Cross-Sectional Studies; Diet; Female; Geo | 2018 |
Effect of Uric Acid Control on Serum Creatinine.
Topics: Aged; Allopurinol; Antimetabolites; Comorbidity; Correlation of Data; Creatinine; Disease Progressio | 2019 |
Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Topics: Adult; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephriti | 2018 |
Association of Serum Uric Acid with Arterial Stiffness in Peritoneal Dialysis Patients.
Topics: Adult; Age Factors; Ankle Brachial Index; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2018 |
Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
Topics: Adult; Aged; Albuminuria; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mel | 2019 |
Pre- and Postdialysis Uric Acid Difference and Risk of Long-Term All-Cause and Cardiovascular Mortalities in Japanese Hemodialysis Patients; Miyazaki Dialysis Cohort Study.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Cohort Studies; Female; Humans; Ki | 2019 |
Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Aged; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Intima-Media Thickness; C | 2019 |
UA promotes epithelial‑mesenchymal transition in peritoneal mesothelial cells.
Topics: Cell Line; Cell Survival; Epithelial-Mesenchymal Transition; Epithelium; Humans; Kidney Failure, Chr | 2019 |
Novel plasma peptide markers involved in the pathology of CKD identified using mass spectrometric approach.
Topics: Aged; Biomarkers; C-Reactive Protein; Cohort Studies; Disease Progression; Female; Humans; Kidney Fa | 2019 |
Clinical efficacy of sevelamer hydrochloride in patients with end-stage renal disease: a retrospective study.
Topics: Adult; Bone Diseases; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Fai | 2013 |
Uric acid levels and all-cause mortality in peritoneal dialysis patients.
Topics: Aged; Cause of Death; Comorbidity; Female; Forecasting; Humans; Hyperuricemia; Kaplan-Meier Estimate | 2013 |
Role of platelets in the modulation of kidney allograft recipients' immune systems.
Topics: Adult; Aged; Allografts; Blood Platelets; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Fe | 2013 |
Nephroprotective effects of Isaria felina in rats with adenine-induced chronic renal failure.
Topics: Adenine; Animals; Ascomycota; Biological Products; Blood Urea Nitrogen; Cordyceps; Creatinine; Disea | 2013 |
Serum uric acid levels and long-term outcomes in chronic kidney disease.
Topics: Aged; Allopurinol; Biomarkers; Cause of Death; Female; Glomerular Filtration Rate; Gout Suppressants | 2014 |
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Child; Child, Presc | 2014 |
[Evaluation of dialysis in patients with end-stage renal disease by salivary urea, creatinine and uric acid].
Topics: Creatinine; Humans; Kidney Failure, Chronic; Renal Dialysis; Renal Insufficiency, Chronic; Saliva; U | 2013 |
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascul | 2014 |
Circulating purine compounds, uric acid, and xanthine oxidase/dehydrogenase relationship in essential hypertension and end stage renal disease.
Topics: Adenine Nucleotides; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Blood P | 2014 |
Online Kt/V monitoring in haemodialysis by UV absorbance: variations during intra-dialytic meals.
Topics: Aged; Aged, 80 and over; Blood Glucose; Creatinine; Humans; Kidney Failure, Chronic; Meals; Middle A | 2014 |
Serum uric acid level and cardiovascular risks in hemodialysis patients: an Algerian cohort study.
Topics: Adult; Aged; Algeria; Cardiovascular Diseases; Female; Humans; Hyperuricemia; Kidney Failure, Chroni | 2014 |
Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma.
Topics: Acute Kidney Injury; Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; | 2014 |
Kidney function and metabolic profile of chronic kidney disease and hemodialysis patients during Ramadan fasting.
Topics: Adult; Aged; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Erythrocyte Count; Fastin | 2014 |
Uric acid and clinical correlates of endothelial function in kidney transplant recipients.
Topics: Cross-Sectional Studies; Endothelium, Vascular; Female; Follow-Up Studies; Glomerular Filtration Rat | 2014 |
Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.
Topics: Adult; Age Factors; Albuminuria; Body Mass Index; Female; Glomerular Filtration Rate; Glomeruloscler | 2014 |
High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
Topics: Biomarkers; Biopsy; Chi-Square Distribution; Disease Progression; Female; Glomerulonephritis, IGA; H | 2015 |
Smaller caliber renal arteries are a novel feature of uromodulin-associated kidney disease.
Topics: Adolescent; Adult; Aged; Angiography; Child; Chronic Disease; Female; Genotype; Glomerular Filtratio | 2015 |
Gout and sickle cell disease: not all pain is sickle cell pain.
Topics: Acute Disease; Adult; Age of Onset; Aged; Aged, 80 and over; Anemia, Sickle Cell; Female; Gout; Hemo | 2015 |
Protein-bound solute removal during extended multipass versus standard hemodialysis.
Topics: Aged; Appointments and Schedules; Cross-Over Studies; Female; Hemodialysis Solutions; Humans; Kidney | 2015 |
Optical Estimation of Beta 2 Microglobulin during Hemodiafiltration – Does It Work?
Topics: Aged; Aged, 80 and over; beta 2-Microglobulin; Creatinine; Dialysis Solutions; Female; Hemodiafiltra | 2015 |
Clinical implications and outcome prediction in chronic hemodialysis patients with lower serum potassium×uric acid product.
Topics: Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Predictive Value of Tests; Pr | 2015 |
U-shaped relationship between uric acid and residual renal function decline in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Aged; Anuria; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Logistic M | 2017 |
Icariin protects rats against 5/6 nephrectomy-induced chronic kidney failure by increasing the number of renal stem cells.
Topics: Animals; Blood Urea Nitrogen; Bone Morphogenetic Protein 7; Cell Proliferation; Creatinine; Drugs, C | 2015 |
Got Milk? Breastfeeding and Milk Analysis of a Mother on Chronic Hemodialysis.
Topics: Adult; Breast Feeding; Creatine; Female; Humans; Kidney Failure, Chronic; Milk, Human; Mothers; Post | 2015 |
Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Disease Progression; Female; Follow-Up Studies; Humans; | 2015 |
Atrial electromechanical delay and left atrial mechanical functions in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Age Factors; Aged; Atrial Function, Left; Blood Pressure; Calcium; Case-Control Studies; Echo | 2016 |
Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Topics: Academic Medical Centers; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cause of Death; Cohor | 2016 |
[Uric acid and kidneys – Physiological and pathophysiological aspects].
Topics: Gout; Humans; Hyperuricemia; Kidney; Kidney Failure, Chronic; Kidney Tubules; Risk Factors; Uric Aci | 2016 |
Longitudinal Study of Serum Uric Acid, Nutritional Status, and Mortality in Maintenance Hemodialysis Patients.
Topics: Aged; Anthropometry; Cardiovascular Diseases; Cause of Death; Female; Humans; Kidney Failure, Chroni | 2016 |
Externally Oriented Thinking Predicts Phosphorus Levels in Dialyzed Patients.
Topics: Adult; Affective Symptoms; Biomarkers; Creatinine; Dialysis; Female; Humans; Kidney Failure, Chronic | 2016 |
Clinical and pathological analysis of IgA nephropathy with chronic renal failure.
Topics: Adult; Biopsy; Blood Pressure; Blood Urea Nitrogen; Creatinine; Disease Progression; Female; Follow- | 2016 |
A J-shaped association between serum uric acid levels and poor renal survival in female patients with IgA nephropathy.
Topics: Adult; Disease Progression; Female; Glomerulonephritis, IGA; Humans; Kidney; Kidney Failure, Chronic | 2017 |
Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients.
Topics: Aged; Area Under Curve; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Humans; K | 2017 |
Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic Kidney Disease.
Topics: Creatinine; Cross-Sectional Studies; Electrolytes; Female; Glomerular Filtration Rate; Glycosuria; H | 2016 |
Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case-control study.
Topics: Adult; Case-Control Studies; Cholesterol; Disease Progression; Female; Glomerular Filtration Rate; G | 2017 |
Role of Uremic Toxins on Apoptosis With Varying Periods of Hemodialysis.
Topics: Apoptosis; Caspases; Cross-Sectional Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle | 2017 |
High Uric Acid Ameliorates Indoxyl Sulfate-Induced Endothelial Dysfunction and Is Associated with Lower Mortality among Hemodialysis Patients.
Topics: Adult; Aged; Biomarkers; Cause of Death; Cells, Cultured; Chi-Square Distribution; Endothelial Cells | 2017 |
Correlation between Inflammatory Biomarkers and Red Blood Cell Life Span in Chronic Hemodialysis Patients.
Topics: Adult; Aged; Anemia; Biomarkers; Blood Urea Nitrogen; Erythrocyte Aging; Female; Humans; Inflammatio | 2017 |
Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
Topics: Aged; Aged, 80 and over; Case-Control Studies; CD47 Antigen; CD59 Antigens; Cell Shape; Clusterin; E | 2017 |
[Acute and chronic renal insufficiency. Diagnostics and practical implications].
Topics: Acute Kidney Injury; Creatinine; Diagnosis, Differential; Humans; Kidney Diseases; Kidney Failure, C | 2008 |
[Long-term outcomes and formation of chronic disease of the kidneys in patients with a history of hemorrhagic fever with renal syndrome].
Topics: Adult; beta-N-Acetylhexosaminidases; Biomarkers; Blood Flow Velocity; Disease Progression; Female; F | 2008 |
Use of colorimetric test strips for monitoring the effect of hemodialysis on salivary nitrite and uric acid in patients with end-stage renal disease: a proof of principle.
Topics: Colorimetry; Health; Humans; Kidney Failure, Chronic; Nitrites; Oxidation-Reduction; Reagent Strips; | 2008 |
Low serum uric acid level is a risk factor for death in incident hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cause of Death; Comorbidity; Female; Humans; Hypoalbumin | 2009 |
Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients.
Topics: Blood Glucose; Cerebral Infarction; Cholesterol; Female; Glycated Hemoglobin; Hematocrit; Humans; Ki | 2008 |
Serum uric acid and endothelial dysfunction in continuous ambulatory peritoneal dialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Endothelium, Vascular; Female; | 2009 |
[Field planting of Bacillus bifidus and Bacillus acidi lactic on various gastrointestinal sites and their decomposition of low molecule urotoxins in rats with renal failure].
Topics: Animals; Bifidobacterium; Blood Urea Nitrogen; Creatinine; Gastrointestinal Tract; Kidney Failure, C | 2009 |
Risk factors for end-stage renal disease: 25-year follow-up.
Topics: Adult; Aged; Aged, 80 and over; Black or African American; Confidence Intervals; Creatinine; Female; | 2009 |
Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients.
Topics: Absorption; Adult; Aged; Aged, 80 and over; Chelating Agents; Female; Follow-Up Studies; Humans; Hyp | 2009 |
Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
Topics: Adult; Age of Onset; Biomarkers; Cohort Studies; Female; Glomerular Filtration Rate; Humans; Hyperur | 2009 |
Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients.
Topics: Adult; Aged; Female; Humans; Hypertension; Hyperuricemia; Kidney; Kidney Failure, Chronic; Male; Mid | 2009 |
Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
Topics: Adult; Aged; Bicarbonates; Biomarkers; Chromatography, High Pressure Liquid; Female; Hemodialysis So | 2009 |
KLOTHO gene polymorphisms G-395A and C1818T are associated with low-density lipoprotein cholesterol and uric acid in Japanese hemodialysis patients.
Topics: Aged; Asian People; Cholesterol, LDL; Female; Gene Frequency; Genetic Predisposition to Disease; Gen | 2009 |
Uric acid, cardiovascular mortality, and long-term outcomes in CKD.
Topics: Cardiovascular Diseases; Humans; Kidney Failure, Chronic; Time Factors; Treatment Outcome; Uric Acid | 2009 |
A rare cause of chronic renal failure in a girl with elevated serum uric acid level.
Topics: Adolescent; Diagnosis, Differential; DNA Mutational Analysis; Family Health; Female; Humans; Hyperur | 2010 |
The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.
Topics: Adult; Allopurinol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Gout Supp | 2009 |
Aminothiols and allantoin in chronic dialysis patients: effects of hemodialysis sessions.
Topics: Adult; Aged; Aged, 80 and over; Allantoin; Analysis of Variance; Electrophoresis, Capillary; Female; | 2010 |
Relationship between insulin resistance and inflamation markers in hemodialysis patients.
Topics: Albumins; Analysis of Variance; Biomarkers; Blood Glucose; C-Reactive Protein; Female; Fibrinogen; H | 2010 |
The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ the effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot stu
Topics: Allopurinol; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Metabolic Syndrome; Oxidative | 2010 |
Beta-2 microglobulin levels in hemodialysis patients.
Topics: beta 2-Microglobulin; Creatinine; Cross-Sectional Studies; Diabetic Nephropathies; Female; Hematocri | 2010 |
Analysis of factors associated with renal function in Chinese adults with congenital solitary kidney.
Topics: Adult; Biomarkers; Creatinine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hype | 2010 |
Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21.
Topics: Chromosomes, Human, Pair 2; Female; Genetic Heterogeneity; Genetic Linkage; Genetic Loci; Genetic Pr | 2011 |
The anomalies associated with congenital solitary functioning kidney in children.
Topics: Abnormalities, Multiple; Adolescent; Albuminuria; Child; Child, Preschool; Female; Hospitals, Univer | 2011 |
Serum uric acid is inversely related to acute ischemic stroke morbidity in hemodialysis patients.
Topics: Adult; Age Factors; Aged; Brain Ischemia; Female; Humans; Inflammation; Kidney Failure, Chronic; Mal | 2011 |
Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study.
Topics: Acute Kidney Injury; Cohort Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; | 2011 |
High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Body Mass Index; Chronic Disease; Cross-Sectional Studies; | 2010 |
Gout and chronic kidney disease.
Topics: Gout; Humans; Hyperuricemia; Kidney Failure, Chronic; Uric Acid | 2011 |
Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease.
Topics: Adult; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Endothelium, Vascular; Female; Glomerul | 2011 |
Uric acid levels predict future development of chronic kidney disease.
Topics: Aged; Body Mass Index; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Ch | 2011 |
Hyperuricemia after renal transplantation.
Topics: Adult; Female; Graft Survival; Humans; Hyperuricemia; Kidney Failure, Chronic; Kidney Transplantatio | 2011 |
Serum uric acid is associated with high blood pressure in pediatric hemodialysis patients.
Topics: Adolescent; Antihypertensive Agents; Biomarkers; Blood Pressure; Body Weight; Child; Female; Humans; | 2011 |
Noninvasive skin measurements to monitor chronic renal failure pathogenesis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Humans; Hydrophobic and Hydrophilic Interactions | 2011 |
Altered serum selenium and uric acid levels and dyslipidemia in hemodialysis patients could be associated with enhanced cardiovascular risk.
Topics: Aged; Cardiovascular Diseases; Cholesterol, HDL; Dyslipidemias; Female; Humans; Kidney Failure, Chro | 2011 |
Diabetes: Lowering serum uric acid levels to prevent kidney failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Diabetic Nephropathies; Humans; Hyperuricemia; Kidney Failu | 2011 |
Chronic kidney disease in gout in a managed care setting.
Topics: Adult; Aged; Allopurinol; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Kidney Failure | 2011 |
Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.
Topics: Adult; Belgium; Biomarkers; Central Nervous System Diseases; Chi-Square Distribution; Dental Enamel; | 2011 |
Lipid peroxidation and parathyroid hormone influence the cytosolic calcium levels of erythrocytes in peritoneal dialysis patients.
Topics: Adult; Blood Cell Count; C-Reactive Protein; Calcium; Case-Control Studies; Cytosol; Erythrocytes; F | 2011 |
Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.
Topics: Aged; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hype | 2012 |
[Exploration on the establishment of animal models for gouty nephropathy complicated with chronic renal failure].
Topics: Animals; Disease Models, Animal; Gout; Hyperuricemia; Kidney Failure, Chronic; Male; Rats; Rats, Wis | 2011 |
Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
Topics: Benzbromarone; Female; Glomerular Filtration Rate; Humans; Hyperuricemia; Kidney Failure, Chronic; M | 2011 |
Relationship between hyperuricemia and chronic kidney disease.
Topics: Glomerulonephritis, IGA; Humans; Hypertension; Hyperuricemia; Kidney; Kidney Failure, Chronic; Kidne | 2011 |
The frequency of prediabetes and contributing factors in patients with chronic kidney disease.
Topics: Aged; Blood Glucose; Chi-Square Distribution; Cholesterol; Female; Glucose Tolerance Test; Humans; K | 2011 |
Family history of exceptional longevity is associated with lower serum uric acid levels in Ashkenazi Jews.
Topics: Aged; Aged, 80 and over; Cross-Sectional Studies; Family Health; Female; Glomerular Filtration Rate; | 2012 |
Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients.
Topics: Adolescent; Adult; Aged; Atherosclerosis; Biomarkers; Blood Flow Velocity; C-Reactive Protein; Carot | 2012 |
24-h residual urine volume at hemodialysis initiation: a possible predictor for acute ischemic stroke incurrence in hemodialysis patients.
Topics: Age Factors; Aged; Brain Ischemia; Cerebral Infarction; Data Interpretation, Statistical; Diabetes C | 2013 |
High uric acid and low superoxide dismutase as possible predictors of all-cause and cardiovascular mortality in hemodialysis patients.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Cause of Death; Cohort Studies; Confidence Intervals; Enz | 2013 |
Multipass haemodialysis: a novel dialysis modality.
Topics: Adolescent; Adult; Biomarkers; Creatinine; Dialysis Solutions; Female; Follow-Up Studies; Humans; Ki | 2013 |
The association between serum uric acid and renal damage in a community-based population: the Takahata study.
Topics: Adult; Aged; Albuminuria; beta 2-Microglobulin; Creatinine; Cross-Sectional Studies; Female; Humans; | 2013 |
Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.
Topics: Adult; Cohort Studies; Disease Progression; Female; Humans; Hypertension; Hyperuricemia; Kidney; Kid | 2013 |
Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
Topics: Adult; Blood Urea Nitrogen; Confidence Intervals; Creatinine; Follow-Up Studies; Glomerular Filtrati | 2013 |
Is there association between uric acid and inflammation in hemodialysis patients?
Topics: Adult; Aged; Cross-Sectional Studies; Female; Humans; Inflammation; Kidney Failure, Chronic; Male; M | 2013 |
Hyperuricemia and gout: a reign of complacency.
Topics: Allopurinol; Colchicine; Coronary Disease; Gout; Gout Suppressants; Humans; Kidney Failure, Chronic; | 2002 |
Urate homeostasis in polycystic kidney disease: comparison with chronic glomerulonephritic kidney.
Topics: Chronic Disease; Female; Glomerulonephritis; Homeostasis; Humans; Kidney; Kidney Failure, Chronic; M | 2002 |
Genetic mapping studies of familial juvenile hyperuricemic nephropathy on chromosome 16p11-p13.
Topics: Child; Chromosome Mapping; Chromosome Segregation; Chromosomes, Human, Pair 16; Female; Genetic Hete | 2003 |
Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; F2-Isoprostanes; Female; Humans; Kidney Failure, Chronic; Lipids; Ma | 2003 |
Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene.
Topics: Adolescent; Alleles; Base Pairing; Chronic Disease; Creatinine; Female; Gene Deletion; Genes, Domina | 2003 |
Total and corrected antioxidant capacity in hemodialyzed patients.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Analysis of Variance; Antioxidants; Bilirubin; Female; Hem | 2003 |
RECURRENT ACUTE (?GOUTY) ARTHRITIS IN CHRONIC RENAL FAILURE TREATED WITH PERIODIC HEMODIALYSIS.
Topics: Alkaline Phosphatase; Arthritis; Blood Chemical Analysis; Calcinosis; Calcium; Colchicine; Fingers; | 1964 |
HEMODIALYSIS FOR CHRONIC RENAL FAILURE. II. BIOCHEMICAL AND CLINICAL ASPECTS.
Topics: Anemia; Biochemical Phenomena; Biochemistry; Blood; Blood Pressure; Blood Urea Nitrogen; Calcium; Ch | 1965 |
THE TREATMENT OF CHRONIC RENAL FAILURE BY A MODIFIED GIOVANNETTI DIET.
Topics: Blood Chemical Analysis; Diet; Diet Therapy; Dietary Proteins; Glomerular Filtration Rate; Humans; K | 1965 |
Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Analysis of Variance; Cause of Death; China; Cohor | 2004 |
Direct detection of renal function markers using microchip CE with pulsed electrochemical detection.
Topics: Biomarkers; Creatine; Creatinine; Electrochemistry; Humans; Kidney; Kidney Failure, Chronic; Microch | 2004 |
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Topics: Adult; Aged; Cohort Studies; Female; Humans; Hyperuricemia; Kidney Failure, Chronic; Male; Mass Scre | 2004 |
[Rasburicase (Fasturtec)].
Topics: Crystallization; Glomerular Filtration Rate; Gout; Humans; Hyperuricemia; Kidney Failure, Chronic; K | 2004 |
Disturbances in renal autoregulation and the susceptibility to hypertension-induced chronic kidney disease.
Topics: Aging; Animals; Diabetes Mellitus; Disease Models, Animal; Endothelium, Vascular; Fetal Growth Retar | 2004 |
Changes in conjugated linoleic acid and palmitoleic acid are correlated to retinol levels in chronic renal failure in both hemodialysis and conservative treatment patients.
Topics: Adipose Tissue; Aged; Albumins; Cholesterol; Cholesterol, HDL; Chromatography, High Pressure Liquid; | 2005 |
Fatal drug reaction due to allopurinol therapy in a 72-year-old man.
Topics: Aged; Allopurinol; Epidermis; Fatal Outcome; Gout Suppressants; Humans; Kidney Failure, Chronic; Mal | 2005 |
An unusual patient with kidney stones composed of 1-methyluric acid.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Coffee; Humans; Kidney Calculi; Kidney Failure, | 2006 |
[Serum uric acid and C-reactive protein levels in patients with chronic kidney disease].
Topics: C-Reactive Protein; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Uric Acid | 2005 |
Concomitant polyarticular septic and gouty arthritis.
Topics: Aged; Arthritis, Gouty; Arthritis, Infectious; Fatal Outcome; Humans; Kidney Failure, Chronic; Male; | 2006 |
Excellent response to the clinical treatment of tophaceous gout.
Topics: Aged; Allopurinol; Benzbromarone; Glomerular Filtration Rate; Gout; Gout Suppressants; Humans; Kidne | 2007 |
Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Blood Glucose; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabetes Mellitus | 2007 |
Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE.
Topics: Allantoin; Chronic Disease; Electrophoresis, Capillary; Heart Diseases; Humans; Hypoxanthine; Kidney | 2007 |
Differences in postmortem urea nitrogen, creatinine and uric acid levels between blood and pericardial fluid in acute death.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asphyxia; Biomarkers; Blood Urea Nitrogen; Cerebrovascul | 2007 |
Phagocyte-derived oxidants and plasma antioxidants in haemodialysed patients.
Topics: Adult; Aged; Antioxidants; Bilirubin; Female; Free Radicals; Humans; Kidney Failure, Chronic; Lumine | 2007 |
Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Chromatography, High Pressure Liquid; Creatinin | 2007 |
[Renal manifestations in rheumatic diseases].
Topics: Amyloidosis; Diagnosis, Differential; Glomerulonephritis, IGA; Glomerulonephritis, Membranoprolifera | 2007 |
Sleep quality in patients with chronic renal failure: a 3-year longitudinal study.
Topics: Adult; Aged; Body Mass Index; Creatinine; Cross-Sectional Studies; Disease Progression; Female; Ferr | 2008 |
Laboratory and sonographic findings in dialyzed patients with bilateral chronic knee pain versus dialyzed asymptomatic patients.
Topics: beta 2-Microglobulin; Biomarkers; C-Reactive Protein; Humans; Kidney Failure, Chronic; Knee Joint; P | 2007 |
Determinants of urinary calcium and uric acid excretion in children after renal transplantation.
Topics: Adolescent; Adult; Biomarkers; Calcium; Child; Child, Preschool; Female; Hematuria; Humans; Immunosu | 2007 |
Experimental investigation and observations on the diuretic action of quinethazone.
Topics: Acetazolamide; Adult; Chlorides; Chlorothiazide; Creatine; Diuresis; Drug Synergism; Edema; Female; | 1966 |
Metastatic calcinosis cutis with renal hyperparathyroidism.
Topics: Adult; Blood Chemical Analysis; Calcinosis; Female; Humans; Hyperparathyroidism; Hypertension, Renal | 1967 |
[The importance of the lithiasis factor in chronic renal insufficiency in uricemia].
Topics: Female; Gout; Humans; Kidney Calculi; Kidney Failure, Chronic; Male; Middle Aged; Uric Acid | 1967 |
[Hypo-uricemic action of benzodiarone in chronic renal insufficiency].
Topics: Adolescent; Adult; Aged; Benzofurans; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ur | 1967 |
Interference in colorimetric reactions for measuring hydrogen peroxide.
Topics: Catalase; Colorimetry; Humans; Hydrogen Peroxide; Kidney Failure, Chronic; Renal Dialysis; Sarcosine | 1984 |
A new bedside hemodialysis monitor for both acetate and bicarbonate dialysis.
Topics: Acetates; Bicarbonates; Blood Urea Nitrogen; Creatinine; Dialysis Solutions; Humans; Kidney Failure, | 1983 |
Short-time peritoneal dialysis.
Topics: Creatinine; Electrolytes; Female; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Urea; | 1984 |
An orally administered microcapsule system for treating chronic renal failure patients.
Topics: Administration, Oral; Adsorption; Animals; Capsules; Creatinine; Digestive System; Dogs; Humans; Kid | 1984 |
Haemoperfusion in the treatment of chronic renal failure in patients on haemodialysis.
Topics: Adolescent; Adsorption; Adult; Charcoal; Creatinine; Female; Hemoperfusion; Humans; Kidney Failure, | 1984 |
[Prevention of calculus recurrence in impaired kidney function].
Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Calcium Phosphates; Electrolytes; Humans; Kidney; Ki | 1984 |
Transperitoneal solute movement in children.
Topics: Adolescent; Biological Transport; Blood Urea Nitrogen; Child; Child, Preschool; Creatinine; Humans; | 1983 |
Renal failure in infancy due to over-production of urate.
Topics: Allopurinol; Aortic Coarctation; Humans; Hypoxanthine Phosphoribosyltransferase; Infant; Kidney Fail | 1984 |
Effect of hyperosmolar peritoneal dialysis fluid on the elimination of small- and medium-molecular substances.
Topics: Adolescent; Adult; Blood Glucose; Creatinine; Humans; Kidney Failure, Chronic; Middle Aged; Osmolar | 1983 |
[Results of the determination of enteral calcium absorption and calcium kinetics with 47Ca in patients with chronic recurring urolithiasis].
Topics: Adult; Calcium; Calcium Oxalate; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; M | 1983 |
CAPD + hemoperfusion once a week in the management of children with end-stage renal disease.
Topics: Child; Creatinine; Female; Hemoperfusion; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis | 1983 |
[Compounds of low and medium molecular weight in the blood ultrafiltrate of patients with chronic renal failure].
Topics: Creatinine; Electrolytes; Humans; Kidney Failure, Chronic; Molecular Weight; Ultrafiltration; Urea; | 1983 |
A new approach to glomerular filtration.
Topics: Adult; Aged; Blood; Blood Proteins; Blood Urea Nitrogen; Creatinine; Electrolytes; Female; Humans; K | 1983 |
[When should hyperuricemia be treated?].
Topics: Gout; Hematologic Diseases; Humans; Kidney Failure, Chronic; Uric Acid; Urinary Calculi | 1984 |
Hemofiltration for long-term maintenance of patients with end stage renal disease: impact on hypertension.
Topics: Adult; Aged; Blood; Blood Pressure; Blood Urea Nitrogen; Blood Volume; Body Weight; Creatinine; Hema | 1980 |
Accelerated atherosclerosis in patients on maintenance dialysis.
Topics: Adult; Arteriosclerosis; Blood Platelets; Diabetes Mellitus; Female; Humans; Hypertension; Kidney Fa | 1980 |
Minor haemoglobin fractions in uraemic and in diabetic patients.
Topics: Adult; Bicarbonates; Blood Glucose; Creatinine; Diabetes Mellitus; Female; Glycated Hemoglobin; Glyc | 1981 |
Clinical disorders of uric acid metabolism.
Topics: Amidophosphoribosyltransferase; Diet; Gout; Humans; Hypoxanthine Phosphoribosyltransferase; Kidney; | 1981 |
Uric acid turnover in normals, in gout and in chronic renal failure using 14C-uric acid.
Topics: Carbon Radioisotopes; Gout; Humans; Kidney Failure, Chronic; Kinetics; Radioisotope Dilution Techniq | 1980 |
The effects of cimetidine (Tagamet) on renal function in patients with renal failure.
Topics: Adult; Aged; beta 2-Microglobulin; Calcium; Cimetidine; Creatinine; Female; Glomerular Filtration Ra | 1980 |
Chronic renal insufficiency (CRI) in urolithiasis.
Topics: Adolescent; Adult; Aged; Calcium Oxalate; Female; Glomerular Filtration Rate; Humans; Kidney Calculi | 1980 |
Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls.
Topics: Arthritis; Biopsy, Needle; Gout; Humans; Kidney Failure, Chronic; Metatarsophalangeal Joint; Neutrop | 1982 |
CAPD plus hemoperfusion once a week for end stage renal disease.
Topics: Adult; Charcoal; Creatinine; Female; Hemoperfusion; Humans; Kidney Failure, Chronic; Male; Peritonea | 1982 |
[Uricemia in long term dialysis].
Topics: Humans; Kidney Failure, Chronic; Renal Dialysis; Uric Acid | 1981 |
[When is hemofiltration indicated, in the treatment of renal insufficiency? (author's transl)].
Topics: Blood; Creatinine; Hemodynamics; Humans; Kidney Failure, Chronic; Renal Dialysis; Ultrafiltration; U | 1980 |
[Semi-continuous peritoneal dialysis - an advantageous modification of the peritoneal dialysis technic].
Topics: Adolescent; Adult; Aged; Creatinine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Per | 1981 |
Familial gout and renal failure.
Topics: Adult; Child; Creatinine; Female; Gout; Humans; Kidney Failure, Chronic; Male; Pedigree; Uric Acid | 1981 |
[Amino acid substitution with Infesol in chronically hemodialyzed children].
Topics: Adolescent; Amino Acids; Child; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Protein Defi | 1981 |
Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
Topics: Adult; Cholesterol; Creatinine; Evaluation Studies as Topic; Female; Hemoperfusion; Humans; Kidney F | 1981 |
[Effect of salmon calcitonin on urinary excretion in patients with chronic renal insufficiency (author's transl)].
Topics: Animals; Calcitonin; Creatinine; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance | 1981 |
[Attempt at normalizing the uricemia in gout].
Topics: Adolescent; Adult; Aged; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Gout; | 1980 |
Studies with allopurinol in patients with impaired renal function.
Topics: Allopurinol; Humans; Kidney; Kidney Failure, Chronic; Oxypurinol; Renal Dialysis; Uric Acid | 1980 |
Clinical features of 4,000 gouty subjects in Japan.
Topics: Adult; Age Factors; Female; Gout; Humans; Hypertension; Japan; Kidney Failure, Chronic; Male; Middle | 1980 |
[Epidemiology and clinical aspects of hyperuricemia and gout].
Topics: Aged; Alcohol Drinking; Blood Pressure; Body Weight; Diagnosis, Differential; Feeding Behavior; Gout | 1980 |
[Treatment of chronic kidney failure with carob gum].
Topics: Absorption; Creatinine; Gastrointestinal Agents; Humans; Kidney Failure, Chronic; Urea; Uric Acid | 1980 |
Capillary electrophoresis as a clinical tool. Determination of organic anions in normal and uremic serum using photodiode-array detection.
Topics: Anions; Electrophoresis, Capillary; Hippurates; Humans; Hypoxanthine; Hypoxanthines; Kidney Failure, | 1995 |
Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Blood Proteins; Cholesterol; Female; Humans; Kidney Failur | 1995 |
The decline in serum albumin after conversion to high flux, high efficiency dialysis.
Topics: Blood Urea Nitrogen; Cellulose; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Membranes, | 1994 |
Familial hyperuricemic nephropathy.
Topics: Adolescent; Adult; Child; Family Health; Female; Genes, Dominant; Gout; Humans; Hypertension; Kidney | 1995 |
Enhanced enteric excretion of urate in rats with chronic renal failure.
Topics: Animals; Biological Transport; Colon; Creatinine; Ileum; Intestinal Mucosa; Jejunum; Kidney Failure, | 1994 |
Body lead stores and urate excretion in men with chronic renal disease.
Topics: Adult; Arthritis, Gouty; Body Burden; Creatinine; Humans; Kidney Failure, Chronic; Lead; Male; Middl | 1994 |
Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobin.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Bicarbonates; Calcium; Creatinine; Diagnosis, D | 1993 |
Gouty arthritis in end-stage renal disease: clinical course and rarity of new cases.
Topics: Adult; Aged; Arthritis, Gouty; Chi-Square Distribution; Female; Humans; Kidney Failure, Chronic; Mal | 1994 |
[Role of aldosterone in essential arterial hypertension complicated by chronic renal insufficiency].
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Blood Pressure; Cations; Creatinine; Female; Humans; | 1993 |
Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure.
Topics: Adult; Aged; Allopurinol; Animals; Calcitriol; Calcium; DNA; Female; Humans; Kidney Failure, Chronic | 1993 |
Efficiency of hemodialysis of pyrimidine compounds in patients with chronic renal failure.
Topics: Adult; Aged; Allopurinol; Creatinine; Female; Half-Life; Humans; Kidney Failure, Chronic; Male; Midd | 1993 |
[A case of Down syndrome with chronic renal failure caused by long-term asymptomatic hyperuricemia].
Topics: Adult; Down Syndrome; Humans; Kidney Failure, Chronic; Male; Uric Acid | 1993 |
[Therapeutic effect of hemodialysis on gouty arthritis and tophi in 2 patients with chronic renal failure].
Topics: Adult; Aged; Arthritis, Gouty; Finger Joint; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; | 1993 |
Hereditary nephropathy associated with hyperuricemia and gout.
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Gout; Humans; Kidney; Kidney Failure, Chronic; | 1993 |
Stereoselective disposition of ibuprofen in patients with compromised renal haemodynamics.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Coronary Disease; Diabetes Mellitus; Female; Heart Fa | 1995 |
Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biological Trans | 1996 |
Effect of chronic experimental renal insufficiency on urate metabolism.
Topics: Animals; Erythropoietin; Intestinal Mucosa; Kidney; Kidney Failure, Chronic; Liver; Male; Nephrectom | 1995 |
Renal handling of urate in a patient with familial juvenile gouty nephropathy.
Topics: Adolescent; Benzbromarone; Female; Genes, Dominant; Gout; Gout Suppressants; Humans; Kidney; Kidney | 1996 |
New prescription of peritoneal dialysis: intermittent ambulatory peritoneal dialysis.
Topics: Aged; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Electrolytes; Female; Humans; Kidney | 1996 |
Abnormal antioxidant vitamin and carotenoid status in chronic renal failure.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Carotenoids; Cholesterol; Humans; Kidney Failure, Chronic; | 1996 |
[Structural-metabolic features of uremic gastroenteropathy].
Topics: Chronic Disease; Creatinine; Gastroenteritis; Glomerulonephritis; Humans; Kidney Failure, Chronic; P | 1996 |
Uricemia in hemodialyzed patients.
Topics: Adolescent; Adult; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Rheum | 1996 |
Purine metabolism in patients with gout: the role of lead.
Topics: Aged; Arteriosclerosis; Chelating Agents; Creatinine; Edetic Acid; Female; Gout; Humans; Hypoxanthin | 1997 |
Medical findings and predictors of long-term physical outcome in anorexia nervosa: a prospective, 12-year follow-up study.
Topics: Adolescent; Adult; Anorexia Nervosa; Body Weight; Cause of Death; Comorbidity; Creatinine; Female; F | 1997 |
Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Topics: Adolescent; Azathioprine; Biopsy; Chelating Agents; Child; Child, Preschool; Chromium Radioisotopes; | 1997 |
How should we treat tophaceous gout in patients with allopurinol hypersensitivity?
Topics: Adolescent; Adult; Aged; Allopurinol; Benzbromarone; Creatinine; Drug Hypersensitivity; Gout; Gout S | 1998 |
Severe debilitating polyarticular gout and terminal renal failure in an allopurinol 'non-responder'.
Topics: Adult; Allopurinol; Arthritis, Gouty; Combined Modality Therapy; Drug Resistance; Fatal Outcome; Gou | 1998 |
Apoptosis of tubular epithelial cells in familial juvenile gouty nephropathy.
Topics: Adult; Apoptosis; Benzbromarone; Biopsy; Biotin; Deoxyuracil Nucleotides; DNA Fragmentation; Family | 1998 |
Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Gout; Humans; Kidney Diseases; Kidney Failure, C | 1998 |
Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.
Topics: Aged; Antioxidants; Ascorbic Acid; Biomarkers; Female; Free Radical Scavengers; Glutathione Peroxida | 1999 |
Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Topics: Biological Transport; Capillaries; Creatinine; Cross-Sectional Studies; Dialysis Solutions; Endothel | 1999 |
Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis.
Topics: Aged; Animals; Blood Viscosity; Creatinine; Erythrocyte Deformability; Evaluation Studies as Topic; | 1999 |
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy.
Topics: Adolescent; Adult; Aged; Child; Female; Glomerulonephritis, IGA; Humans; Hypercholesterolemia; Hyper | 2000 |
Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients?
Topics: Adult; Aged; Aged, 80 and over; Crystallization; Cytokines; Cytological Techniques; Female; Gout; Hu | 2000 |
Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.
Topics: Aged; Analysis of Variance; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Case-Control Studi | 2000 |
[Bartter's syndrome with hyperuricemia and nephrocalcinosis].
Topics: Adult; Bartter Syndrome; Diagnosis, Differential; Disease Progression; Humans; Kidney Failure, Chron | 2000 |
Dehydroascorbic acid and oxidative stress in haemodialysis patients.
Topics: Aging; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Case-Control Studies; | 2001 |
[Bartter's syndrome with hyperuricemia].
Topics: Adult; Aldosterone; Bartter Syndrome; Child; Female; Humans; Hypokalemia; Kidney Failure, Chronic; P | 2001 |
High-throughput multi-analyte screening for renal disease using capillary electrophoresis.
Topics: Creatine; Creatinine; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Kidney Failure | 2001 |
Polyglucose dialysis solution induces changes in blood chemistry.
Topics: Blood Proteins; Blood Urea Nitrogen; Calcium; Creatinine; Dialysis Solutions; Glucans; Humans; Hydro | 2001 |
Partial hypoxanthine-Guanine phosphoribosyltransferase deficiency as the unsuspected cause of renal disease spanning three generations: a cautionary tale.
Topics: Adolescent; Erythrocytes; Humans; Kidney Failure, Chronic; Lesch-Nyhan Syndrome; Male; Nuclear Famil | 2002 |
[How to treat hyperuricemia and gout attacks in compensated kidney failure?].
Topics: Aged; Aged, 80 and over; Allopurinol; Glucocorticoids; Gout; Gout Suppressants; Humans; Kidney Failu | 2002 |
The evaluation of oxidative stress in patients with chronic renal failure.
Topics: Adult; Blood Urea Nitrogen; Creatinine; Dialysis; Female; Humans; Kidney Failure, Chronic; Male; Mal | 2002 |
Familial juvenile hyperuricaemic nephropathy in a Caucasian family associated with inborn malformations.
Topics: Adult; Austria; Child; Congenital Abnormalities; Creatinine; Female; Humans; Hyperuricemia; Kidney D | 2002 |
Uric acid and the kidney.
Topics: Acute Kidney Injury; Ammonia; Animals; Glomerular Filtration Rate; Glutamine; Gout; Humans; Hydrogen | 1976 |
Clinical and technical aspects of hemofiltration.
Topics: Blood Pressure; Blood Urea Nitrogen; Calcium; Creatinine; Filtration; Humans; Hydrogen-Ion Concentra | 1978 |
[Various clinical and physiopathological aspects of polycystic kidney].
Topics: Adolescent; Adult; Aged; Auditory Threshold; Female; gamma-Glutamyltransferase; Hearing Loss, Conduc | 1979 |
Hemofiltration, an alternative method for treatment of end-stage renal failure.
Topics: Creatinine; Diffusion; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Membranes, Artificial; | 1977 |
Renal failure secondary to leukemic infiltration of the kidneys.
Topics: Calcium; Creatinine; Female; Humans; Kidney Failure, Chronic; Kidney Neoplasms; Leukemia, Lymphoid; | 1977 |
[Ultraviolet spectrophotomerty studies of serum dialysate from patients with long term intermittent artificial kidney treatment].
Topics: Blood Urea Nitrogen; Creatinine; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Long-Term Car | 1977 |
Recessive X-linked hyperuricemia with gout and renal damage, normal activity of hypoxanthine phosphoribosyltransferase and resistance to azaguanine.
Topics: Adenine Phosphoribosyltransferase; Adolescent; Adult; Azaguanine; Azathioprine; Erythrocytes; Female | 1979 |
[Multiple myeloma of bones. Retrospective study of prognostic factors based on a series of 243 patients].
Topics: Adult; Aged; Alkylating Agents; Blood Cell Count; Blood Platelets; Calcium; Female; Hemoglobins; Hum | 1979 |
Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol.
Topics: Allopurinol; Gout; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors; | 1979 |
Measurement of peritoneal clearances in self-dialysis patients.
Topics: Ascitic Fluid; Biological Transport; Creatinine; Humans; Kidney Failure, Chronic; Methods; Middle Ag | 1979 |
[Blood and urine uric acid in chronic renal insufficiency].
Topics: Adolescent; Adult; Creatinine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Uremia; U | 1979 |
Long-term clinical assessment of combined ACAC hemoperfusion-ultrafiltration in uremia.
Topics: Blood Chemical Analysis; Capsules; Charcoal; Creatinine; Evaluation Studies as Topic; Hemoperfusion; | 1979 |
Azotaemia in severe head injury--central dysregulation or renal failure?
Topics: Brain; Brain Injuries; Creatinine; Humans; Kidney; Kidney Failure, Chronic; Urea; Uremia; Uric Acid | 1978 |
Use of diuretics in treatment of hypertension secondary to renal disease.
Topics: Adult; Aldosterone; Antihypertensive Agents; Creatinine; Female; Furosemide; Humans; Hydrochlorothia | 1978 |
[Treatment of chronic renal insufficiency by hemofiltration. Clinical experiences during the first year of utilization in Geneva].
Topics: Adult; Aged; Alkaline Phosphatase; Blood Urea Nitrogen; Calcium; Carbon Dioxide; Cholesterol; Creati | 1978 |
[Single-needle dialysis. Experiences at the Kidney Transplant Unit of the Clinical Hospital of the University of São Paulo Medical School].
Topics: Creatinine; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Needles; Phosphorus; Renal Dialysi | 1978 |
Some unusual features of gouty arthritis in females.
Topics: Adult; Age Factors; Aged; Black or African American; Female; Gout; Humans; Hypertension; Kidney Calc | 1977 |
[Mechanisms of action of benzbromarone. Study in 3 anephric subjects. Preliminary results in 3 cases].
Topics: Adult; Benzbromarone; Benzofurans; Glomerulonephritis; Humans; Hypertension, Renal; Kidney Failure, | 1977 |
[Clinical experiences with Nepross C-02 dialyzer].
Topics: Creatinine; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Phosphates; Renal Dialysis; Ultraf | 1977 |
[De novo purine biosynthesis. In vitro measurement in hyperuricemia (author's transl)].
Topics: Adult; Allopurinol; Azaserine; Carbon Radioisotopes; Female; Formates; Gout; Humans; In Vitro Techni | 1977 |
Controlled ultrafiltration (UF) with hemodialysis (HD): analysis of coupling between convective and diffusive mass transfer in a new HD-UF system.
Topics: Creatinine; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Methylmethacrylates; Renal Dialysi | 1977 |
Biological reactors for renal support.
Topics: Ammonia; Bacteria; Humans; Kidney Failure, Chronic; Male; Urea; Uric Acid; Urine | 1977 |
The gouty kidney.
Topics: Animals; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Gout; Humans; Kidney; Kidney C | 1977 |
[Secondary gout in chronic kidney failure].
Topics: Aged; Chronic Disease; Female; Gout; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Pye | 1976 |
Identification of beta-aminoisobutyric acid in uremic serum.
Topics: Aminoisobutyric Acids; Blood Urea Nitrogen; Chromatography, Gas; Chromatography, Ion Exchange; Chrom | 1976 |
[Determination of some biochemical indices of renal failure in the abdominal fluid and plasma in patients on peritoneal dialysis].
Topics: Ascitic Fluid; Electrolytes; Humans; Kidney Failure, Chronic; Peritoneal Dialysis; Potassium; Sodium | 1976 |
Hyperuricemia and renal failure-presenting manifestations of occult hematologic malignancies.
Topics: Adolescent; Anuria; Child; Gout; Humans; Kidney; Kidney Failure, Chronic; Leukemia; Leukemia, Monocy | 1976 |
Dialysate regeneration: 30-liter dialysate supply system with sorbents.
Topics: Adsorption; Blood Urea Nitrogen; Charcoal; Creatinine; Female; Guanidines; Humans; Kidney Failure, C | 1976 |
[Clinical study of LC 75 (Ampliuril pH) in the states of hyperuricemia].
Topics: Benzofurans; Carbonates; Coronary Disease; Diabetes Complications; Gout; Humans; Hypertension; Kidne | 1975 |
Origin and extrarenal elimination of uric acid in man.
Topics: Amidophosphoribosyltransferase; Dietary Proteins; Glutamine; Gout; Humans; Hypoxanthine Phosphoribos | 1975 |
Intrinsic renal disease leading to abnormal urate excretion.
Topics: Acute Kidney Injury; Gout; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Tubules; Metabol | 1975 |
Clincial performance characteristics of a new combined system for simulatenous hemoperfusion-hemodialysis-ultrafiltration in series.
Topics: Blood Urea Nitrogen; Creatinine; Evaluation Studies as Topic; Glomerulonephritis; Humans; Kidney Fai | 1975 |
Dietary management of patients in chronic renal failure.
Topics: Acid-Base Equilibrium; Administration, Oral; Amino Acids; Blood Urea Nitrogen; Carbon Dioxide; Creat | 1975 |
[Recurrent Urolithiasis during Childhood (author's transl)].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cystine; Czechoslovakia; Female; Focal Infection; | 1975 |
[Urolithiasis during childhood (author's transl)].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cystine; Female; Focal Infection; Humans; Infant; | 1975 |
Excretion of inhibitors of calcification in urine Part II. Findings in patients with chronic renal failure.
Topics: Adult; Animals; Calcification, Physiologic; Calcium; Cartilage; Chlorides; Circadian Rhythm; Creatin | 1975 |
[Problems in the conservative management of renal insufficiency using a strict protein-deficient diet (potato-egg diet)].
Topics: Blood Urea Nitrogen; Calcium; Creatine; Diet; Eggs; Humans; Kidney Failure, Chronic; Uric Acid; Vege | 1975 |
Gout, uric acid and renal disease.
Topics: Arthritis; Gout; Humans; Kidney Diseases; Kidney Failure, Chronic; Metabolic Diseases; Uric Acid | 1976 |
Study on the inhibitory effect of uremic plasma on lipoprotein lipase.
Topics: Adult; Chemical Fractionation; Creatinine; Female; Humans; Kidney Failure, Chronic; Lipoprotein Lipa | 1992 |
Short time treatment with high-efficiency paired filtration dialysis for chronic renal failure.
Topics: Adult; Aged; Anuria; beta 2-Microglobulin; Cardiovascular Diseases; Creatinine; Hemofiltration; Huma | 1992 |
Evaluation of hemodialysis efficiency by an edema fluid model.
Topics: Adult; Aged; Creatinine; Edema; Extracellular Space; Humans; Kidney Failure, Chronic; Middle Aged; R | 1992 |
[Metabolic disorder of purine nucleotide in patients with chronic renal failure].
Topics: Allopurinol; Humans; Hypoxanthine; Hypoxanthines; Kidney Failure, Chronic; Purine Nucleotides; Renal | 1992 |
Familial nephropathy and gout: which comes first?
Topics: Adult; Creatinine; Female; Gout; Humans; Hypoxanthine; Hypoxanthines; Kidney Diseases; Kidney Failur | 1991 |
Continuous intestinal dialysis for uraemia by intermittent oral intake of non-absorbable solutions. An experimental study.
Topics: Administration, Oral; Creatinine; Humans; Intestinal Mucosa; Kidney Failure, Chronic; Male; Mannitol | 1991 |
Female gout. Clinical spectrum and uric acid metabolism.
Topics: Adult; Age Factors; Diuretics; Female; Gout; Humans; Hypertension; Kidney Failure, Chronic; Male; Me | 1991 |
Decreased fractional excretion of urate as an indicator of prerenal azotemia.
Topics: Acute Kidney Injury; Aged; Diagnosis, Differential; Female; Humans; Kidney Failure, Chronic; Male; U | 1990 |
Acute hyperuricemic nephropathy and renal failure after transplantation.
Topics: Adult; Cyclosporins; Graft Rejection; Graft vs Host Disease; Humans; Kidney; Kidney Failure, Chronic | 1990 |
[Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
Topics: Adult; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; | 1990 |
Automated fructosamine assay with improved accuracy used to quantify nonenzymatic glycation of serum proteins in diabetes mellitus and chronic renal failure.
Topics: Adult; Autoanalysis; Azo Compounds; Blood Glucose; Blood Proteins; Child; Detergents; Diabetes Melli | 1990 |
Familial hyperuricemia and renal insufficiency.
Topics: Adolescent; Adult; Allopurinol; Gout; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Pedigr | 1990 |
Comparisons of peritoneal function between diabetic and nondiabetic patients with end stage renal disease.
Topics: Aged; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Midd | 1990 |
[Aplastic anemia probably induced by allopurinol in a patient with renal insufficiency].
Topics: Allopurinol; Anemia, Aplastic; Female; Humans; Kidney Failure, Chronic; Middle Aged; Uric Acid | 1990 |
[Determination of the uric acid content of the blood serum by high-performance liquid chromatography].
Topics: Calibration; Chromatography, High Pressure Liquid; Coronary Disease; Evaluation Studies as Topic; Hu | 1986 |
Amyloid urinary-tract calculi in patients on chronic dialysis.
Topics: Amyloid; Ascorbic Acid; beta 2-Microglobulin; Humans; Immunodiffusion; Kidney Failure, Chronic; Rena | 1989 |
The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
Topics: Adult; Aged; Calcium; Creatinine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Perito | 1989 |
[A new role of uric acid as an antioxidant in human plasma].
Topics: Allantoin; Antioxidants; Female; Free Radicals; Humans; Hydrogen Peroxide; Kidney Failure, Chronic; | 1989 |
[Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].
Topics: Creatinine; Electrolytes; Furosemide; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Per | 1989 |
[Fatal toxic epidermolysis following administration of allopurinol].
Topics: Aged; Allopurinol; Epidermolysis Bullosa; Gastrointestinal Hemorrhage; Humans; Kidney Failure, Chron | 1989 |
Hyperuricemia, gout, and autosomal dominant polycystic kidney disease.
Topics: Aged; Female; Gout; Humans; Hypoxanthine Phosphoribosyltransferase; Kidney Failure, Chronic; Male; M | 1989 |
[Allopurinol-induced kidney failure with hepatitis and squamous dermatitis in pre-existing kidney insufficiency].
Topics: Acute Kidney Injury; Aged; Allopurinol; Chemical and Drug Induced Liver Injury; Dermatitis, Exfoliat | 1987 |
Renal handling of uric acid under cyclosporin A treatment.
Topics: Azathioprine; Child; Cyclosporins; Drug Therapy, Combination; Humans; Kidney; Kidney Failure, Chroni | 1988 |
Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis.
Topics: Aged; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Theophyllin | 1988 |
[Uric acid concentrations of the kidney in primary gout].
Topics: Female; Gout; Humans; Kidney; Kidney Cortex; Kidney Failure, Chronic; Male; Middle Aged; Uric Acid | 1988 |
Evaluation and tolerance of a new polycarbonate membrane in elderly patients. Preliminary results.
Topics: Age Factors; Aged; Blood Gas Analysis; Complement C3; Complement C3a; Creatinine; Dental Cements; Ev | 1986 |
Intra-individual variation of some analytes in serum of patients with chronic renal failure.
Topics: Adult; Alkaline Phosphatase; alpha-Amylases; Blood Proteins; Calcium; Chlorides; Creatinine; Female; | 1987 |
Hyperuricemia and uric acid nephropathy.
Topics: Aged; Allopurinol; Female; Gout; Humans; Kidney Diseases; Kidney Failure, Chronic; Nephritis, Inters | 1987 |
Evaluation of the renal mechanisms for urate homeostasis in uremic patients by probenecid and pyrazinamide test.
Topics: Absorption; Creatinine; Female; Glomerular Filtration Rate; Gout; Homeostasis; Humans; Kidney Failur | 1987 |
[Clinical experience with a new uricolytic agent].
Topics: Adolescent; Adult; Aged; Female; Gout; Humans; Kidney Failure, Chronic; Male; Middle Aged; Urate Oxi | 1986 |
Frequency of intraarticular monosodium urate (MSU) crystals in asymptomatic hyperuricemic subjects.
Topics: Adult; Aged; Arthritis, Rheumatoid; Crystallization; Female; Humans; Joints; Kidney Failure, Chronic | 1986 |
Performance and biocompatibility of the FD 100 Gambrane hollow-fiber dialyzer.
Topics: Biocompatible Materials; Creatinine; Evaluation Studies as Topic; Humans; Kidney Failure, Chronic; P | 1986 |
Clinical evaluation of a flat plate dialyzer equipped with a polycarbonate polyether copolymer membrane.
Topics: Creatinine; Evaluation Studies as Topic; Female; Hemoglobins; Humans; Kidney Failure, Chronic; Kidne | 1986 |
Clinical investigation of the new dialyzer Gambro PRO-3.
Topics: Animals; Blood Pressure; Body Weight; Creatinine; Evaluation Studies as Topic; Female; Humans; Kidne | 1986 |
The Lundia Pro 5 dialyzer, a polycarbonate membrane dialyzer.
Topics: Blood Pressure; Body Weight; Creatinine; Evaluation Studies as Topic; Humans; Kidney Failure, Chroni | 1986 |
Allopurinol in renal failure and the tumour lysis syndrome.
Topics: Adult; Allopurinol; Child; Child, Preschool; Creatinine; Female; Humans; Infant; Kidney Failure, Chr | 1986 |
Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency.
Topics: Adult; Carnitine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Urea; | 1986 |
A continuous hemofiltration system using sorbents for hemofiltrate regeneration.
Topics: Adsorption; Blood; Creatinine; Electrolytes; Humans; Kidney Failure, Chronic; Male; Middle Aged; Tra | 1986 |
Short-term effect of 4% hypertonic glucose as compared to 4% mixed hypertonic mannitol solution in conventional peritoneal dialysis.
Topics: Adult; Aged; Blood Glucose; Blood Urea Nitrogen; Creatinine; Diabetic Nephropathies; Electrolytes; F | 1985 |
Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
Topics: Blood Pressure; Blood Urea Nitrogen; Body Weight; Calcium; Creatinine; Diuresis; Electrolytes; Furos | 1985 |
Influence of Bence-Jones proteins, hyperviscosity, hypercalcemia, hyperuricemia and dehydration on development of renal changes in plasma cell dyscrasias.
Topics: Acute Kidney Injury; Bence Jones Protein; Blood Viscosity; Dehydration; Female; Humans; Hypercalcemi | 1985 |
[Renal insufficiency and uric gout in a lead worker (clinicopathologic conference)].
Topics: Aged; Gout; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Lead Poisoning; Male; Myocardium; | 1985 |
Event-related potential changes during hemodialysis.
Topics: Calcium; Cognition; Electrolytes; Evoked Potentials, Auditory; Female; Humans; Kidney Failure, Chron | 1985 |
Gout and the kidney.
Topics: Allopurinol; Gout; Humans; Kidney Failure, Chronic; Uric Acid; Uricosuric Agents | 1968 |
[Hyperiminoaciduria and disaminoaciduria in endemic (Balkan-)nephropathy (author's transl)].
Topics: Adult; Aged; Alanine; Amino Acids; Chromatography, Thin Layer; Chronic Disease; Creatinine; Female; | 1974 |
Serum middle molecule levels in uremia during long term intermittent hemoperfusions with the acac (coated charcoal) microcapsule artificial kidney.
Topics: Adult; Blood Urea Nitrogen; Calcium; Charcoal; Creatinine; Electromyography; Humans; Kidney Failure, | 1974 |
[Kidney and central nervous system].
Topics: Blood-Brain Barrier; Coma; Creatinine; Guanidines; Humans; Kidney Failure, Chronic; Neurologic Manif | 1971 |
[Female gout. (Analysis of 40 cases)].
Topics: Adolescent; Adult; Aged; Child; Female; Gout; Humans; Kidney Failure, Chronic; Male; Middle Aged; Se | 1967 |
Extended hemodialysis in children with chronic renal failure.
Topics: Adolescent; Anemia; Blood Flow Velocity; Blood Urea Nitrogen; Body Weight; Calcinosis; Calcium; Chil | 1968 |
[Uric acid inhibitors in the treatment of gout. Apropos of 126 cases].
Topics: Adult; Aged; Allopurinol; Colchicine; Drug Synergism; Female; Gout; Humans; Kidney Calculi; Kidney F | 1970 |
A model of renal insufficiency in the chick.
Topics: Animals; Calcium; Chickens; Disease Models, Animal; Kidney Failure, Chronic; Ligation; Magnesium; Ma | 1972 |
Chronic lead nephropathy.
Topics: Adult; Bone and Bones; Chelating Agents; Child; Child, Preschool; Edetic Acid; Environmental Exposur | 1973 |
Dialysis schedule and peripheral neuropathy.
Topics: Adult; Appointments and Schedules; Blood Pressure; Body Weight; Creatinine; Female; Hematocrit; Huma | 1973 |
[Prevention of renal lithiasis].
Topics: Calcium; Cystinuria; Diet; Gout; Humans; Kidney; Kidney Calculi; Kidney Failure, Chronic; Metabolism | 1974 |
A model for evening home hemodialysis.
Topics: Adolescent; Adult; Blood Pressure; Blood Urea Nitrogen; Body Weight; Cobalt Radioisotopes; Creatinin | 1974 |
ASAHI hollow fiber kidney (ASAHI HFK) --- progress report.
Topics: Acid-Base Equilibrium; Anti-Bacterial Agents; Bicarbonates; Blood Cell Count; Blood Platelets; Blood | 1974 |
[Laboratory requirements in emergency and intermittent haemodialysis. The orders given by the clinician to the laboratory (author's transl)].
Topics: Acid-Base Equilibrium; Acute Kidney Injury; Anuria; Creatinine; Diagnosis, Differential; Humans; Kid | 1974 |
Serum uric acid in normal and hypertensive Australian subjects.
Topics: Adolescent; Adult; Age Factors; Australia; Child; Colorimetry; Debrisoquin; Female; Guanethidine; Hu | 1972 |
Laboratory data analysis system. IV. Multivariate diagnosis.
Topics: Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Cholecys | 1972 |
Nonhypercalcemic sarcoid nephropathy.
Topics: Adult; Blood Urea Nitrogen; Calcium; Creatinine; Fluorescent Antibody Technique; Humans; Isoniazid; | 1972 |
[Dialysis-free treatment of chronic kidney insufficiency].
Topics: Acidosis, Renal Tubular; Anemia; Anuria; Diet Therapy; Dietary Proteins; Drinking; Heart Diseases; H | 1974 |
Urography in renal failure: acid-base balance.
Topics: Acid-Base Equilibrium; Blood Urea Nitrogen; Carbon Dioxide; Contrast Media; Creatinine; Humans; Hydr | 1972 |
Indirect assessment of left ventricular function following hemodialysis in patients with chronic renal disease.
Topics: Adult; Blood Pressure; Blood Urea Nitrogen; Calcium; Cardiac Output; Creatinine; Female; Glomerulone | 1972 |
ACAC microcapsule artificial kidney for the long term and short term management of eleven patients with chronic renal failure.
Topics: Adult; Aged; Blood Flow Velocity; Capsules; Charcoal; Creatinine; Drug Compounding; Female; Heparin; | 1972 |
[Use of enzymatic uricolysis in the treatment of hyperuricemia of renal origin].
Topics: Gout; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis; Urate Oxidase; Uric | 1973 |
Hemodialysis in myelomatosis.
Topics: Acute Kidney Injury; Aged; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Multiple Myeloma; P | 1973 |
[Results of Allopurinol treatment in patients with hyperuricemia in chronic renal failure].
Topics: Adolescent; Adult; Allopurinol; Female; Humans; Kidney Failure, Chronic; Liver; Male; Middle Aged; U | 1973 |
Fluid secretion in isolated proximal straight renal tubules. Effect of human uremic serum.
Topics: Acetates; Aminohippuric Acids; Animals; Benzoates; Blood Urea Nitrogen; Creatinine; Female; Guanidin | 1973 |
[New, special preparations registered in Austria].
Topics: Austria; Benzofurans; Chemical Phenomena; Chemistry; Gout; Humans; Ketones; Kidney Failure, Chronic; | 1973 |
[Postdiuretic behavior of uric acid clearance following intravenous furosemide administration].
Topics: Furosemide; Glomerular Filtration Rate; Humans; Injections, Intravenous; Kidney Failure, Chronic; Ur | 1973 |
[Benzbromaron in the treatment of hyperuricemia].
Topics: Adult; Aged; Benzofurans; Humans; Ketones; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Uric | 1973 |
Uric acid and the kidney.
Topics: Aged; Allopurinol; Animals; Diabetes Mellitus; Gout; Humans; Hydrogen-Ion Concentration; Hypercholes | 1973 |
Primary and secondary renal failure in a total community (Tecumseh, Michigan): preponderance in the elderly and possible antecedent factors.
Topics: Age Factors; Aged; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Cholesterol; Coronary Disease | 1974 |
Erythrocytosis associated with chronic renal disease.
Topics: Adult; Biopsy; Blood Urea Nitrogen; Blood Volume Determination; Creatinine; Erythrocyte Count; Glome | 1974 |
[What sould be done for a high concentration of blood urea?].
Topics: Acute Kidney Injury; Anemia; Bone Diseases; Calcium; Cardiovascular Diseases; Creatinine; Gastrointe | 1974 |
The uptake of glycine-14C into the adenine and guanine of DNA and insoluble RNA of human leucocytes.
Topics: Adenine; Autoanalysis; Carbon Radioisotopes; Chromatography, Paper; DNA; Female; Glycine; Gout; Guan | 1974 |
Calcinosis cutis and renal failure.
Topics: Aluminum Hydroxide; Calcinosis; Calcium; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phospho | 1974 |
Salicylate-mediated increase in urate removal during hemodialysis: evidence for urate binding to protein in vivo.
Topics: Aspirin; Blood Proteins; Depression, Chemical; In Vitro Techniques; Kidney Failure, Chronic; Male; P | 1974 |
[Combination of allopurinol and benziodarone in prolonged treatment of hyperuricemia due to chronic renal insufficiency].
Topics: Adult; Allopurinol; Analysis of Variance; Benzofurans; Drug Combinations; Female; Humans; Kidney Fai | 1972 |
[Gout, diabetes mellitus and fatty liver].
Topics: Adult; Arteriosclerosis; Body Weight; Diabetes Complications; Fatty Liver; Female; Gout; Humans; Hyp | 1972 |
Uric acid in advanced renal failure.
Topics: Absorption; Adult; Allopurinol; Biological Transport; Chronic Disease; Glomerular Filtration Rate; H | 1972 |
[Is there a specific glomerulitis associated with gouty hyperuricemia? A case].
Topics: Glomerulonephritis; Gout; Humans; Kidney Failure, Chronic; Male; Middle Aged; Uric Acid | 1971 |
[Renal clearance of uric acid in chronic renal insufficiency].
Topics: Acid-Base Equilibrium; Adult; Creatinine; Female; Humans; Hydrogen-Ion Concentration; Kidney; Kidney | 1971 |
[Physiopathology and treatment of hyperuricemia and gout].
Topics: Acidosis; Acute Disease; Gout; Humans; Kidney Failure, Chronic; Orotic Acid; Purines; Urate Oxidase; | 1971 |
[Hyperuricemia induced by diuretics in hypertensive patients. Curative and preventive treatment with benziodarone].
Topics: Adult; Benzofurans; Diuretics; Female; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle A | 1971 |
Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane-coated activated charcoal.
Topics: Adsorption; Aged; Blood Flow Velocity; Blood Platelets; Capsules; Charcoal; Creatinine; Embolism; Fe | 1971 |
Clinical maintenance hemodialysis with a sorbent-based, low-volume dialysate regeneration system.
Topics: Adsorption; Adult; Blood Pressure; Blood Urea Nitrogen; Calcium; Carbon; Chlorides; Creatinine; Hema | 1971 |
Clinical evaluation of disposable kiil envelope insert.
Topics: Adult; Creatinine; Hemodialysis, Home; Humans; In Vitro Techniques; Kidney Failure, Chronic; Kidneys | 1971 |
Allopurinol in treatment of patients with gout and chronic renal failure.
Topics: Adult; Aged; Allopurinol; Female; Gout; Humans; Hypoxanthines; Kidney Failure, Chronic; Kidney Funct | 1967 |
[Diagnostic value of hyperuricemia].
Topics: Adult; Allopurinol; Child; Diabetes Mellitus; Female; Glycogen Storage Disease; Gout; Humans; Hypert | 1968 |
[Changes in the Achilles tendon reflex time in patients with kidney insufficiency].
Topics: Achilles Tendon; Humans; Kidney Failure, Chronic; Potassium; Reflex, Stretch; Thyroid Diseases; Uric | 1966 |
The relative contributions of tubular reabsorption and secretion to urate excretion in lead nephropathy.
Topics: Absorption; Adult; Female; Glomerular Filtration Rate; Gout; Humans; Insulin; Kidney Failure, Chroni | 1971 |
[Apparently primary kidney disease revealing latent error of purine metabolism in 2 adolescents].
Topics: Adolescent; Adult; Allopurinol; Diet Therapy; Diet, Sodium-Restricted; Diuretics; Gout; Humans; Kidn | 1969 |
[Effects of intravenous administration of a lipid emulsion in patients with acute and chronic renal insufficiency].
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Creatinine; Female; Humans; Kidney Failure, Chronic; L | 1969 |
[A new uricemia-lowering agent: benziodarone. Its use in therapy of urate retention in the course of chronic renal insufficiency].
Topics: Benzofurans; Humans; Kidney Failure, Chronic; Uric Acid; Uricosuric Agents; Vasodilator Agents; Xant | 1969 |
[Gout and hyperuricemia associated with lead poisoning].
Topics: Adult; Glomerular Filtration Rate; Gout; Humans; Kidney Failure, Chronic; Kidney Tubules; Lead Poiso | 1969 |
[Therapy of chronic kidney failure].
Topics: Creatinine; Diet Therapy; Diet, Sodium-Restricted; Dietary Proteins; Humans; Hypertension; Kidney Fa | 1969 |
[Guidelines for therapy with diuretics].
Topics: Alkalosis; Carbohydrate Metabolism; Diuretics; Drug Synergism; Glaucoma; Humans; Hypertension; Hypok | 1970 |
[Renal excretion of uric acid in various conditions inducing hyperuricemia].
Topics: Adolescent; Adult; Aged; Female; Gout; Humans; Hydrochlorothiazide; Hypertension, Renal; Kidney Fail | 1970 |
The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney.
Topics: Albumins; Animals; Biomedical Engineering; Blood Flow Velocity; Calcium; Charcoal; Creatinine; Dogs; | 1970 |
Mannitol osmotic diuresis in patients with chronic renal failure.
Topics: Adolescent; Adult; Aged; Bicarbonates; Creatinine; Diuresis; Female; Glomerular Filtration Rate; Hum | 1970 |
Implications of dietary therapy.
Topics: Animals; Creatinine; Diet Therapy; Dietary Proteins; Dogs; Glucose; Guanidines; Humans; Hydrogen-Ion | 1970 |
Clinical survey of 354 patients with gout.
Topics: Adolescent; Adult; Age Factors; Aged; Alcohol Drinking; Blood Urea Nitrogen; Body Weight; Child; Com | 1970 |
[Technic of determination of serum allantoin and study of the action of uricase].
Topics: Allantoin; Humans; Hydantoins; Indicators and Reagents; Kidney Failure, Chronic; Methods; Urate Oxid | 1970 |
[Benziodarone therapy in hyperuricemia in the aged].
Topics: Age Factors; Aged; Cardiovascular Diseases; Gout; Humans; Kidney Failure, Chronic; Respiratory Insuf | 1970 |
Triglyceride concentrations in primary gout and gout of chronic lead nephropathy.
Topics: Adult; Aged; Alcoholic Beverages; Cholesterol; Gout; Humans; Kidney Failure, Chronic; Lead Poisoning | 1971 |
[The kidney and hyperuricemia].
Topics: Diuretics; Gout; Humans; Kidney Calculi; Kidney Diseases; Kidney Failure, Chronic; Kidney Function T | 1971 |
Acute effects of high doses of frusemide in patients with chronic renal failure.
Topics: Acid-Base Equilibrium; Bicarbonates; Creatinine; Furosemide; Humans; Hydrogen; Kidney Failure, Chron | 1971 |
High dose frusemide in the treatment of hypertension in chronic renal insufficiency and of terminal renal failure.
Topics: Adolescent; Adult; Creatine; Creatinine; Diuresis; Female; Furosemide; Gout; Humans; Hypertension, R | 1971 |
[Study of the hypouricemic effect of benziodarone in chronic renal insufficiency].
Topics: Benzofurans; Female; Humans; Kidney Failure, Chronic; Male; Uremia; Uric Acid; Uricosuric Agents | 1967 |
[Ethacrynic acid: research on the mechanism of action and clinical use].
Topics: Adolescent; Adult; Aged; Child; Diabetes Insipidus; Diuresis; Edema; Ethacrynic Acid; Female; Heart | 1968 |
[Secondary gout, 6-years after acute renal failure].
Topics: Accidents, Traffic; Acute Kidney Injury; Adult; Blood Pressure; Creatinine; Electrolytes; Erythrocyt | 1968 |
Major surgery in patients on maintenance hemodialysis.
Topics: Adolescent; Adult; Electrocardiography; Humans; Hypertension, Renal; Kidney Failure, Chronic; Middle | 1968 |
Renal urate deposits in chronic renal insufficiency.
Topics: Adult; Aged; Gout; Humans; Kidney; Kidney Failure, Chronic; Male; Uric Acid | 1968 |
[Secondary gout, 6 years after acute renal failure].
Topics: Accidents, Traffic; Acute Kidney Injury; Adult; Blood Pressure; Creatinine; Electrolytes; Erythrocyt | 1968 |
Nephropathy in chronic lead poisoning.
Topics: Adult; Chronic Disease; Colic; Creatinine; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Ki | 1968 |
[Clinico-metabolic effects induced by the administration of concentrated liver extract in chronic uremia].
Topics: Adolescent; Adult; Aged; Creatinine; Diet Therapy; Electrolytes; Female; Humans; Kidney Failure, Chr | 1968 |
[1st results with the use of a new plate dialyzer with optimum flow control].
Topics: Acute Kidney Injury; Chronic Disease; Creatinine; Glomerulonephritis; Humans; Kidney Failure, Chroni | 1968 |
Determination of uric acid levels in uraemia by enzymatic and colorimetric techniques.
Topics: Acute Kidney Injury; Colorimetry; Gout; Humans; Kidney Failure, Chronic; Methods; Phosphotungstic Ac | 1968 |
[Allopurinol in the treatment of gout: initial results].
Topics: Adult; Aged; Allopurinol; Female; Gastrointestinal Diseases; Gout; Humans; Kidney Failure, Chronic; | 1968 |
A new cuprophan no-prime disposable cartridge dialyzer.
Topics: Blood Urea Nitrogen; Chlorides; Creatinine; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Me | 1968 |
[Phosphate and uric acid transport in terminal kidney failure].
Topics: Biological Transport; Humans; Kidney; Kidney Failure, Chronic; Phosphates; Uric Acid | 1968 |
Nyhan-Lesch syndrome and juvenile gout (2 cases).
Topics: Adult; Child, Preschool; Deficiency Diseases; Gout; Guanine; Humans; Hypoxanthines; Kidney Failure, | 1968 |
[Value of determination of uric acid in urine in the diagnosis of renal insufficiency].
Topics: Acute Kidney Injury; Chronic Disease; Creatinine; Diagnosis, Differential; Humans; Kidney Diseases; | 1968 |
[Allopurinol: its clinical use].
Topics: Adult; Aged; Allopurinol; Child; Diuretics; Female; Gout; Humans; Kidney Diseases; Kidney Failure, C | 1968 |
[Prolonged allopurinol therapy in chronic renal insufficiency].
Topics: Adult; Aged; Allopurinol; Creatinine; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Ni | 1968 |
[Uric acid-urea relationship in blood plasma (index), its significance in the early diagnosis of renal insufficiency and its application in general pathology].
Topics: Adult; Aged; Blood Urea Nitrogen; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Uric A | 1968 |
[Physiopathological and clinical aspects of renal insuffic- iency].
Topics: Acute Kidney Injury; Carbohydrate Metabolism; Electrolytes; Hemodynamics; Humans; Kidney Failure, Ch | 1969 |
Comparison of urinary phosphate, urate and magnisium excretion following parathyroid hormone administration to normal man.
Topics: Adult; Female; Humans; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Parathyroid Hormone; P | 1969 |
[First experiences with the cuprophane coil ExO1].
Topics: Blood Urea Nitrogen; Creatinine; Filtration; Humans; Kidney Failure, Chronic; Kidneys, Artificial; M | 1969 |
Crystal-induced inflammation associated with chronic renal failure treated with periodic hemodialysis.
Topics: Antacids; Apatites; Arthritis; Calcinosis; Calcium; Colchicine; Hand; Humans; Joint Diseases; Kidney | 1969 |
The effect of peritoneal dialysis upon the amino acids and other nitrogenous compounds in the blood and dialysates from patients with renal failure.
Topics: Adult; Amino Acids; Aspartic Acid; Butyrates; Creatinine; Diet Therapy; Female; Glutamates; Glycine; | 1969 |
[Secondary gout in renal insufficiency].
Topics: Adult; Blood; Glomerulonephritis; Gout; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Fun | 1965 |
[Trial treatments of hyperuricemia in patients with chronic renal failure. I. Action of benziodarone].
Topics: Blood; Furans; Gout; Humans; Kidney Diseases; Kidney Failure, Chronic; Uremia; Uric Acid; Vasodilato | 1966 |
Allopurinol in thiazide-induced hyperuricaemia.
Topics: Allopurinol; Clopamide; Enzyme Therapy; Gout; Hematologic Diseases; Humans; Hypertension; Kidney Fai | 1966 |
Allopurinol in patients with impaired renal function.
Topics: Adolescent; Adult; Aged; Allopurinol; Child; Creatine; Enzyme Therapy; Female; Gout; Humans; Hydroge | 1966 |
Allopurinol therapy of gout with renal complications.
Topics: Adult; Allopurinol; Calcium; Creatine; Enzyme Therapy; Gout; Humans; Kidney Failure, Chronic; Male; | 1966 |
Automated peritoneal dialysis: analysis of several methods of peritoneal dialysis.
Topics: Automation; Creatine; Humans; Kidney Failure, Chronic; Peritoneal Dialysis; Urea; Uric Acid | 1966 |
Elevation of the concentration of plasma oxalic acid in renal failure.
Topics: Chromatography, Gel; Creatine; Humans; Kidney Failure, Chronic; Oxalates; Renal Dialysis; Urea; Uric | 1966 |
[On dialysis therapy of chronic kidney failure].
Topics: Adult; Blood Pressure; Blood Proteins; Body Weight; Calcium; Chlorides; Electrocardiography; Female; | 1966 |